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ABSTRACT 
 
With the rising obesity and the increasing age of the population, a large proportion of 
patients who undergo Total Knee Arthroplasty (TKA) are obese. Knowing the health 
risks associated with obesity, it is important to determine if the outcomes of a TKA is 
compromised in obese patients. 
Significant discrepancies in the findings of previous studies assessing the effect of body 
mass index (BMI) on TKA outcomes were observed in a literature review, thus making it 
difficult to confirm an effect of obesity measured as BMI on the outcomes after TKA. 
This thesis comprises two studies which further explored the effects of BMI and other 
body composition measures on the outcome of TKA.  
1. The aim of a retrospective epidemiological study was to assess the effect of BMI on 
patient reported outcomes after TKA. 
2. The aim of the prospective cohort study was to assess the effect of body composition, 
measured by waist circumference (WC), waist to hip ratio (WHR), bioelectrical 
impedance analysis (BIA), ultrasonography (US) and BMI, on patient reported outcomes 
after TKA.  
It was concluded from these two studies that group division of obesity based on the 
classification of BMI greater or less than 30 kg/m
2
 could not identify an effect of obesity 
on outcomes. However, on using BMI as a continuous variable, an adverse effect of BMI 
on knee function and overall physical health was evident for higher BMI ranges. Body 
composition measures of BIA and US did not detect an effect of obesity for any 
outcomes. Effect of obesity detected by BMI and WC was similar. 
The negative association of BMI and outcomes observed was very weak across BMI 
ranges of 25-30 kg/m
2
and a significant association was achieved due to poorer patient 
reported physical function (indicated by Short Form 12 and Oxford Knee Score 
questionnaires) in some cases with very high BMI values (> 40 kg/m
2
). In addition to this 
finding, the lack of group difference when outcomes were evaluated across a BMI of 30 
kg/m
2
in the two studies and the disparity between studies in the results when using a BMI 
classification of 30 kg/m
2
 supported the conclusion that a BMI classification across a cut-
off value of 30 kg/m
2
 does not predict a poor result in obese after TKA.  
However, because of the limited number of highly obese (> 35kg/m
2
) participants in both 
studies of the thesis and often in previous studies, no definite conclusions regarding the 
effect of higher obesity levels on the outcome of TKR can be drawn from the studies in 
this thesis. Adequately powered future studies with more morbidly obese participants 
could give more definitive answers to the effect of BMI and other measures of body 
composition on outcomes following TKA. 
LIST OF KEYWORDS: Obesity, Total Knee Arthroplasty, Outcomes, Body Mass Index, Body 
composition.   
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INTRODUCTION TO THESIS 
 
 
The prevalence of obesity and overweight in the general population is rising worldwide 
and one of the common and disabling problems secondary to obesity is the development 
and progression of osteoarthritis. Large scale studies such as the Farmingham study 
(Felson et al. 1988), studies by Lohmander et al. (2009) and Wang et al. (2009) among 
others have found evidence of a strong positive association of obesity with the risk of 
knee osteoarthritis and the progression of the disease to a stage where a total knee 
arthroplasty is required.  
Not surprisingly, with the increased prevalence of obesity and the increasing age of the 
population, impact of obesity on the progression of osteoarthritis is such that the 
proportion of obese patients undergoing TKA is high and is increasing over the years. 
Total knee arthroplasty is one of the most widely performed surgical operations and has a 
high success rate in improving the function and quality of life in patients with knee 
osteoarthritis. With the known risk of obesity with surgical complications, operative 
difficulties, whether or not the success in improving joint function and patient’s quality of 
life by TKA is affected by obesity such that obese patients are predisposed to adverse 
outcomes, has been a topic of much debate. There have been doubts regarding the safety, 
prudence and cost effectiveness of total knee arthroplasty in obese patients. Moreover, it 
has been reported that obese patients present for total knee arthroplasty at a younger age 
(Namba et al. 2005;Kulkarni et al. 2011).  Obesity at a younger age combined with the 
increasing life span of the population would imply that obese patients would have a 
greater chance in the longer term of having a revision surgery which are technically and 
economically more demanding procedures. 
Considering these perceived risks and cost implications, obese patients are specifically 
advised and informed of the possibility of an increased risk of complications and possible 
poor outcomes. In some health care trusts, patients are encouraged to lose weight prior to 
14 
 
surgery, for example, in the Oxfordshire NHS trust, patients with BMI 35-40 kg/m
2
 are 
advised to join a weight loss programme and for patients with BMI >40kg/m
2
, it is 
mandatory to undergo a weight loss programme.  
Obesity in the U.K. has been found to be more prevalent in the lower socio-economic 
groups (National Obesity Observatory 2010) and for these patients’ weight loss and 
access to a weight loss programmes are more challenging. If patients are advised to join a 
weight loss programme prior to surgery, waiting time before surgery would increase 
during which their osteoarthritic disability is likely to further increase. With increasing 
financial pressures, some primary care trusts have proposed barring of total knee 
arthroplasty procedures in obese with BMI >30 kg/m
2
 (Davis and Porteous 2007). 
Previous research on the effect of obesity on success or results of total knee arthroplasty 
has been inconclusive due to considerable differences between the findings of the studies. 
Some studies have found comparable results of the surgery between obese and non-obese 
(Stickles et al. 2001; Amin et al. 2006, Nunez et al. 2010), while others have shown 
evidence for compromised results of the surgery in obese (Foran et al. 2004a; Foran et 
al.; 2004b; Jackson et al. 2009; Dowsey et al. 2010). The two main aspects in a research 
evaluating the effects of obesity on TKA outcomes are; how obesity is defined and how 
outcomes are measured. A range of outcomes that are both assessed by the investigator 
and reported by patients have been employed to define outcomes in studies. In the early 
studies in this area, outcomes have been primarily measured by the investigator. The 
recognition of the importance of patient perceived outcomes in providing a complete 
picture of the results has led to the assessment of obese and non-obese patients’ 
perception of the outcomes of their total knee arthroplasty.  
Definition of obesity in the literature assessing TKA outcomes in obese patients so far 
has been based on body weight and body mass index (BMI). However, the association 
between obesity and a joint with osteoarthritis has been shown to be more complex than 
just as function of body weight and body mass. Since measures of body weight and BMI 
are limited in their assessment of true obesity or adiposity, it still remains to be explored 
if other aspects of body composition show any effect on TKA outcomes.  
15 
 
Therefore, the current thesis addresses the following two main research questions: 
1. Does obesity as estimated by body mass index affect total knee arthroplasty 
outcomes? 
2. Does obesity measured by a range of body composition measurement methods in 
addition to body mass index affect total knee arthroplasty outcomes? 
These research questions have been approached in this thesis in the following three parts: 
1. Literature review, with the aim: to critically evaluate previous research studies 
assessing the effect of obesity on total knee arthroplasty outcomes and derive 
conclusion from the evidence regarding the effect of BMI on post-operative 
complications, joint function, overall physical function and prosthetic longevity 
after total knee arthroplasty. 
2. Retrospective epidemiological study, with the aim: to evaluate the effect of BMI 
on the clinical and patient perceived outcomes for up to one year following a total 
knee arthroplasty. 
3. Prospective cohort study, with the aim: to evaluate the effect of obesity as 
measured by five body composition measurement methods on the clinical and 
patient perceived outcomes for up to one year following a total knee arthroplasty. 
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OVERVIEW OF THE CHAPTERS 
 
 
Chapter one provides a summary of the background literature on osteoarthritis and weight 
loss as an intervention for the treatment of osteoarthritis. The majority of people 
undergoing TKA have an underlying diagnosis of osteoarthritis and only small 
percentages in both studies were diagnosed with rheumatoid arthritis. 
Chapter two provides a summary of the background literature on total knee arthroplasty 
as an intervention for treating end stage knee disease and its prevalence. The chapter 
discusses the outcomes after surgery and the instruments used to measure these 
outcomes.  
Chapter three discusses the literature assessing the association of obesity with knee 
osteoarthritis and provides a brief overview of the prevalence of obesity in the general 
population and among total knee arthroplasty patients and methods of measurement of 
body composition.  
Chapter four presents the literature review of the effect of obesity on total knee 
arthroplasty outcomes. This includes the background to the literature review, evaluation 
of previous studies to assess the effect of body mass index on post-operative 
complications, functional outcomes and prosthetic longevity and finally, conclusions of 
the literature review. Discussions of other factors which may be associated with obesity 
and may have an effect on outcomes are also given in this chapter. 
Chapter five presents the retrospective epidemiological evaluation of the effect of body 
mass index on clinical outcomes (post-operative complications); patient perceived knee 
function (measured by oxford knee score questionnaire) and patient perceived quality of 
life (measured by Short Form 12 health survey) at six months and one year after total 
knee arthroplasty. The chapter includes a background and aim of the study, methods 
followed to acquire data, analysis and reporting of the results and a discussion of the 
findings. 
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Chapter six (methods) seven (inter and intra-rater reliability of the measurement of fat 
thickness and intra-rater reliability of the measurement of body fat percentage) and eight 
(results and discussion) present the prospective cohort study assessing the effect of 
various measures of body composition on the clinical and functional outcomes after 
TKA. The body composition measures are body mass index, waist circumference, waist 
to hip ratio, fat percentage as measured by bioelectrical impedance analysis, and fat 
thickness as measured by ultrasonography.). Clinical and functional outcomes, post-
operative complications; patient perceived knee function (measured by oxford knee score 
questionnaire), patient perceived quality of life (measured by Short Form 12 health 
survey), pain perception (measured by visual analogue pain scale) were assessed at six 
weeks, six months and one year after total knee arthroplasty.  
Chapter nine integrates and summarizes the main findings of the thesis, implications of 
the findings, future research suggestions and the conclusion of the thesis. 
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CHAPTER 1: OSTEOARTHRITIS 
 
 
1.1. Chapter Overview 
 
This chapter begins with the definitions of osteoarthritis followed by the current 
prevalence of knee osteoarthritis, its clinical features and impairment of function caused 
by osteoarthritis. Etiology of osteoarthritis is then discussed followed by current opinions 
with regard to the treatment of osteoarthritis. Finally, a section on weight loss as an 
intervention for knee osteoarthritis is presented. 
 
 
1.2. Defining Osteoarthritis 
 
Early definitions of osteoarthritis (OA) in 1904 by Goldthwaite describe it as bone 
hypertrophy with focal cartilage damage to allow differentiation of osteoarthritis from 
other forms of arthritis (McAlindon and Dieppe 1989). Since then, there have been 
multiple definitions of osteoarthritis, and these definitions can be based around clinical 
features, pathological findings or radiographic features (Spector et al. 1993). While 
clinically it may be known what constitutes osteoarthritis, there is a lack of general 
consensus on a precise definition of osteoarthritis for epidemiologic and outcomes studies 
(Spector et al. 1993; Lanyon et al. 1998). A definition of osteoarthritis encompassing all 
of its three main domains of pain, disability and structural changes is difficult because of 
the lack of agreement between these domains (Lanyon et al. 1998). This lack of 
association seen between the structural changes (as assessed by radiography) and 
symptoms experienced by the patient is striking. For example, a recent systematic review 
of the discordance between clinical (symptomatic) and radiographic knee osteoarthritis 
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found that, in those with radiographic changes of osteoarthritis, the proportion of patients 
experiencing pain ranged from 15% - 81%, while, 15% - 76% of those with knee pain 
were found to have radiographic changes of osteoarthritis (Bedson and Croft 2008).  
Thus, osteoarthritis can be asymptomatic and the association between the joint 
anatomical changes and the symptoms is weak. Furthermore, the association between the 
progression of structural changes and the changes in symptom is also weak (Brandt 
2009). 
A more inclusive definition developed recently by a panel of experts is as follows: 
‘OA diseases are a result of both mechanical and biological events that destabilise 
the normal coupling of degradation and synthesis of articular cartilage 
chondrocytes and extracellular matrix and subchondral bone. Although they may 
be initiated by multiple factors, including genetic, developmental, metabolic and 
traumatic, OA diseases involve all the tissues of the diarthrodial joint. Ultimately 
OA diseases are manifested by morphologic, biochemical, molecular and 
biomechanical changes of both cell and matrix which lead to softening, 
fibrillation, ulceration, loss of articular cartilage, sclerosis, eburnation of 
subchondral bone, osteophytes and subchondral cysts. When clinically evident, 
OA diseases are characterised by joint pain, tenderness, limitation of movement, 
crepitus, occasional effusion and variable degrees of inflammation without 
systemic effects.’ 
(Kuettner and Goldberg 1995, cited in Sharma and Kapoor 2007, pp. 3) 
Brandt (2009) however argues that the above definition gives a general emphasis on joint 
damage and particular indication to articular cartilage loss but fails to recognize that 
osteoarthritis represents the joints attempt to repair the damage cause by local 
biomechanical problems. Brandt (2009) defines osteoarthritis as the failure of the joint 
caused due to mechanical stress on the joint tissues. Due to this mechanical abnormality, 
the body’s innate mechanism to repair the damaged tissue is ineffective. 
Based on evidence to date, the latest consensus on defining osteoarthritis has further 
evolved to: 
‘OA is usually a progressive disease of synovial joints that represents failed repair 
of joint damage that results from stresses that may be initiated by an abnormality 
in any of the synovial tissues, including articular cartilage, subchondral bone, 
ligaments, menisci (when present), periarticular muscles, peripheral nerves or 
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synovium. This ultimately results in breakdown of cartilage and bone, leading to 
symptoms of pain stiffness and functional disability. Abnormal intra-articular 
stress and failure of repair may arise as results of biomechanical, biochemical 
and/or genetic factors.’ 
(Lane et al. 2011). 
 
 
1.3. Osteoarthritis signs and symptoms 
 
1.3.1 Prevalence 
Osteoarthritis is one of the leading causes of disability especially in the elderly (Peat et al. 
2001). The above discussed discordance between symptoms and structural changes of 
osteoarthritis also affect the estimation of prevalence of osteoarthritis. Peat et al. (2001) 
in their review of the community burden of knee osteoarthritis point out that this need for 
distinction between radiographic changes and symptoms is evident from the results of 
population surveys such that 50% of the individuals with knee osteoarthritis shown by 
radiographic evidence had no knee pain. Moreover, in 50% of those who complained of 
knee pain, no definite radiographic evidence of OA was seen. Thus, prevalence of 
osteoarthritis would depend much on how osteoarthritis is defined i.e., if the population 
prevalence estimates are based on pain, disability and/or radiographic changes. 
The prevalence of osteoarthritis does have a striking correlation with age such that 
regardless of the definition of osteoarthritis it is highly uncommon under the age of 40 
years and highly prevalent after 60 years of age (Felson 2003). Current data on knee 
osteoarthritis in the United Kingdom show that one in every five persons between the 
ages of 50-59 years has painful knee osteoarthritis and this increases to one in every two 
persons with painful knee osteoarthritis in persons above the age of 80 years, thus clearly 
showing an increasing prevalence with age (Arthritis Research U.K. 2008).  
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A higher prevalence of knee osteoarthritis has been seen in women and the gender 
disparity rises with increasing age and is suggested to be consistent with the role of post-
menopausal hormone deficiency (Felson 2003)  
 
1.3.2 Clinical features 
Plain radiography is considered the gold standard in imaging for osteoarthritis. 
Radiography has the advantage that high resolution images in weight bearing position can 
be easily obtained (Bijlsma et al. 2011). 
The radiographic criteria for OA proposed by Kellgren and Lawrence (1957) were 
accepted by the World Health Organization (WHO) in 1961 as the standard for 
radiographic grading of osteoarthritis and have since been used widely for 
epidemiological studies (Altman et al. 1986; Bijlsma et al. 2011). The Kellgren and 
Lawrence scale focuses on the following radiographic features of osteoarthritis: 
osteophyte formation, joint space narrowing, and bone sclerosis. Combinations of these 
changes were considered to develop an ordinal scale to grade the severity of osteoarthritis 
(Bijlsma et al. 2011). Limitations of this grading have been noted since, the primary 
being that no weight bearing positions were used for knee radiographs thus limiting the 
accurate assessment of the degree of joint space narrowing. Several groups since have 
developed reliable grading schema for the knee, in an attempt to overcome these 
limitations of a global grading scale (Flores and Hochberg 2003). 
According to the recommendations of clinical diagnosis developed by European League 
of Associations for Rheumatology (EULAR, Zhang et al. 2010), diagnosis of knee OA 
can be made on the basis of: 
a. background risk (population prevalence of knee OA) 
b. patients risk factors (e.g., age, gender, BMI, occupation) 
c. symptoms (persistent knee pain, stiffness of the joint, functional limitation) 
d. physical examination (crepitus, restricted movement, bony enlargement) 
e. plain radiographs, to be used as an adjunct for the purpose of diagnosis.  
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These recommendations were made on the basis of expert opinion and systematic review. 
While there is no universally applicable reference standard for knee osteoarthritis 
diagnosis, these recommendations were made on a combination of radiographic evidence 
and clinical features. However, if above diagnosis differ in atypical patients younger than 
40 years of age was not examined by the panel.  
The first point of contact of an osteoarthritis patient with the doctors is usually due to 
pain which is the first and the predominant symptom (Bijlsma et al. 2011). The nature of 
pain is intermittent and aggravates on weight bearing (Bijlsma et al. 2011) and stiffness 
in the joints is experienced either in the morning after a period of inactivity or in the 
evening. O’Reily and Doherty (2003) also list tenderness, joint deformity and instability 
as possible symptoms. 
The impact of osteoarthritis on specific functions is specific to the joint involved. The 
most common limitation caused by knee osteoarthritis is on mobility. In fact, the 
difficulty in walking and stair climbing due to osteoarthritis of the knee is as great as that 
attributable to cardio vascular disease and greater than any other condition in an elderly 
person (Felson 2000), clearly a substantial impact on function. Creamer et al. (2003) 
developed a model to assess the determinants of functional impairment in knee 
osteoarthritis patients using self-report pain and function measure and found that pain 
severity, obesity and helplessness accounted for 59.5% variance in the Western Ontario 
McMaster Universities Osteoarthritis Index (WOMAC).  
Additionally, anxiety, depression and inability to sleep associated with the symptoms 
may contribute to disability and diminish the quality of life of the patient (Bijlsma et al. 
2011).Factors linked to the risk of physical disability in osteoarthritis are pain 
(McAlindon and Dieppe 1989; Creamer et al. 2000), psychosocial factors (O’Reilly and 
Doherty 2003), muscle weakness, poor aerobic capacity (Sharma et al. 2003), 
radiographic disease severity (Guccione et al. 1990). 
The impact of osteoarthritis is not just limited to the physical performance of the 
individual. Disability is defined as ‘the impairment performance of socially defined life 
tasks in a typical socio cultural and physical environment.’(Jette et al. 2002 cited in 
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Sharma et al. 2003). While arthritis primarily limits the physical functioning of the 
individual, the concept of function also includes psychological and social functioning. 
Although these are distinct dimensions, they influence each other in that the physical 
function may influence the psychological and social functions and physical function may 
in turn be influenced by psychological and social function (Guccione1997).  
While the role of osteoarthritis in consequent disability of a person seems obvious 
enough, Guccione (1997) points to factors which complicate the study of the link of 
osteoarthritis to disability. Firstly, radiographic evidence of OA does not necessarily 
mean it is symptomatic; therefore, it is important to consider whether the presence of 
arthritis is regarded as problematic by the patient or the clinician. Secondly, the 
prevalence of the disease may have led to it being too common and not as serious as other 
ailments of the geriatric population. And finally, measurement of disability due to 
osteoarthritis is also affected by other comorbidity present in the patient.  
 
 
1.4. Etiology of osteoarthritis 
 
Susceptibility to osteoarthritis is due to interplay of local and systemic factors (Jordan et 
al. 2000). Felson (2003) suggests that the most common local factor leading to 
osteoarthritis is a previous injury to the joint such that a major injury to the joint can 
damage a number of structures within it, altering its biomechanics and the stresses placed 
across the joint and thus making it vulnerable. The Framingham study (Felson et al. 
1988), found a statistically significant relative risk of the later development of 
osteoarthritis in males and females with a history of major injury to the knee (relative risk 
of 3.5 and 2.2 respectively). Another study by Roos et al. (1995), which assessed the 
influence of time and age on the development of osteoarthritis after knee injury, 
concludes that development of osteoarthritis after injury is faster in older patients than in 
younger ones. Therefore, it is suggested that a major injury to the joint in itself can lead 
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to osteoarthritis of the joint; however, more commonly it is the effect of an injury on the 
joint in a person with a systemic vulnerability depending on their age and other factors 
which causes OA. Thus, indicating a local and systemic interplay leading to osteoarthritis 
in an individual (Felson et al. 2003).  
Other factors affecting the joint include quadriceps muscle weakness, obesity, and 
repeated use/strain of the joint due to occupational, athletic activities. Earlier for certain 
factors like obesity it was not clear if obesity preceded OA or was a consequence of the 
disability and immobility caused by OA. It is now known that being overweight precedes 
the development of OA and also increases the likelihood of the disease progression 
(Felson et al. 1988). The effect of obesity on OA has been further discussed in Chapter 3.   
Felson et al. (2000) in an evidence update review listed other local vulnerabilities which 
include: 
a. Knee laxity: Greater varus-valgus laxity of the knee was seen in those with 
osteoarthritis than older control knees without arthritis. Moreover, varus-valgus laxity 
increases with age suggests the possibility that a proportion of the laxity preceded the 
disease and could have predisposed to the disease (Sharma et al.1999). 
b. Mal-alignment: There is paucity of evidence regarding whether mal-alignment of the 
joint is an independent risk factor for the development of osteoarthritis. However, it 
has been shown that a varus alignment in primary osteoarthritis can increase the risk 
of a medial progression and a valgus alignment can increase the risk of lateral 
progression (adjusted odd ratio of 4.09 and 4.89 respectively) (Sharma et al. 2001) 
c. Proprioception: Proprioceptive accuracy at the knee declined with age and was worse 
in osteoarthritis patients when compared to age matched controls in a study by 
Sharma et al. (1997). The decline in proprioception reduces the ability to maintain 
joint stability in dynamic conditions. 
While these above factors are essentially alterations of the mechanical environment of the 
joint which adversely affects the load distribution across the joint, systemic factors which 
increase the risk of osteoarthritis include age, gender, hormonal status, bone density, 
probable nutritional deficiencies and genetic influences (Felson et al. 2000). 
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1.5. Osteoarthritis treatment concepts 
 
The recognition of osteoarthritis as a complex disease and the fact that there is a great 
degree of variation in the clinical and structural characteristics of osteoarthritis in 
different individuals has restricted the development of a generic plan for the management 
of osteoarthritis (Bjilsma et al. 2011). However, there is some consensus on the central 
objectives of the management of osteoarthritis in the recommendations made by expert 
panels such as EULAR; Osteoarthritis Research Society International (ORSI) and 
National Collaborating Centre for Chronic Conditions (NCC-CC). The three main 
treatment modalities recommended by NCC-CC (2008) are:  
a. Non pharmacologic management including patient education and recommendations 
for lifestyle change, exercise, weight reduction, joint protection measures such as 
insoles, braces, activity pacing and treatment modalities such as transcutaneous 
electrical nerve stimulation, ultrasound, heat and ice. 
b. Pharmacological management includes paracetamol, topical Non-Steroidal Anti 
Inflammatory Drugs (NSAID), oral NSAID, opioid analgesic. Intra-articular 
corticosteroids are recommended as an adjunct for pain relief and can be effective 
during periods of inflammatory flares. 
c. Surgical options include total knee arthroplasty when the above non-surgical 
management has failed to reduce symptoms which have made a substantial impact on 
the patient’s quality of life. Surgical lavage and debridement have not been generally 
advised as a part of osteoarthritic management.  
Pain and functional limitations are the main problems affecting an OA patient for which 
they seek treatment. However, the disparity between pain, disability and radiographic 
changes of OA lead to a considerable variation in pain and disability between individuals 
and this is compounded by factors such as age, comorbidity, personality and expectations 
of health care delivery (Brandt et al. 2003). This has led to a shift to a holistic approach to 
the management of osteoarthritis tailored to individual needs of the patients (NCC-CC 
2008).  
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1.6. Weight loss as an intervention for knee osteoarthritis 
 
Significant association of body mass/body weight with the risk and the progression of 
osteoarthritis have been found in several studies (Hartz et al. 1986;Felson et al. 1988; 
Sturmer et al. 2000). This will be discussed in further detail in Chapter 3. Two high 
quality randomized controlled trials (RCT) undertaken to assess the effects of weight loss 
programmes on the symptoms of OA conclude that weight loss does results in 
improvement in pain and function in knee osteoarthritis patients (Messier et al. 
2004;Christensenet al. 2005). Short term weight loss was assessed by Christensen et al. 
(2005) over a period of eight weeks evaluating a low energy diet group versus a control 
diet group. The study saw significant improvement in symptoms (measured by WOMAC 
scores) in the low energy diet group and found that a 10% reduction in weight lead to a 
28% improvement in function. Messier et al. (2004) conducted a four arm RCT 
comparing control, diet only, exercise only, diet plus exercise groups over 18 months and 
found that the combination of diet plus exercise had the most beneficial effect on function 
and pain. The recommendation of weight loss as a therapeutic intervention for knee 
osteoarthritis patients is further supported by meta-analysis of four RCTs conducted by 
Christensen et al. (2007) (including the above mentioned two RCTs) They noted that for 
an average reduction of 6.1 kg, the pooled effect size (ES) for improvement in pain and 
disability was 0.20 (95% CI 0 to 0.39; p=0.05) and 0.23 (95% CI 0.04 to 0.42; p=0.02) 
respectively. The diversity across the studies was substantial especially considering the 
different approaches used for weight loss and the duration of the study. Meta regression 
models used in the analysis to understand the dose response effect for clinical practice 
found that the prediction of reduction in pain resulting from weight loss was inconsistent 
but weight loss greater than 5.1% at the rate of 0.24% per week would result in a 
significant reduction in disability. Supported by this evidence and expert clinical opinion, 
weight loss for overweight knee osteoarthritis patients was recommended as a treatment 
modality for reducing symptoms of knee osteoarthritis (Jordan et al. 2003; Zhang et al. 
2010). 
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1.7. Chapter summary 
 
To summarize, over the last decade, the definition of osteoarthritis has evolved from 
‘hypertrophic arthritis’ to the recognition of osteoarthritis as a complex disease with no 
common pathological pathway. Osteoarthritis is now generally recognized as a 
progressive disease manifested in the structural changes in the joint and an illness 
reflected in pain, functional limitation and deteriorating quality of life in the patient’s 
experience of living with osteoarthritis. One of the leading causes of disability, 
osteoarthritis is highly prevalent after the age of 60 years. Significant association of knee 
osteoarthritis with body weight and evidence of reduction in symptoms with weight loss 
has led to weight loss being is one of the treatment modalities recommended for reducing 
symptoms of knee osteoarthritis. On failure of pharmacological and non-pharmacological 
management of symptoms, a total knee arthroplasty is the recommended line of 
treatment.  
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CHAPTER 2: TOTAL KNEE ARTHROPLASTY 
 
 
2.1.Chapter overview 
 
This chapter presents an overview of total knee arthroplasty (TKA) as an intervention for 
end stage osteoarthritis and its prevalence. Outcomes after TKA are presented followed 
by a discussion of the measurement of outcomes after TKA.   
 
 
2.2. Introduction 
 
Total Knee Arthroplasty has become a highly successful orthopedic procedure for joint 
reconstruction affording pain relief, mobility and functional improvement in patients 
where other non-surgical interventions for the management of arthritis have failed 
(Harwin2002). 
Attempts at treating diseased joints with prosthetic replacements which started over a 
century ago were initially met with failure; primarily due to unsuitable implant material, 
surgical techniques, sepsis and lack of proper indications (Knutson 2003). The evolution 
of TKA especially benefited from advances in the prevention of infection; implant 
material, prosthetic fixation to the bone, surgical instrumentation and knowledge of 
biomechanics of the knee (Deroche 2008). The modern tricompartmental (total) knee 
prosthesis was essentially metal implants including an anatomic shaped femoral 
component, the tibial component as a cemented metal tray on which sits a High Density 
Polyethylene (HDPE) component and a patellar articulation (Knutson 2003). 
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Joint arthroplasty is an intervention for patients with radiographical changes in the knee 
suffering from severe joint pain and disability that has had a substantial effect on their 
quality of life and is refractory to non-surgical management (British Orthopedic 
Association report 1999). Relative indications include progressive deformity and 
instability (British Orthopedic Association report 1999). Age and comorbidity are factors 
taken into consideration to assess risk versus benefits, which may rule out the surgery for 
particular patients (British Orthopedic Association report 1999).  
Although, the operation was only offered to older patients with limited activity levels, it 
has now been shown to be also effective and durable for younger and more active 
patients (Harwin 2002). The surgery is considered ideally suitable for patients above the 
age of 60 years as the implant is more likely to last for the rest of the patient’s life 
(Harwin 2002).Being an elective procedure, patients’ motivation and their willingness or 
reluctance to undergo the surgery also influence whether or not patients undergo surgery. 
 
 
2.3. Rate of TKA 
 
Osteoarthritis is the most frequent cause of rheumatic complaints among all joint specific 
diseases (Brandt 2009). Recent estimates indicate that within the United Kingdom (U.K.), 
more than one million patients consult with their general practitioner each year for 
osteoarthritis (Arthritis research U.K., 2008). Over all, more than six million individuals 
have painful OA in one or both knees (Arthritis research U.K., 2008). 
The increasing prevalance of OA and an increasing average age of the population may 
account for the consistently rising rate of TKA. In addition, changes in medical practice, 
improvement in technology, increasing availability,acceptance and satisfaction with the 
surgery may also account for some of this increase in the rate of TKA (Mehrotra et al. 
2005). A survery of the primary TKA in the USA from 1990 to 2002, found tripling of 
the number of primary TKAover the 13 year period, an increase which was more 
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pronounced than that for primary total hip arthroplasty (Kurtz et al. 2005). Latest fugures 
for England and Wales reveal a total of 86,067 primary TKA in years 2010/11, a 10% 
increase from year 2009/10 (National Joint Registry for England and Wales 2011). For 
Scotland 6,884 primary knee replacements were performed in 2008/09, an increase from 
6160 operations performed in 2007/08 (Scottish Arthroplasty Report 2010). 
 
 
2.4. Outcomes after TKA 
 
Total knee arthroplasty has been long reported to be an effective and safe intervention 
offering significant pain relief and improvement in function for patients with advanced 
arthritis (Callahan et al. 1994; Heck et al. 1998). Meta-analysis of 130 studies reporting 
patient outcomes on 154 cohorts by Callahan et al. (1994) reported that 52% to 100% of 
the patients had good to excellent outcomes (weighted mean of 89.3%) in terms of pain 
relief and mobility measured by the Global Rating Scale at a mean follow up of 4.1 years. 
TKA was shown to be an effective procedure with relatively low risk of serious 
complications and mortality in the majority of patients. Similarly, marked improvements 
in physical function scores using WOMAC and Short Form 36 Health Survey (SF-36) 
were reported in a community based study, showing that at two years, TKA was an 
effective procedure in a community setting (Heck et al. 1998). 
Survivorship of the knee prosthesis in a large study of 11,606 primary TKA showed 
survivorship of 91% at ten years, 84% at 15 years, decreasing to 78% at 20 years (Rand 
et al. 2003). Revision rates reported from the most recent data analyzed from the joint 
registries of six countries and clinical studies were projected at 6% after five years and 
12% after ten years (Labek et al. 2011). A U.K. based study analyzing 4606 TKA’s, 
observed that greater than 90% of the prosthesis survived at 15 years follow up (Roberts 
et al. 2007). Females are reported to less likely undergo revision surgery while younger 
patients (aged less than 55 years) had a lower prosthetic survival rate of 87% at 15 years 
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(Roberts et al. 2007). They noted that failure observed due to aseptic loosening was seen 
to be constant over the 15 years follow up; failure due to infection was common within a 
year of the surgery, while, failure of the polyethylene was seen at approximately eight 
years post-operatively. 
It has been recognized that patient expectations determine the success of an intervention 
and the patient’s perception of the outcome of the surgery is considered essential in the 
evaluation of treatment (Weiss et al. 2002). Various questionnaires have been used in 
order to measure patient’s perception of their function and pain after TKA, both specific 
to the knee joint such as WOMAC, Oxford Knee Score (OKS), and those measuring the 
overall health related quality of life such as the Short Form 36 Health Survey. Substantial 
improvements in the scores for physical health, such as those for pain and knee function 
have been reported by several studies (Xie et al. 2010;Ethgenet al. 2004; Nilsdotter et al. 
2009). Nilsdotter et al. (2009) observed that while there was clinically significant 
improvement in 88% and 81% of patients respectively for pain and activities of daily 
living at five years postoperatively, the maximum improvement was seen at one year 
post-operatively indicating some decline in function from one to five years after TKA. 
The authors suggest the role of musculoskeletal and other comorbidity and irreversible 
damage of the disease (OA) in causing deterioration in function. 
Total knee arthroplasty patients participate in a wide range of activities (Nilsdotter et al. 
2009; Noble et al. 2005; Weiss et al. 2002). There is a high correlation between the 
importance of an activity and the frequency of participation indicating that knee 
replacement enables patients to perform activities they consider important or that patients 
perform these activities irrespective of the function achieved in their knee (Weiss et al. 
2002). In their sample of 176 patients, Weiss et al. (2002) found stretching exercise 
(56%), kneeling (52%) and gardening (50%) were activities graded most important to 
patients in their assessment. However more than 75% of the patients who squatted and 
kneeled reported limitations. On comparing TKA patients with age matched controls with 
no previous knee disorders, Noble et al. (2005) observed that overall, 52% of the TKA 
patients reported some limitation in functional activity compared to 22% of subjects with 
no previous knee disorders and as the activities became more demanding, the gap 
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between the two groups widened. The activities in which the control group did better that 
the TKA patients included kneeling, squatting, stretching, gardening, tennis, dancing. 
Thus, although this procedure restores the patient’s ability to do routine tasks, deficit still 
remain for functional tasks that are important to the patient especially those involving 
kneeling and squatting (Noble et al. 2005).  
Total knee arthroplasty has considerably advanced in terms of surgical techniques, 
prosthetic fixation and a multitude of different prosthesis with varying degrees of tibio 
femoral conformity (Jordan et al. 2003). Despite these advancements in TKA as an 
intervention, knees that have undergone total knee replacement cannot replicate the 
functional status of a healthy, uninjured adult knee (Dye 2005). As seen by Noble et al. 
(2005), for biomechanically demanding activities such as kneeling, squatting, moving 
laterally, turning and cutting, carrying loads, TKA patients experience substantial 
functional impairment compared to the age and gender matched individuals suggesting 
further room for improvement in surgical technique and prosthetic design. In addition, 
these functional deficits will also exist because of the irreversible effects of the disease 
and factors predisposing some individuals to joint degeneration (Noble et al. 2005; 
Nilsdotter et al. 2009). 
In a qualitative and systematic review of health related quality of life (HRQoL) in total 
hip and knee arthroplasty patients, the greatest improvement in HRQoL was seen in the 
first three to six months after surgery. Substantial improvements though noted for 
physical health scores, the improvement in social health and mental health was less 
obvious. It is argued that these dimensions are not related to knee surgery, and that 
surgery may relieve a specific complaint but it might not enhance the overall quality of 
life. On the other hand, it has been found that the pre-operative mental health was a 
significant factor affecting the post TKA function (Escobar et al. 2007, Ayers et al. 2005) 
Also, other factors such as comorbidity, use of medication, and social support are likely 
influence the success or failure of the operation in improving the HRQoL. An interview 
of ten TKA patients six months after their surgery, found that patients had a strong desire 
to report the outcomes in positive terms initially, despite some pain and disability 
remaining after the surgery (Woolhead et al. 2005). While pleased that an intervention 
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had been carried out to relieve pain and disability and that they were able to do more 
activities than before, patients try to rationalize and reason in an attempt to diminish the 
disappointment with the residual pain. The predominant rationalization was self-blame 
for the continued pain and immobility which the authors suggest may represent an 
attempt to take control over the outcomes. Thus while quantitative studies may report 
good or excellent outcomes after TKA in majority of the patients, it should be noted that 
there exists marked disparity between the patient’s evaluations of the outcomes, 
qualitatively or through a self-report outcomes after TKA and that done by a clinician 
(Wylde et al. 2007). 
The available literature suggests that overall; TKA is a valuable intervention in relieving 
pain and restoring function. However, the evidence of the effectiveness of TKA is based 
on observational study and not randomized controlled trials. Comparison of TKA with 
placebo or other treatment methods using a well-designed study is often impossible due 
to ethical considerations. Blinding of investigator is not feasible in a clinical setting. 
Furthermore, wide variation in the indications for TKA, types of prosthesis and variation 
in availability of TKA in different areas affect comparison of TKA outcomes from the 
literature.  
 
 
2.5. Measure of the outcomes after total knee arthroplasty 
 
There are many approaches to surgical outcome measurement by a diverse range of 
disciplines which may or may not be directly involved in patients’ medical care  Thus the 
term outcome of a surgical procedure, though in some cases may be synonymous with the 
result of a surgery, is a much more multifaceted and complex issue.. The assessment and 
documentation of the results of the surgery in terms of impressions of symptoms, 
functional status, physical examinations and laboratory or radiographic findings, the 
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relative importance of these assessments depends on who is performing the evaluation; 
the surgeon, the patients or the health service researchers (Johansen 2002) 
 
2.5.1. Hospital for Special Surgery knee rating score (HSS) and American Knee Society’s 
Clinical Rating System (KSS) 
With the evolution of a multitude of prostheses, surgical approaches, a number of rating 
systems to evaluate knee function have been developed. A review of the rating systems 
identified 34 different rating systems in the orthopaedic literature between 1972 and 1992 
(Drake et al. 1994). Of these the most widely used were Hospital for Special Surgery 
knee rating score (HSS) and American Knee Society’s Clinical Rating System (KSS) 
(Drake et al. 1994). The HSS was developed in 1976 (Insall et al. 1976) and used widely 
for its ease of use; weighing primarily on pain, function and range of movement. Insall et 
al. (1989) later published the American Knee Society’s Clinical Rating System (KSS) in 
an attempt correct the deficiencies of the HSS score. The KSS separated the knee 
function from overall patient function so as to enable knee function to not be subject to 
deterioration by comorbidity The KSS though not validated at the time of publication has 
been validated and tested for reliability and responsiveness to change against WOMAC 
and SF36 showing adequate construct validity but poor internal consistency (Lingard et 
al. 2001). Also, in terms of inter-observer reliability; Bach et al. (2002) found that the 
knee score had poor reproducibility.  However, the KSS is now one of the most 
commonly used rating systems for the knee in the U.K. These scoring systems are easy to 
use and understandable to the clinician; however, they do not represent the full range of a 
patient’s lifestyle. Both KSS and HSS are evaluations done by an observer using a 
combination of interview and physical examination.  
Details of the psychometric properties of HSS and KSS are as shown in Table 1. 
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2.5.2. Patient perceived outcomes 
Early literature measured the effectiveness of TKA primarily on the basis of its technical 
success in terms of prosthesis longevity, physician defined pain relief and function. It is 
recognized that there exists disparity between the physician’s and patient’s evaluation of 
the outcomes, especially when the patients were dissatisfied with the surgery (Wright et 
al. 1994). TKA is a procedure performed primarily with the aim to achieve pain relief and 
restore function and the goals of the patients will differ with respect to the post-operative 
function and activity. However, these patient goals and whether the patient thinks that he 
or she has significant residual disability determine the success of the surgery. Therefore 
patients’ perspectives on the outcomes are considered an important component of 
evaluation.  
Patient self-assessment techniques are generally simple and readily accepted by patients 
(Heike et al. 2003). The techniques mostly involve questionnaires which are self- 
administered by the patients or administered through an interviewer. A number of patient 
reported questionnaires have been developed in clinical research with excellent 
psychometric properties measuring knee specific function or generic health status. 
However, a problem with these techniques is that the perception of change derives its 
significance from the comparison between the starting or the pre-operative state and the 
post-operative state (Heike et al. 2003). Therefore for a persons with poor starting state, a 
relatively small change from pre-operative to post-operative status would be perceived as 
a clinically significant change while for those with a better pre-operative state, the same 
amount of change will not be considered by the patient as a significant change.  
Various patient-reported instruments are available to assess TKA outcomes and are 
referred to as generic when developed for general population and joint specific when 
developed for a particular joint condition. Among the self-assessed knee scoring systems, 
the most widely used are the Western Ontario and McMaster University Osteoarthritis 
Index (WOMAC) and the Short Form 36 (SF36). While WOMAC was originally 
developed to assess the effectiveness of NSAIDs as treatment for osteoarthritis (Bellamy 
et al. 1988), SF36 is a generic health measure (Ware and Sherbourne1992). The Oxford 
Knee Score, OKS is a knee scoring system which was specifically developed for total 
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knee arthroplasty patients and is also in wide use, especially in the U.K. (Dawson et al. 
1998). 
Details of the psychometric properties of WOMAC, SF-36 and OKS are as shown in 
Table 1. 
 
Oxford Knee Score (OKS) 
The OKS questionnaire was developed by the authors using patient inputs in order to 
make the questionnaire as valid and sensitive as possible (Dawson et al. 1998). It has 
been tested by its authors for internal consistency (Cronbachs alpha = 0.87-0.93), test 
retest reliability (r= 0.92), construct validity and sensitivity to change with KSS, SF36 
and Health Assessment Questionnaire (HAQ) (Dawson et al. 1998). The Oxford Knee 
Score is an attempt to create an assessment tool specific to the total knee replacement. Its 
short and simplified form allows for patient compliance and is currently the most 
preferred method of assessment by the active members of the British Association of 
Surgery of Knee (Davies 2002). 
 
Short Form -12 Health Survey (SF-12) 
With the recognition that a comprehensive assessment of outcomes of care goes beyond 
the traditional clinical view to also include the patients overall health and general 
wellbeing, a number of questionnaires have been developed to assess dimensions 
covering physical, psychological and social function. As mentioned earlier, the Short 
Form 36 (SF36) is one of the most widely used generic outcome measures for TKA 
patients. It has shown suitability in terms of validity and internal consistency as an 
outcome measure for routine use within the NHS for some common clinical conditions 
(Garrat et al. 1993). The Short From -12 (SF12) questionnaire was derived from the SF36 
in an attempt to create a shorter version of the SF36 scale (Ware et al. 1996). Based on 
the findings that the physical and mental health factors account for 80-85% of the 
reliability variance in the eight scales of SF36 and that the Physical Component Summary 
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(PCS) and Mental Component Summary (MCS) detected the hypothesized differences in 
nearly all test using physical criteria and mental criteria respectively; the authors saw it 
possible to reduce the number of health dimensions into PCS and MCS without 
substantial loss of information (Ware et al. 1996). This adaptation of the SF36 into SF12 
showed a close and linear relation with the SF-36 while its brevity added to patient 
compliance (Wareet al. 1996). 
 
The current thesis uses a combination of a joint/disease specific outcomes measure and a 
generic health outcomes measure through the OKS and SF12 questionnaires. A disease 
specific questionnaire is more responsive in the evaluation of a particular condition 
(Brazier et al. 1999). Also, considering that functional ability, especially in the elderly is 
influenced by factors not related to the joint such as comorbidity and psychosocial 
factors, the generic health instruments adds to the evaluation in the dimensions of 
physical , psychological and social function. Furthermore, OKS and SF12 are instruments 
that are routinely used for TKA patients within the NHS Lothian allowing for comparison 
between the results of the retrospective and prospective studies of the thesis. 
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Table 1 Psychometric properties and applicability of outcomes questionnaires used commonly for TKA patients 
Outcome measure Measurement  Validity Reliability Responsiveness Applicability  
HSS 
(Insall 1976) 
Pain, function, 
range of motion, 
muscle strength, 
flexion deformity, 
instability, 
deduction for 
walking aid, 
extension lag and 
varus/valgus. 
 
Well correlated with 
kinesiologic 
measurement of post-
operative function, 
prosthetic alignment thus 
valid (Gore et al. 1986) 
Good inter-observer 
reliability, r=0.82 
(Bach et al. (2002) 
 Easy to use and widely 
followed. However, was 
developed when TKA 
was at its infancy and 
the expectations of 
outcomes were less 
(Insall et al. 1989) 
KSS 
(Insall 1989) 
Knee score (pain, 
range of motion, 
stability, and 
alignment, 
deduction for 
flexion contracture 
and extension lag). 
Function (walking, 
stair climbing, 
deduction for 
walking aid).  
 
Validated against 
WOMAC and SF36. 
Good convergent 
construct validity 
between knee score and 
WOMAC pain score, 
r=0.68. and KSS function 
score SF36(PC), r=0.72; 
12 month post op 
(Lingard et al.2001),  
correlation between items 
poor.  
Knee score has poor 
inter-observer 
reproducibility (r= 
0.48). Good inter-
observer 
reproducibility in 
case of function 
score, r=0.78. (Bach 
et al. 2002) 
KSS knee score and 
WOMAC pain score 
more responsive than 
SF36 pain score. KSS 
less responsive than 
WOMAC and SF36 
for patient perceived 
outcomes (Lingard et 
al 2001) 
More responsive than 
SF36, walk test, stair 
test, time trade off 
(Kreibich et al. 1996) 
 
Clearly separates knee 
function from overall 
physical function. 
Concise and easy to use 
and currently most 
widely used in the U.K. 
Also, most used in 
related research (Davis 
2002) 
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Outcome measure Measurement  Validity Reliability Responsiveness Applicability  
WOMAC 
Bellamy et al. (1988) 
Three components: 
Pain, stiffness, 
function. 
Self-reported 
 
Validated for measuring 
outcomes post TKA by 
Bellamy et al. (1988) 
Self-reported measure 
thus removes observer 
bias 
More responsive than the 
KSS (Lingard et al. 
2001). More responsive 
than SF36, walk test, 
stair test, time trade 
off(Kreibich et al. 1996) 
Self-report measure thus 
less labour intensive. 
However, response from 
subject is an influencing 
factor. 
SF36 
(Ware and 
Sherbourne 1992; 
Functional status 
(physical function, 
social function, 
physical role 
function, emotional 
role function); 
Wellbeing (mental 
health, energy, pain) 
and General health 
perception. 
Self-reported 
Well validated and tested 
for reliability (Ware and 
Sherbourne 
1992;McHorney, et 
al.1993). Valid and 
internally consistent for 
patient outcomes NHS 
(Garrat et al. 1993) 
Self-reported measure 
thus removes observer 
bias. Good test retest 
reliability, r = 0.85 
(Beaton et al. 1997) 
Most responsive among 
NHP, OHS, Duke health 
profile and Sickness 
impact profile in subjects 
with musculoskeletal 
disorders (Beaton et al. 
1997) 
Self-report measure thus 
lesslabour intensive. 
However, it is a generic 
measure and not specific to 
knee thus sections such as 
pain assessment might not 
be as responsive as 
KSS/WOMAC. 
Oxford Knee Score 
(Dawson et al. 1998) 
12 questions on 
patient’s perception 
of pain and function. 
Self-reported. 
Validated against KSS and 
SF36 (Dawson et al. 1998) 
Self-reported measure 
thus no observer bias.  
Test retest reliability 
good, r=0.92 (Dawson et 
al. 1998) 
Self-reported thus less 
labour intensive. On 
comparison with 
WOMAC, it is more 
specifically for knee 
surgery and simpler to 
process. Though it may be 
widely used clinically in 
the U.K. related researches 
seem to make more use of 
the WOMAC. 
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2.6. Chapter summary 
 
Total knee arthroplasty has been known to be a safe and effective orthopaedic procedure 
for the treatment of end-stage osteoarthritis. Advances in the procedure and availability 
have led to its wide utilization. Although a TKA cannot restore the joint function to 
normal, it offers considerable relief from pain and restoration of function. There are 
various approaches to measuring outcomes after TKA including a variety of scoring 
systems used measured by an examiner and those measured by patients themselves. 
Among the patient reported outcomes, WOMAC and SF36 have been most widely used 
in TKA patients. The studies in the current thesis have assessed outcomes after TKA 
using a combination of knee specific (OKS) and generic (SF12) patient reported 
outcomes to allow for responsiveness to the functional changes particular to the joint as 
well as take into consideration the physical, psychological and social dimensions which 
affect the overall functional ability.  
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CHAPTER 3: OBESITY 
 
 
3.1. Chapter overview 
 
This chapter presents an overview of the prevalence of obesity in the general population 
and TKA population. The effect of obesity on an osteoarthritic joint is then discussed 
followed by a brief discussion of methods of measuring body composition.  
 
 
3.2. Obesity: Overview and prevalence in the general population 
 
Obesity has been defined as the accumulation of excessive body fat to the extent that it 
may have a detrimental effect on health (World Health Organization, WHO 2000). Body 
mass index (BMI) is widely used in clinical settings and population studies to measure 
obesity. With a reasonable correlation with body fat mass and obesity associated health 
risks, BMI is a useful measure to estimate the prevalence of obesity at population level 
(Canyon and Buchan 2007). According to the WHO classification of obesity, a BMI 
between 25 to 29.9 kg/m
2 
is considered overweight while a BMI greater than 29.9 kg/m
2 
is considered obese.  
The WHO report (2000) describes obesity as the most common nutritional disorder which 
is increasing at an alarming rate in both developed and developing countries. A steady 
rise in the prevalence of obesity has been reported in Scotland since 1995. In Scotland, 
among men aged 16-64 years, the prevalence rose from 15.9% in 1995 to 26.6 % in 2010. 
For females of the same age range the figures rose from 17.3% in 1995 28.1% in 2010 
(Scottish Health Survey 2010). The figures for obesity prevalence in 2009 and 2010 were 
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similar but it has been suggested that this might not necessarily mean that the increase 
over time has started to plateau and that only once further prevalence data for 2011 and 
onwards, it can be known if the rise is continued or stabilized (Scottish Health Survey 
2010). In England, according to the Health Survey for England report (2010), the obesity 
prevalence in England have risen  from 13% in 1993 to 26% in 2010 for men and 
correspondingly from 16% to 26% for women. The survey also illustrate that obesity 
tends to increase with age and regional differences are seen with the prevalence of 
obesity greater in North England and Scotland (Rennie and Jebb 2005). 
 
 
3.3. Prevalence of obesity in the TKA population 
 
The above health survey reports have reported that obesity increases with age and 
declines from the 7
th
 decade of life. Flegal et al. (2002) in their survey in America 
observed that the peak incidence of obesity occurred in the 6
th
 decade. A similar trend 
was seen in the Scottish Health survey with highest incidences of obesity in the age rages 
55-64 years (38.3% in this age group were obese in 2010) and 65- 74 years (33% obese in 
this age range in 2010). This also coincides with the age range for primary total knee 
arthroplasty in Scotland for year 2009 when a median of 69 years and inter quartile range 
of 62-75 years was reported (Scottish Arthroplasty Project report 2010). Thus with the 
increasing obesity and aging population, it seems likely that a considerable proportion of 
patients undergoing total knee arthroplasty will be in the obese category. 
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3.4. Obesity and its effect on knee osteoarthritis 
 
A strong positive association of obesity and knee osteoarthritis has long been established 
by several studies including cohort studies, cross sectional studies and case control 
studies (Felson et al. 1988, Hartz et al. 1986, Sturmer et al. 2000). One of the key studies 
in this area, the Farmingham study by Felson et al. (1988), in a cohort of 1450 
individuals, saw a strong and consistent association of obesity and overweight with the 
onset of knee osteoarthritis. Overweight and obesity in this study were defined as the 
heaviest and the second heaviest quintiles of the Metropolitan Relative Weight
1
. The 
study found that increasing weight was associated with greater risk of both symptomatic 
and asymptomatic, radiographic knee osteoarthritis (relative risk = 1.54, 95% CI = 1.18-
2.02 for men) and this association were persistent after controlling for age, uric acid 
levels and physical activity levels. Also, the association between obesity and knee 
osteoarthritis was seen to be stronger for women (relative risk = 1.93, 95% CI = 1.56-
2.37). Assessment of knee osteoarthritis at follow up (34 years) after baseline 
measurements of weight, allows this study to address the time sequence between obesity 
and development of knee osteoarthritis as opposed to cross sectional studies such as that 
by Strummer et al. (2000) as OA could lead to a sedentary life and consequently obesity.  
It is proposed that the link between obesity and knee osteoarthritis is because of the 
increased forces on the cartilage due to the additional weight. Also, obesity causes 
subchondral bone stiffness such that the bone is not deformable to impact loads and 
transmits greater forces than normal to the overlying cartilage thus rendering the cartilage 
vulnerable to degeneration (Felson et al. 1988;Hills et al. 2002; Marks 2007,). Messier et 
al. (1994) analyzed the effect of knee OA on gait and observed a transient peak in the 
ground reaction force data symbolizing an increased force on heel impact, in obese 
patients. They conclude that a shorter period of eccentric quadriceps muscle action at heel 
strike results in decreased shock absorption. Decrease shock absorption and repeated 
impulse loading results in stiffening of the bone due to the healing of micro fractures. The 
notion that obesity increases the loading at the joint though seems like an obvious one, it 
does not answer why all obese persons do not have OA and how these individuals 
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compensate for increased load on their knee joint. Devita and Hortobagyi. (2003) on 
comparing the knee kinetics during walking between lean individuals and obese but 
otherwise healthy individuals found that the knee torque and power in obese was lower 
when walking at their self-selected pace and equal torque and power when walking in the 
same speed as the lean individuals. Therefore they proposed that ability to reorganize 
neuromuscular function so as to produce a gait pattern which induces lesser load on the 
joint allows some obese individuals to maintain the integrity of the knee joint. On the 
other hand, in other obese individuals, the biomechanical loading of the knee joint due to 
excess weight represents a possible pathway for the pathogenesis of OA (Messier et al. 
2005). In obese individuals with OA, Messier et al. (2005) saw a significant relationship 
between weight loss and decrease in compressive knee joint forces such that with every 
unit of reduction in weight, there was a four unit reduction in the compressive joint forces 
at the knee.  
The increased compressive forces at the knee joint due to excess weight implies that the 
same association must be true for all other weight bearing joints in obese persons, such 
as, the hip. However, the association of obesity with hip OA is not as strong as that with 
knee osteoarthritis. The association of obesity with radiographic hip osteoarthritis is 
unclear as some studies find a significant association with hip OA (Oliveria et al. 1999; 
Jarvholm et al. 2005) and while others have found no significant association between 
obesity and hip OA (Reijman et al. 2006; Grotle et al. 2008). In a systematic review of 
the influence of obesity on the development of hip osteoarthritis, moderate evidence was 
found for a positive association of obesity with hip osteoarthritis with an odds ratio of 
approximately two (Lievense et al. 2002). It is suggested that a lack of association 
between increased weight and hip OA may be evidence for the differential effects of 
increased load of knee and hip joints. Reijman et al. (2006) suggest that while 
malalignment is not a problem per definition in a ball and socket joint like the hip, it is a 
problem in a hinge joint like the knee. Since it is reported that the effect of obesity is 
modified by malalignment of the joint (Felson et al. . 2004), Reijman et al. (2006) further 
suggest that the higher stresses caused by obesity are compounded in a malaligned hinge 
joint owing to the smaller area for the forces to act upon. Sturmer et al. (2000) further 
hypothesize that the distribution of body fat might also explain the observed difference in 
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the link between obesity and bilateral OA of the hip and knee, such that, while fat at the 
waist is supported by both hip and knee, the thigh and hip fat have less influence on the 
compressive stresses at the hip.   
The effect of obesity on onset of OA due increase in the compressive forces in the joints 
is further confounded by the association seen between obesity and hand OA. A recent 
systematic review (Yusuf et al. 2010), of the 15 studies that were considered high quality 
studies, 10 studies pointed to a positive association between BMI and hand OA. This 
indicates that factors other than mechanical effects of obesity play a role in the 
development of osteoarthritis. It is suggested that these patterns of joint involvement in 
osteoarthritis may be caused by systemic factors such as the adipokines released by fat 
tissues thus providing a metabolic link between obesity and osteoarthritis. Adipokines 
such as leptins secreted by adipose tissues have been observed in the synovial fluid of 
osteoarthritic joint. Moreover, the level and pattern of expression of leptins have been 
correlated with both BMI and the grade of cartilage destruction (Dumond et al. 2003). 
From these findings, it is hypothesized that the dysregulation of lipid haemostasis can be 
one of the pathological mechanisms causing osteoarthritis (Pottie et al. 2006). 
The association of obesity with onset of knee OA is seen to be stronger in females than in 
males (Felson 1988; Sturmer 2000). While no link between estrogen use in women and 
osteoarthritis have yet been found, it has been hypothesized that differences in the body 
composition of males and females may have a role in determining the association of 
obesity with osteoarthritis (Hills et al. 2002). At identical heights, an average female has 
8-10% higher body fat and lower muscle mass than an average male (Syed and Davis 
2000). The lower proportion of muscle mass may mean lesser musculoskeletal support 
and decreased ability for shock absorption at the joint for females thus predisposing the 
knee joint to greater forces and an increased degeneration of the cartilage (Syed and 
Davis 2000; Hills et al. 2002). 
The reduction in lean mass and increase in body fat is also a function of aging. The 
reduction in lean mass is possibly parallel with the reduction in muscle mass, muscle 
strength and functional capacity (Messier et al. 1994). The decrease in the muscle 
strength of key leg muscles such as quadriceps may lead to a reduced period of 
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quadriceps eccentric activity at heel strike as mentioned above (Messier et al. 1994). Syed 
and Davis (2000) suggest a combination of early muscle fatigue due to weakness and 
increase in ground reaction forces in obese result in the higher loading detrimental to the 
knee.  
In the study of association of obesity as a significant risk factor for osteoarthritis, obesity 
has been usually characterized by BMI. As BMI is a measure of combined fat and lean 
mass, it does not distinguish between the relative contribution of the adipose tissue and 
muscle mass towards the mechanisms leading to the development of OA. Various studies 
have assessed the association of other measures of body composition with the 
development of osteoarthritis. However, the evidence is conflicting with regards to 
independent effects of these measures. Hart and Spector (1993) observed that body fat 
distribution measures such a waist, hip and thigh circumferences did not have a greater 
predictive ability over BMI for the development of osteoarthritis. Similarly, Hochberg et 
al. (1995) observed that body fat percentage and waist to hip ratio had no significant 
association with knee OA after adjusting for BMI. These studies suggest that the 
influence of obesity on the development of knee osteoarthritis is primarily through 
increased mechanical loading due to increased mass than through systemic or metabolic 
effects of adiposity. Using Dual-energy X-ray absorptiometry (DXA) scan to produce 
total body fat mass, lean mass and bone mass, Abbate et al. (2006) found that neither 
these parameters nor waist to hip ratio offered any advantage over BMI in predicting 
knee osteoarthritis. Sowers et al. (2008) on the other hand observed that statistical models 
that included age and body composition (differentiated as fat mass and skeletal muscle 
mass) had a better statistical fit than BMI in order to explain the odds of onset of knee 
OA and its severity. Sowers et al. (2008) propose that the difference in their finding was 
due to the evaluation of lean mass (comprising muscle, bone, intracellular and 
extracellular fluids) by Abate et al. (2006) as opposed to the muscle mass. Two recent 
and largest prospective cohort studies (Lohmander et al. 2009 and Wang et al. 2009) 
assessed the association of various overweight and obesity measure on the risk of severe 
knee osteoarthritis (defined as risk of a knee arthroplasty) and found an association 
between various obesity measures and the risk of knee arthroplasty. Lohmander et al. 
(2009) observed that there was a BMI, weight and waist circumference were significantly 
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associated with knee osteoarthritis with relative risk (95% CI) of 8.1(5.3 to 12.4) for 
BMI, 6.7 (4.5 to 9.9) for waist circumference, 6.5 (4.6 to 9.43) for weight but body fat 
percentage (BF%) and waist to hip ratio (WHR) was only weakly associated with knee 
osteoarthritis (relative risk [95% CI]  = 3.6 [2.6 to 5.0] for BF% and 2.2 [1.7 to 3.0] for 
WHR). Wang et al. 2009 saw a three to four fold increase in the risk of primary total knee 
replacement when comparing the first and the fourth quintiles of BMI, weight, fat mass 
and fat percentage. The waist circumference and the waist to hip ratio, however, had a 
weaker association with the risk.  Therefore, with the association of BMI, adipose 
distribution and adipose mass with the risk of knee arthroplasty, these studies concluded 
that both mechanical and metabolic effect of obesity play a role in the development of 
osteoarthritis.  
 
3.4.1. Section summary 
Though a positive association of obesity with the development of osteoarthritis has been 
established, the importance of understanding the mechanism by which obesity affects the 
joint in the prevention and treatment of OA has been recognized. The most obvious 
mechanism through which obesity predisposes OA is proposed to be the mechanical 
effect of the increased load on the joint and the resultant cartilage degeneration. However, 
the differential effect of higher mass on other weight bearing joints, association of obesity 
with non-weight bearing joints, the fact that not all obese persons are affected by 
osteoarthritis and the greater association of obesity with knee osteoarthritis in women 
than men indicates towards mechanisms other than just the mechanical effect of a greater 
mass. The literature assessing the association of various measures of obesity and 
overweight with knee OA shows inconsistencies. These could be a resultant of the 
different categorization of the measures used in studies. Also, the studies vary in defining 
knee osteoarthritis radiograhically, symptomatically or as patients who have been 
recommended a knee arthroplasty.  
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3.5. Measurement of obesity 
 
Details of validity and applicability of various body composition measures have been 
listed in Table 2. 
The most widely used measures of obesity both in practice and in research are the 
anthropometric measures such as BMI, waist circumference, waist to hip ratio and skin 
fold thickness measurement. While BMI measures total body mass, waist circumference 
and waist to hip ratio are used to estimate abdominal obesity and fat distribution. The 
simplicity of use of these anthropometric measures and their association with health risks 
enable them to be widely used in large population studies and are reported as estimates of 
obesity in health reports (WHO 1995, Scottish Health Survey 2010, Health Survey for 
England 2010). Anthropometric measure used to estimate subcutaneous fat thickness is 
the skinfold measurement. Subcutaneous fat thickness is now also measured using the 
ultrasound technique. Though more difficult to use and more expensive than skinfold 
measure the ultrasonography technique offers the advantage of avoiding tissue 
compression, no requirement for palpation of muscle tissue interface and valid 
measurements in obese subjects compared to skinfold measure (Selkow et al. 2011). 
No particular method of body composition is considered as the best or ‘gold standard’. 
Methods like Computerised Tomography Scan (CT scan), Magnetic Resonance Imaging 
(MRI), hydrodensitometry show high levels of accuracy in measuring fat mass (Table 2) 
(Rossner et al.; 1990; Abate et al. 1994; Mitsiopoulos et al.1998; Ginde et al. 2005). 
However, the application of these methods in clinical and research settings is limited by 
cost and labour implication in addition to safety issues such as exposure to radiation. Less 
expensive and elaborate measurement methods which are fairly accurate, are the air 
displacement plethysmography and the dual X ray absorptiometry (DXA) (Snijder et al. 
2002; Ginde et al. 2005; Noreen and Lemon 2006; Anderson 2007; Hill et al. 2007). 
However, these still involve considerable cost and specialist skill for use in the clinical 
setting. Dual X ray absorptiometry is relatively cheaper than the above methods and has 
been well validated against CT scan. It has also shown to have high inter-tester reliability 
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(r = 0.99) (Snijder et al. 2002; Hill et al. 2007). However, the weight limit of the DXA 
compartment and limited portability makes its use difficult especially where heavy post-
operative patients are concerned. Among the more clinically viable methods of 
measurement of body composition, the bioelectrical impedance analyzers measure the 
total body water from which fat mass and lean mass is estimated. The method is 
noninvasive, cost effective and portable and therefore an attractive alternative for clinical 
or field application (Kyle et al.2004) 
The assessment of the effect of obesity and osteoarthritis has been primarily done by 
employing obesity measures of weight and BMI. Later studies have also linked waist 
circumference, waist to hip ratio and body fat percentage in the association of obesity and 
osteoarthritis. For TKA patients, the effect of obesity on outcomes have  todate been 
measured by weight and BMI. The following chapters of the thesis aim to present the 
findings of the effect of obesity on TKA outcomes with obesity measured as BMI; and 
also assess the effect of obesity as measured by a range of body composition measures 
including waist circumference, waist to hip ratio, bioelectrical impedance analysis and 
ultrasonography in addition to BMI on outcomes following TKA. 
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Table 2 Body composition measurement methods: validity and applicability 
Measurement 
Technique 
Accuracy /validation Applicability 
CT scan High 
Validated against cadaver study (Mitsipoulos et al. 
1998 r = 0.99); and cross sectional planimetry in 
cadavers(Rossner 1990 r = 0.99)            
Difficult 
Cost 
Exposure to radiations 
MRI High 
Validated against cadaver study (Mitsiopoulos et al. 
1998 r = 0.99; Abate et al., 1994 diff = 0.076kg) 
Inter-observer reliability good, r = 0.99 
(Mitsiopoulos et al. 1998) 
Difficult 
Cost 
 
Hydrostatic weighing 
(HW) 
 
Measures body volume 
from which body fat is 
determined 
High 
Considered ‘gold standard’ for measuring body 
volume and thus used as reference method for 
validating other method (Ginde et al. 2005) 
Difficult 
Cost and labour 
intensive 
Patient discomfort and 
apprehension 
Safety issues 
Time consuming 
Air displacement 
plethysmography 
 
Measures body volume 
from which body fat is 
determined 
High 
Validated against hydrostatic weighing (Ginde et al. 
2005, r = 0.94) 
Test retest reliability good r = 0.99 (Noreen and 
Lemon, 2006) 
Contrary, within day reliability good r= 0.98 but 
significant differences between different day 
measures (Anderson 2007) 
Difficult 
More suitable 
alternative to HW. 
Suitable for very heavy 
patients 
Cost  and specialist skill 
required 
DEXA 
 
Measures bone mineral 
density, fat mass and soft 
tissue mass. 
High 
Validated against CT scan for determining total 
abdominal fat, r = 0.87 to 0.98 (Snijder et al. 2002) 
High inter tester reliability for fat mass (r = 0.99) 
and lean mass (r = 0.98) (Hill et al. 2007) 
Moderate 
Cost 
Severely obese may 
exceed the weight limit 
of the compartment 
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Ultrasound  
 
Moderate 
Validated against CT scan for abdominal adipose r 
= 0.81 (Stolk et al. 2001), and total fat r = 0.75 
(Ribeiro-Filho et al. 2003) 
Some studies show poor reliability, however, Stolk 
et al. (2001) show good reliability with a strict 
protocol, r = 0.94 
 
Moderate 
Portable  
Skill required 
BIA 
 
Measures electrical 
resistance offered by 
body, thus estimates 
TBW which is used to 
calculate fat free mass 
and fat mass. 
High 
 
Hand held BIA validated against DEXA r = 
0.87(men); r = 0.83 (women) (Deurenberg et al. 
2001) 
Easy 
Not expensive 
Portable 
Hydration condition 
should be maintained 
for accurate 
measurement 
Skin fold measurement 
Skinfold thickness 
measured using callipers 
Low 
Five currently used equations validated against HW 
in children showed large errors. Thus suggested that 
it can be useful as an indices and not a measure 
(Reilly et al. 1995) 
Results affected by inter-observer errors, choice of 
calipers, selection of skinfold sites (Pollock et al. 
1988) 
 
Easy 
Simple and quick 
Minimum labour and 
cost 
 
BMI 
Calculated as weight (in 
kilograms) divided by 
square of height in 
meters 
Moderate 
Can be used as baseline data or longitudinal 
measure to determine relative body weight. Does 
not differentiate fat and fat free mass thus accuracy 
in determining total body fat doubtful (Wells and 
Fewtrell 2006) 
Easy 
Simple and quick 
Reliable  
Waist circumference 
 
Used as an indicator of 
abdominal fat 
Moderate 
Validation against MRI for abdominal fat (r = 0.4-
0.8).Waist to hip ratio showed inconsistent or no 
significant relation to abdominal fat (r = 0.4-0.7) 
(Chan et al. 2003) 
Easy 
Simple and quick 
Reliable 
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CHAPTER 4: EFFECT OF BMI ON OUTCOMES FOLLOWING TKA- 
LITERATURE REVIEW 
 
 
4.1. Chapter overview 
 
This chapter presents the literature review used to evaluate the effect of obesity (defined 
by BMI) on outcomes following TKA. After a brief background to the literature review; 
previous evidence of the effect of BMI on post-operative complications, questionnaire 
based functional outcomes and prosthetic longevity is discussed. This is followed by a 
discussion of the other factors associated with obesity which may influence the outcomes. 
Finally, a summary of the conclusions from the evidence is presented.  
 
 
4.2. Introduction and background 
 
It is seen that the proportion of patients with higher body mass index (BMI) undergoing 
total knee arthroplasty (TKA) is much higher than that of patients with lower BMI 
(Bostman 1994; Fehring et al. 2007). Moreover, this trend of higher proportion of 
patients with greater body mass among the total knee arthroplasty population shows an 
increase over the years (Fehring et al. 2007).  
The influence of obesity on knee osteoarthritis implies that with increasing obesity and 
aging of the population, the proportion of obese osteoarthritis patients undergoing total 
knee replacement is on the rise and is likely to reach higher levels in future.  
These increasing trends in the prevalence of obesity in TKA population have led to 
concerns regarding the outcomes of the surgery in obese patients. Obesity is considered 
53 
 
as a risk factor for a number of surgical complications and despite advancements and 
improvement in alignment and insertion techniques, there also remain concerns about the 
impact of the added stress on the underlying bone and implant material in obese patients 
thereby affecting the prosthetic longevity and functional gain (Winiarsky et al. 1998, 
Miric et al. 2002, Namba et al. 2005). 
In addition to concerns over the increased rates of peri-operative complications, increased 
stress on the implanted prosthesis and thus the success of surgery in this patient group, 
there are implications of increased financial burden on health care services in managing 
these complications. In response to a perceived increased risk and cost of the procedure in 
these patients, three primary care trusts recently followed the ‘Ipswich protocol’ which 
restricted access to TKA in patients with BMI ≥ 30 kg/m2(Gillespie and Porteous 2007). 
This prioritization in favor of non-obese has been the topic of much controversy since 
there is little agreement over predilection for adverse outcomes in the obese TKA 
population. Several studies report no significant differences in the outcomes in obese and 
non-obese patients (Jiganti et al. 1993; Spicer et al., 2001; Stickles et al., 2001; 
Deshmukh et al., 2002; Amin et al. 2006a) and on the other hand, some studies find obese 
patients with inferior outcomes in terms of post-operative complications, function and 
revision rates (Winiarsky, et al.1998; Griffin et al., 1998; Miric et al., 2002; Foran et al., 
2004; Namba et al., 2005; Jackson et al 2009; Dowsey et al. 2010). 
Thus as the prevalence of obesity and aging of the population continues to rise, it is 
important to define the relationship between obesity and the outcomes of TKA. From the 
demographics of obesity in the U.K it is clear that in regions like Scotland, the prevalence 
of obesity is high and indeed higher than the U.K average prevalence thus making it 
important for assessing the influence of obesity on TKA outcomes especially in this 
region.  
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4.3. Obesity and post-operative complications post TKA 
 
Obesity, defined by BMI has been identified as an independent risk factor for post-
operative complication in patients undergoing lower limb arthroplasty by some studies 
(Jain et al. 2005; Parvizi et al. 2007). Based on a nationwide inpatient care database 
investigating approximately one million patients in the U.S.A, the study by Jain et al. 
(2005) showed that the risk of postoperative complications after major joint arthroplasty 
(shoulder, hip and knee) was 1.3 times more likely in obese.patients  
Specific to the TKA population, two earlier studies investigating the link between obesity 
and post-operative complications have defined obesity in terms of ideal body weight 
derived from insurance company statistics (Stern and Insall 1990 and Jiganti et al. 1993). 
In a retrospective review comparing 51 non-obese TKA patients with 103 obese TKA 
patients by Jiganti et al. (1993), there was no association between obesity and peri-
operative morbidity. These findings were concurrent with that from the study by Stern 
and Insall (1990). Though not statistically significant, Jiganti et al. (1993) in fact saw a 
lower rate of major and minor complications in obese patients. Although, it has been 
noted, that on the comparison of sample characteristics of the obese and non-obese 
groups in this study, pre-existing medical conditions and rheumatoid arthritis were higher 
in their non-obese group (30% in non-obese patients vs. 14% in obese patients).  
The most common definition of obesity that is currently used is the Body Mass Index 
(BMI) and has been used to define obesity in most of the papers under review. BMI is 
also known as the Quetlet Index and is calculated as the ratio of the body weight in 
kilograms to the square of height in meters. Using BMI, obesity is then defined as BMI 
equal to or greater than 30 kg/m². A more detailed classification of BMI suggests division 
into five groups of BMI, these being BMI < 25 kg/m
2
 (healthy); BMI = 25-29.9 kg/m
2
 
(overweight); BMI = 30-34.9 kg/m
2
 (class I obese); BMI = 35-39.9 kg/m
2
 (class II obese) 
; BMI ≥ 40 kg/m2 (class III obese) (WHO 2000) 
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4.3.1. Comparison between obese (BMI ≥30 kg/m2) and non-obese (BMI <30 kg/m2) 
patients 
In a prospective study comparing 210 TKA in non-obese with 160 TKA in patients with 
obesity, there was no difference across the two BMI groups (non-obese patients with 
BMI<30 kg/m² and obese patients with BMI ≥30 kg/m²) for superficial wound infection, 
deep joint infection, deep vein thrombosis (DVT), pulmonary embolism and peri-
operative mortality (Amin et al. 2006a).On the other hand, a study by Dowsey et al. 
(2010), saw significantly higher rates prosthetic infection, superficial wound 
complication and deep vein thrombosis (DVT) in their 261 obese patients (BMI = 30-39 
kg/m²) than in their 211 non-obese (BMI < 30 kg/m²) TKA patients. An overall 
complications rate of 3% (a DVT, wound dehiscence and a foot drop) was seen in 78 
obese TKA patients compared to 0% in 78 non-obese TKA patients in a retrospective 
matched study (Foran et al. 2004b). This higher rate of complication in obese patients 
however, did not reach statistical significance in this study.  
 
4.3.2. Comparison between obese (BMI ≥35) and non-obese (BMI <35) patients 
While the above studies grouped obese and non-obese based on BMI a cut off value of 30 
kg/m², Miric et al. (2002) in a prospective review divided obese and non-obese groups 
based on BMI greater or less than 35 kg/m². They found a significantly increased 
incidence of post-operative complications in obese TKA patients (n = 86) i.e., the number 
of patients who had a complication or multiple complications was higher in patients with 
a BMI ≥ 35 kg/m² compared to non-obese TKA patients with BMI < 35 kg/m² (n = 320). 
Of the patients with BMI ≥ 35 kg/m², 38% experienced a complication, whereas only 
25% of patients with BMI < 35 kg/m²experienced some type of peri-operative 
complication. In this study complications were defined as ‘any problem that required 
additional therapeutic intervention’ and individual complications categorized according 
to the body system affected were not analyzed separately. Also, in contrast to Jiganti et 
al. (1993), who observed greater number of comorbidity in their non-obese group,  a 
higher rate of significant preexisting medical condition (cardiac and diabetes mellitus) 
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was seen in the group of patients with higher BMI in this study. Another study found a 
higher rate of post-operative infection in patients with BMI ≥ 35 kg/m² but saw a similar 
distribution of other medical complications like DVT, cardiac, gastro intestinal and 
pulmonary complications between their obese and non-obese groups (Namba et al. 2005). 
A case control study with 12 month follow up (Nunez et al. 2010), reported greater intra 
operative difficulties and more severe complications in their obese group (BMI > 35 
kg/m
2
) which included deep infection, loosening of tibial implant, re intervention for 
patellar prosthesis and re intervention for arthrolysis due to stiffness compared to the 
matched control group (BMI <35 kg/m
2
, matched for age, sex and pre-operative 
WOMAC score). In contrast to these findings, Stickles et al. (2001) saw no difference in 
the complication rates between obese and non-obese and even across their five BMI 
groups (grouping as described above).  
 
4.3.3. Post-operative complications in the morbidly obese (BMI ≥ 40kg/m2) 
Significantly higher rates of wound complication, infections, prosthetic failure and intra 
operative avulsion of medial collateral ligament have reported in the morbidly obese by 
Winiarsky et al. (1998). Similarly, Amin et al. (2006b) saw a higher rate of these 
complications in their morbidly obese groups. However, there was no intra operative 
avulsion of the medial collateral ligament in the morbidly obese group as that reported by 
Winiarsky et al. (1998). Krushell and Fingeroth (2007), in a retrospective examination of 
39 TKA in patients with BMI ≥40 kg/m2 vs. 39 controls with BMI < 30 kg/m2, also saw a 
significantly higher rate of early wound complications in their morbidly obese group. 
Thus, the evidence above does indicate that the risk of post-operative infection increases 
after a BMI of 40 kg/m
2
.Thelatter two  studies have compared morbidly obese (BMI ≥40 
kg/m
2
 ) with the non-obese patients (BMI <30 kg/m
2
). On comparing  patients with BMI 
greater than 40 kg/m
2 
and patients with a BMI < 40 kg/m
2
, similar to Winiarsky et al. 
(1998), Maliznak et al. (2009) reported a 3.2 times odds of infection in patient (p <0.05). 
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4.3.4. BMI and post-operative complications: Summary 
The relationship between obesity and the rates of post-operative complications following 
a TKA is not very clear from the literature. One of the difficulties in comparing the 
literature is the use of different measures to define obesity. Earlier studies have defined 
obesity as 20% above the ideal body weight based on 1983 Metropolitan life insurance 
company statistics (Stern and Insall 1990; Jigati et al. 1993). Later studies and in fact 
most studies till now have defined obesity in terms of BMI. Body mass index by these 
authors is considered a more established measure of obesity which has a better correlation 
with body fat compared to measures purely based on weight. On comparison of studies 
which have used BMI to define obesity for assessment of post-operative complication 
rates, the results still appear conflicting. While Miric et al. (2002), Namba et al. (2005), 
Nunez et al. (2010) and Dowsey et al. (2010) reported some association between BMI 
and post-operative complications, Amin et al. (2006a), Stickles et al (2001)reported no 
differences across the BMI groups. The division of patients into ‘obese’ and ‘non-obese’ 
groups was also different in the studies. Body mass index cut off value defining obesity 
was 30 kg/m
2
 in some studies, 35 kg/m
2
 in others while the study by Stickles et al. (2001) 
divided the patients into five BMI groups (< 25 kg/m
2
, healthy; 25-29.9 kg/m
2
, 
overweight; 30-34.9 kg.m
2
, class I obese, 35-39.9 kg/m
2
, class II obese; > 40 kg/m
2
, class 
III obese). Some consistency was seen in the reports showing an increased risk of 
infection in BMI greater than 35 kg/m
2
 and more so in studies comparing morbidly obese 
(BMI > 40 kg/m
2
) with BMI < 30 kg/m
2
 (Amin et al. 2006b; Krushell and Fingeroth 
2007) or BMI < 40kg/m
2
 
Another difficulty in comparison between literatures is due to the different approaches by 
authors towards defining and classifying post-operative complications. While Stern and 
Insall (1990) have recorded data on relatively few complications (thrombophlebitis and 
wound complications), Miric et al. (2002) have considered a more comprehensive list of 
complications classifying them according to the site of affection. The focus of most 
studies is on post-operative rates of infection and wound complications. Differences 
further exist in approaches towards defining wound complication and infection. For 
example, Namba et al. (2005) reported an odds ratio of 6.7 times higher risk of infection 
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in highly obese TKA patients (BMI ≥35 kg/m2). This study described superficial 
infection as those cases requiring intravenous antibiotics while those treated operatively 
or any positive culture were considered as deep infection. They did not record superficial 
cellulitis managed with oral antibiotics as an infection. On the other hand, Krushell and 
Fingeroth (2007) who also reported a significantly higher rate of post-operative infection 
in their morbidly obese group (BMI >40 kg/m
2
) did however, record superficial cellulitis 
treated with oral antibiotics as a wound complication.  
There are several factors apart from BMI which may lead to an incident of post-operative 
complication in TKA patients such as other comorbidity. As described in the above 
section, conflicting results were seen in the studies by Miric et al. (2002) and Jiganti et al. 
(1993), where Miric et al. (2002) saw a higher rate of post-operative complications in 
obese while Jiganti et al. (1993) saw a lower rate of post-operative complications in the 
obese. On observing the preexisting medical condition in the groups, it was noted that 
these were higher in the obese group in the study by Miric et al. (2002) and were 
observed higher in the non-obese groups by Jiganti et al. (1993). This indicated that in 
these samples, there is some influence of the preexisting medical comorbidity on the 
groups.  
The conflicting results and the different stratification of obese and non-obese therefore 
makes it difficult to conclude about a specific cut off point of BMI above which 
predisposes a higher risk of post-operative complication. Grouping patients into obese 
and non-obese based on BMI greater or less than 30 kg/m
2 
seem to show conflicting 
results with respect to rates of post-operative infection and DVT between obese and non-
obese. However, there seems to be an association of risk of post-operative complication 
with increasing obesity such that the results of the studies comparing morbidly obese 
patients with BMI > 40 kg/m
2
 with non-obese patients having BMI < 30 kg/m
2 
are more 
concurrent with each other indicating a higher risk of post-operative complication, in 
particular infection, in the patients with BMI > 40 kg/m
2
. Some evidence of the higher 
incidence of post-operative complications, though not consistent in studies, seen when 
classifying patients into highly obese i.e, those with a BMI > 35 kg/m
2
and non-obese 
(BMI < 35 kg/m
2
) could be suggestive of a larger range of patients at an increased risk of 
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post-operative complication than that reported for morbidly obese patients. Group 
comparison between highly obese (BMI > 35 kg/m
2
) and morbidly obese (BMI > 40 
kg/m
2
) have not been done separately. Among studies comparing three or five BMI, 
while Dowsey et al. (2010) (three BMI groups) reported higher prosthetic infection, DVT 
in patients with BMI = 30-39.9 and BMI > 40 kg/m
2 
compared to BMI <30 kg/m
2
, 
Stickles et al. (2001) (five BMI groups) reported no difference in the complication rates 
between their five BMI groups.  
 
 
4.4. Obesity and clinical outcomes scores 
 
Various outcomes scoring systems specific to the knee joint and or assessing patient 
function have been used to compare the outcomes of TKA between obese and non-obese. 
 
4.4.1. Comparison of Knee Society Score (KSS) between obese (BMI ≥ 30 kg/m2) and 
non-obese (BMI <30 kg/m
2
) 
A commonly used scoring system in these studies is the Knee Society Score (KSS) 
(Table 3). This form of scoring system consists of two parts, one objectively evaluating 
the knee joint and the other evaluating the overall functional level of the patient (Insall et 
al. 1989). From the studies comparing the Knee Society Score for obese (BMI > 30 
kg/m
2
) and non-obese (BMI <30 kg/m
2
) at a follow up of ten years or more, Griffin et al. 
(1998) comparing 22 obese and 34 non-obese reported lower i.e., worse function part of 
the KSS in obese as compared to non-obese patients but saw similar knee scores of KSS 
between groups at a mean follow up of 10.6 years. The function score of KSS consists of 
two components of walking ability and stair climbing ability. The average score for 
walking ability in the obese patients in this study was comparable to that in non-obese but 
stair climbing ability was significantly lower in obese patient. This lowered the overall 
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KSS function score in obese patients compared to non-obese patients in this study. A 
study by Foran et al. (2004a) with a follow up of 15 years also saw significantly lower 
post-operative KSS scores in 27 obese patients compared to 27 matched non-obese 
patients at the last follow up. In the study by Griffin et al. (1998) KSS at baseline was not 
measured and therefore it is not known if the obese group in this study had baseline 
scores which could have influenced the poorer post-operative scores. On the other hand, 
the lack of difference in the baseline KSS scores between obese and non-obese in the 
Foran et al. (2004a) study indicates that lower pre baseline scores had little effect on the 
resulting poorer follow up scores in their obese group.  
At a minimum follow up of five years, Foran et al. (2007b) in another study comparing 
outcomes in 78 obese patients (BMI >30 kg/m
2
) with 78 matched controls (BMI <30 
kg/m
2
), reported no significant difference between the baseline KSS scores in obese and 
non-obese but again, the post-operative scores were significantly different between obese 
and non-obese (94 in obese versus 90 in non-obese for KSS knee score and 78 in obese 
vs. 71 in non-obese for KSS function score). Also, the improvement in scores (calculated 
as the difference between baseline and post-operative scores) in obese patients was 
significantly lower. In contrast to the above finding, several authors have not found 
significant differences in scores between obese and non-obese at an average follow up 
five years (Spicer et al. 2001; Amin et al. 2006a; Bourne et al. 2007; Dewan et al. 2009). 
No significant difference was found for post-operative KSS knee score at a five year 
follow up between  125 obese and 158 non-obese (84.1 in obese vs 85.4 in non-obese) by 
Amin et al. (2006). A separate analysis of patients with weight < 100 kg (n = 258) vs 
patients with weight > 100 kg (n = 25) in this study did not show significant difference 
across any group at a five year follow up. Spicer et al. (2001) saw a lower baseline (pre-
operative) KSS function score but comparable baseline  KSS knee score in the 285 obese 
patients compared to 371 non-obese controls in their study. At a mean follow up of 6.3 
years, the post-operative KSS score (knee or function) was not different across groups. 
Despite a lower KSS score in the baseline assessment, the improvement in scores which 
was calculated as the difference between baseline and post-operative score was not 
different between groups in this study which conflicts directly with the findings in the 
two studies by Foran et al. (Foran et al. 2004a and Foran et al. 2004b). 
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Assessing the influence of various patient factors (age, sex, diagnosis, BMI) on TKA 
outcomes with a follow up range of 5-11 years, Bourne et al. (2007) also concluded that 
BMI had little impact on the improvement of KSS scores from pre-operative state to post-
operative state. In fact, Bourne et al. (2007) reported that the improvement in scores was 
greater for the obese; however, this did not reach a statistically significant level.  
At a shorter follow up of one year, two studies in this review reported conflicting results. 
While Deshmukh et al. (2002) using hierarchical regression analysis reported that BMI 
did not account significantly for variation in one year post-operative KSS scores, the 
more recent study by Dowsey et al. (2010) observed a significantly lower one year post-
operative KSS score in their obese (BMI > 30 kg/m
2
) and morbidly obese (BMI > 40 
kg/m
2
) groups compared to the non-obese. In addition, they (Dowsey et al. 2010) 
reported lower improvement particularly in function and pain scores obese and morbidly 
obese 
 
4.4.2. Comparison of Hospital for Special Surgery Score (HSS) between obese (BMI ≥ 30 
kg/m
2
) and non-obese (BMI <30 kg/m
2
) 
Two studies in the review compared HSS between obese (BMI > 30 kg/m
2
) and non-
obese (BMI < 30 kg/m
2
) (Table 4). Griffin et al. (1998) at a ten year follow up reported 
similar scores between obese and non-obese even though the baseline HSS score for their 
obese group was lower. In contrast to this finding, Jackson et al. (2009) reported similar 
baseline scores between their obese and non-obese groups while lower follow up scores 
(average follow up of 9.2 years) in obese and also less improvement in obese at follow up 
compared to non-obese.  
 
4.4.3. Comparison of WOMAC Score between obese and non-obese 
WOMAC is a self-administered knee joint specific questionnaire. At a follow up of 
twelve months post-operatively, BMI did not affect total WOMAC scores (Stickles et al. 
2001, Nunez et al. 2010). A worsening of reported function (decrease in total scores) as 
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BMI increased was observed by Stickles et al. (2001), but the change in the scores from 
baseline to one year was similar across their five BMI groups (Table 5). In the study by 
Nunez et al. (2010), BMI was categorized into severely obese (BMI > 35 kg/m
2
), and 
control (BMI < 35 kg/m
2
). Even with a higher BMI cut off point of 35, the study saw 
similar WOMAC pre-operative and follow up scores between the groups (Effect sizes 
shown in Table 5). At a longer follow up for 5-11 years by Bourne et al. (2007), similar 
improvements in WOMAC scores were seen between their five BMI groups. Conclusions 
from these studies suggest that BMI groups are not significantly different in terms of self-
report knee function as measured by WOMAC.  
 
4.4.4. Comparison of SF36/SF12 scores between obese and non-obese 
The overall health related quality of life measured by the Short Form 36 health survey 
(SF36) was seen to have a similar distribution by Stickles et al. (2001) i.e, the 
improvement of scores from pre-operative to post-operative follow up was similar in 
obese and non-obese groups. Similarly, BMI did not account for variation in SF36 at one 
month, three months or six months post-operatively as assessed by Stevens- Lapsley et al. 
(2009) (Table 6). Cushnaghan et al. (2008) compared SF36 scores in a patient group who 
had undergone TKA for osteoarthritis with a matched control group with knee 
osteoarthritis who had not previously undergone TKA. Comparison was done to assess 
the impact of factors like age, sex, comorbidity, BMI, baseline scores on TKA outcomes 
during a mean follow up period of 6.9 years. On analysis of 108 obese in patient group, it 
was shown that there was apparent improvement in both obese and non-obese in the 
patient group, though the improvement was less in obese compared to non-obese in this 
group (but not significantly lower). This study also compared obese TKA patients with 
obese controls with OA but no TKA and reported that there was a marked decline in 
physical function score of SF36 in obese controls. Therefore from this study it was 
concluded that adverse effects of high BMI with respect to physical function score of 
SF36 in obese patients is smaller compared to obese controls (without TKA) and not 
significant thus indicating a definite advantage of TKA in obese patients.  
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Two studies reviewed assessed Short Form 12 health survey (SF12) scores between obese 
and non-obese. Categorizing patients into five BMI groups, Bourne et al. (2007) saw 
similar improvements in SF12 scores between the BMI groups. However in contrast to 
this finding, Dowsey et al. (2010) reported poorer one year post-operative physical 
function of SF12 cores and lower improvement in SF12 scores in their obese and 
morbidly obese group.  
 
4.4.5. Comparison of patient’s satisfaction with surgery between obese and non-obese 
Patient reported satisfaction levels were found to be similar between obese and non-obese 
groups by (Griffin et al. 1998; Stickles et al. 2001; Jackson et al. 2009).  
However Namba et al. (2005) found a greater patient reported satisfaction in highly obese 
patients (patients with BMI > 35 kg/m
2
) when compared to non-obese patients. This 
result may be reflecting the greater improvement in reported pain in their highly obese 
group.  
 
4.4.6. Outcomes scores in morbidly obese patients (BMI ≥40kg/m2) 
In studies primarily evaluating the TKA outcomes in morbidly obese patients (BMI > 40 
kg/m
2
) , a significantly lower post-operative KSS score was seen in the morbidly obese 
group (Winiarsky et al. 1998; Amin et al. 2006b;  Krushell and Fingeroth 2007) (Table 
3). Although a significantly lower post-operative function score of KSS was seen, the 
knee score of KSS though lower in morbidly obese as compared to non-obese (85.7 vs. 
90.5 and 91 vs. 94), did not reach a statistically significant level (Amin et al. 2006b; 
Krushell and Fingeroth 2007). Similarly, the improvement in KSS function scores 
(difference between the pre-operative and post-operative scores) were significantly lower 
for morbidly obese, however, improvement in KSS knee scores though lower in morbidly 
obese, failed to reach a statistical significance. Subgroup analysis between morbidly 
obese patients (BMI > 40 kg/m
2
) with the non-obese group (BMI < 30 kg/m
2
) revealed 
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both pre-operative and postoperative KSS scores in the morbidly obese group as 
significantly lower at five years in the study by Foran et al. (2004)b.  
For WOMAC scores however, no differences were seen in the baseline scores or 12 
month follow up scores between severely obese (BMI > 35 kg/m
2
), and controls (BMI < 
35 kg/m
2
) by Nunez et al. (2010). Rajgopal et al. (2008) reported  worse WOMAC score 
at both baseline and 12 month follow up,but  they reported no difference in the 
improvement of score (from baseline to follow up) between morbidly obese and the 
controls (BMI < 40 kg/m
2
). 
For the overall health related quality of life measured by SF12, as mentioned above, 
Dowsey et al. (2010) saw a significantly lower one year post-operative SF12 physical 
component score in the morbidly obese but no differences in the mental component score 
between morbidly obese, obese and non-obese. In contrast to this finding Rajgopalet al. 
(2008) reported a lower pre-operative and one year post-operative SF12 scores, the 
improvement in SF12 mental component score of morbidly obese group was significantly 
higher than the non-morbidly obese  
 
4.4.7. BMI and clinical outcomes scores: Summary 
From the review of the above literature for effects of BMI on questionnaire based 
functional outcomes, it is clear that differences exist in the results of the studies making it 
difficult to draw from it conclusively an effect of obesity. These differences in the 
evidence seem to be based around the following predominant factors: 
1. Duration of follow up  
At short term follow up (up to one year), the results are conflicting, with Dowsey et 
al. (2010) reporting lower KSS scores for obese and morbidly obese while Deshmukh 
et al. (2002); Stickles et al. (2001); Nunez et al. (2010) reporting a lack of association 
of BMI with adverse outcomes assessed using KSS and WOMAC.  
65 
 
Evaluation of long term effect of obesity on KSS at follow up from 10 -15 years show 
a decreased score and therefore decreased function in the obese at follow up (Griffin 
et al. 1998; Foran et al. 2004a;). However for HSS score at long term, while a lower 
post-operative function was seen at 9.2 years for obese (Jackson et al. 2009), a lower 
pre-operative HSS for obese but similar follow up HSS scores between groups were 
also reported (Griffin et al. 1998). 
In a second study by Foran et al. (2004b), a poorer absolute follow up KSS score as 
well as less improvement in the scores (from baseline to follow up at five year) for 
the obese patients was reported. However, other studies with similar or slightly longer 
follow up (two years to seven years) have been unable to demonstrate a poorer 
outcome in obese compared to non-obese (Spicer et al. 2001; Amin et al. 2006;  
Bourne et al. 2007; Dewan et al. 2009). 
Therefore, conflicting results were observed for all different durations of follow up 
(one year to nine years). At a greater follow up, after ten to 15 years of surgery, 
poorer KSS scores in obese (BMI >30 kg/m
2
), particularly in the function component 
has been reported though by only two studies with different study designs (Griffin et 
al. 1998; Foran et al. 2004a;). These disparities’ in the results therefore make it 
difficult to conclude if there is a true effect of BMI on outcomes scores and if there is, 
the time point beyond which higher BMI patients are pre disposed to poorer function. 
2. Questionnaire used 
The questionnaire used most commonly in the studies in this population is the KSS 
and the WOMAC questionnaire has been predominantly used among the self-report 
questionnaires. Differences were seen between the two components (knee and 
function) of the KSS score. Some studies have reported low function component of 
KSS scores in obese (Griffin et al. 1998; Spicer et al. 2001; Jackson et al. 2009). 
Function component of KSS and HSS include assessment of walking and stair case 
climbing ability. In the study by Griffin et al. (1998), the average score for walking 
ability in obese was comparable to non-obese but the stair climbing ability was 
significantly lower in obese which lowered the overall KSS function score. In a 
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separate analysis of stair case climbing ability using self-report questions (Stickles et 
al. 2001), it was found that as BMI increased the difficulty in ascending and 
descending stairs increased at a one year follow up. Authors (Griffin et al. 1998) 
propose that since the patello femoral joint reaction forces reaches up to seven to 
eight times body weight, in an obese patient, this is more likely to cause pain after 
surgery. Jackson et al. (2009) also suggest that the decreased range of motion due to 
apposition of soft tissues at higher flexion angle would likely affect function in the 
obese. 
For self-reported knee outcomes such as the WOMAC the literature seems to be 
consistent in concluding similar outcomes for obese and non-obese (Stickles et al. 
2001; Nunez et al. 2010). Patient reported satisfaction with surgery was also equal 
among obese and non-obese patients. This could suggest that even though function 
when assessed objectively by examiners for knee replacement patients based on 
clinical parameters may be poorer for obese patients, the patients perception of the 
improvement in their function and satisfaction with surgery is comparable between 
obese and non-obese (BMI < or >  30 kg/m
2
). 
The greater difficulty in function particularly stair ascending and descending in the 
obese patients (BMI >30 kg/m
2
) has been evidenced by some studies lending support 
to the hypothesis that increased body mass adds to difficulty in performing joint 
loading activities. However this is refuted by evidence from other authors. Multiple 
factors such as cardio-vascular status, respiratory difficulties, pain or disability in 
other joints which affect activity performance contribute to functional difficulty. 
Though it can be supposed that comorbidity would be greater in obese which could 
contribute to the differences in the results.  
3. Patients with BMI ≥ 40 kg/m2 (morbidly obese) 
Results of studies are more consistent when comparing KSS scores for morbidly 
obese and non-obese with the conclusion that the morbidly obese with BMI ≥ 40 
kg/m
2
 have a significantly lower function than the non-morbidly obese with BMI < 
30 kg/m
2
 (Foran et al. 2004b; Amin et al. 2006b; Krushell and Fingeroth 2007). On 
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comparison of BMI ≥ 40 kg/m2 with BMI < 40 kg/m2Winiarsky et al.(1998) also 
reported poorer KSS scores in the morbidly obese group. Self-report knee function 
measured by improvement in the WOMAC scores from baseline to follow up of one 
year in morbidly obese was comparable to non-obese (Rajgopal et al. 2008; Nunez et 
al. 2010). This again suggests that even at higher BMI, though the objective measure 
of function may not be comparable in the morbidly obese patients, patient’s 
perception of function and health seems to improve comparably across BMI groups.  
4. Influence of baseline scores 
Clinical outcome has been analyzed as absolute follow up scores and as improvement 
of scores. When assessing absolute scores, the following striking differences were 
seen: 
a. Comparable baseline scores between obese and non-obese but lower follow up 
scores in obese (Foran et al. 2004a; Foran et al. 2004b; Jackson et al. 2009, 
Dowsey et al. 2010). 
b. Comparable scores between obese and non-obese at baseline and follow up (Amin 
et al. 2006a; Dewan et al. 2009; Nunez et al. 2010)  
c. Lower baseline score in obese but comparable follow up scores between obese 
and non-obese (Spicer et al. 2001, Griffin et al. 1998 for HSS score). 
d. Lower function component in obese at follow up, however, no baseline KSS data 
collected (Griffin et al. 1998 for KSS score). 
The above differences raise questions regarding the influence of the baseline scores in 
studies and reflect the study design used to assess clinical outcomes scores. In order 
to minimize the above said influence, some studies have used controls matched for 
baseline scores (Foran et al. 2004b; Krushell and Fingeroth 2007; Nunez et al. 2010) 
or assessed improvement in scores from baseline to follow up in addition to or instead 
of absolute scores (Stickles et al. 2001; Nunez et al. 2010; Dowsey et al. 2010; 
Jackson et al. 2009; Bourne et al. 2007). Nevertheless, differences in results still 
persist rendering the true effect of obesity unclear.  
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Table 3 Details of previous studies assessing BMI and KSS scores 
Study BMI cut off N (Obese vs 
Non-obese) 
Follow 
up 
Absolute scores Change KSS scores 
Pre op KSS Post op KSS 
Foran et 
al.(2004b) 
 
30  68 vs. 
68(matched) 
6.6 
years 
Not different* Lower in obese 
KSS knee ( p =0.04), ES = -
0.39 
KSS function (p=0.05).  
ES = - 0.3 
Lower in obese  
KSS knee,p= .01, ES = 0.43 
Griffin et al. 
(1998) 
 
30 22 vs. 34 10 
years 
No baseline KSS Lower in obese  
KSS function (63.7 vs. 82.2), 
p< 0.01 
 
Foran et al. 
2004a 
 
30 27 vs. 27 
(matched) 
15 
years 
Not different* Lower in obese 
KSS knee (81 vs. 89), p = 
.019 
 
Amin et al. 
2006a 
 
30 125 vs 158 5 years Not different* Not different*  
84.1 vs. 85.8  
 
Spicer et al. 
2001 
 
30 
(5 groups) 
285 vs. 371 6.3 
years 
Lower in obese KSS 
function, p = <0.01 for BMI 
= 35-39.9 and BMI >40 
Not different*  77.2, 77.9, 
72.9 (obese groups) vs. 79.5 
(non-obese group) 
Not different*  41.1,  44.9,  
40.1 (obese groups) vs. 40.2 
(non-obese 
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Dewan et al. 
2009 
 
3 groups 
(30-39)  
(>40) vs <30 
71,31vs 67  5.4 
years 
Not different*  
 
Not different*  
KSS knee = 88, 85 (obese) vs. 
83 (non-obese) 
KSS function = 71,68 (obese) 
vs. 66  
 
Dowsey et al. 
2010 
 
30  
(3 groups) 
 
30-39,  >40 
Vs. <30  
261, 57 vs. 211 1 year Not different*  
 
Lower in obese and morbidly 
obese 
KSS kee and function, p <0.01 
Lower in obese and morbidly 
obese 
KSS function, p = 0.006 
Total KSS, p = 0.016 
Winiarsky et 
al. 1998 
 
40  
 
40 vs. 1539 5 years Not different*  
 
Lower in morbidly obese  
KSS knee (84 vs.92) and KSS 
function (53 vs. 67), p<0.001 
 
Amin et al. 
(2006b) 
 
40 
(> 40 vs.  
< 30) 
38 vs 38 
(matched) 
3.2 
years 
Not different*  
 
Lower in morbidly obese 
KSS function, 75.6 vs. 83.4, 
p= 0.01 
 
Krushell et al. 
2007   
 
40 
>40 vs.  
<30  
39 TKA vs 39 
matched TKA 
7.5 
years 
Not different*  
 
Lower in morbidly obese 
KSS function (44 vs. 64), 
p<0.01 
Lower improvement in 
morbidly obese 
KSS  function (16 vs. 26) 
Deshmukh et 
al. (2002) 
 
BMI as 
continuous 
variable 
 1 year  BMI accounts for insignificant 
amount of variation (13%) in 
scores 
 
*No statistical significant difference 
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Table 4 Details of previous studies assessing BMI and HSS scores 
Study BMI cut 
off value 
(kg/m
2
) 
N 
(obese vs. 
non-obese) 
Follow up Absolute scores Change/Improvement in 
HSS scores 
Pre op HSS 
 
Post op HSS 
Griffin et al. (1998) 
BMI <30 vs BMI>30 
30 22 vs. 34 10 years Lower in 
obese 
47.7 vs 55,  
p < 0.01 
Not different*  
(88.3 vs 90.3) 
 
Jackson et al. (2009) 
BMI <30 vs BMI>30 
30 50 vs. 50 
(matched) 
9.2 years Not different*  
 
Lower in 
obese 
(83.8 vs. 
87.4),  
p < 0.05 , 
 ES = -0.4 
Less improvement in obese  
(27.3 vs. 33.3), p < 0.05 
ES = -0.39 
*No statistical significant difference 
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Table 5 Details of previous studies assessing BMI and WOMAC scores 
Study BMI cut off 
value 
(kg/m
2
) 
N 
(obese vs. 
non-obese) 
Follow up Absolute scores Change/Improvement in 
WOMAC (total) scores 
Pre op WOMAC 
 
Post op 
WOMAC (total) 
Sticles et al. 2001 
 
<25 
25-29 
30-34 
35-39 
>40 
271, 149, 92 
vs. 146, 204 
1 year Poorer scores as 
BMI increased,  
p < 0.01 
Poorer scores as 
BMI increased,  
p < 0.01 
Not different*  
23.1, 25.3, 26.7 vs. 20.6, 23.4 
Nunez et al. 2010 
 
35 60 vs. 60 
(matched) 
1 year WOMAC 
stiffness lower 
(better) in non-
obese 
53.3 vs. 37.9 
Not different*  
28.3 vs. 28.6, 
ES = -0.016 
Not different*  
33.1 vs. 29.6 (ES of change form 
baseline for each group = 2 vs. 
2.2) 
Rajgopal et al. 2008 40 69 vs. 481 1 year   Not different*  
p = 0.669 
(mean values not given) 
*No statistical significant difference 
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Table 6 Details of previous studies assessing BMI and SF36 or SF12 scores 
Study BMI cut off 
value (kg/m
2
) 
N 
(obese vs. non-
obese) 
Follow up Absolute scores Change/Improvement in 
SF36/SF12 scores 
Pre op SF36/SF12 Post op 
SF36/SF12 
Sticles et al. 2001 
 
<25 
25-29 
30-34 
35-39 
>40 
271, 149, 92 
vs. 146, 204 
1 year Lower scores as 
BMI increased 
(PCS and MCS),  
p < 0.01 
PCS = 38.3, 37.3, 
37.9 vs. 40.2, 40, 
p <0.05 
MCS = 53.7, 52, 52.5 
vs. 53.6, 54.8, p< 
0.05 
Not different*  
PCS = 8.3, 9.5, 9.9 vs. 8, 
9.3 
MCS = 0.7, 0.8,1.2 vs. 1, 
0.5 
Steven-Lapsley et al.2009  BMI as 
continuous 
variable 
106 1 month,3 
months and 6 
months  
  BMI did not account for 
variation in SF36 
r = 0.39 (1 month), 0.49 (3 
months), 0.47 (6 months) 
Dowsey et al. 2010 
 
30  
30-39,  >40 
vs. <30  
261, 57 vs. 211 1 year Not different*  
 
Lower in morbidly 
obese  
PCS (SF12) = 31.1 
(morbidly obese) vs. 
36.3 (obese), 35.8 
(non-obese), p = 0.05 
Not different*  
PCS = 9.9 (obese), 5.3 
(morbidly obese) vs. 9.4 
MCS = 0.4 (obese), 3.3  
(morbidly obese) vs. 0.7 
Rajgopal et al. 2008 40 69 vs. 481 1 year Lower in 
morbidly obese 
PCS (SF12) = 
31.8 vs. 34.8 
MCS = 49.6 vs. 
54.3  
Lower in morbidly 
obese 
p<0.05 (mean values 
not given) 
 
Improvement in MCS more 
in morbidly obese 
 
p < 0.05 
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4.5. Radiological evaluation and prosthesis longevity 
 
A significantly higher incidence of focal osteolysis was seen in obese patients; 13 in 
obese (n = 285) vs. 5 in non-obese (n = 371) (Spicer et al. 2001). However, in this study 
with an average follow up of six years though revision rates in obese exceeded that in 
non-obese (16 in obese vs 13 in non-obese), using revision of any component as end 
point for survival, survivorship analysis showed statistically similar survival rates 
between obese and non-obese (98.1% for obese and 99.9% for non-obese). This similarity 
was maintained till the tenth year which was the last follow up. Amin et al. (2006a) on 
the other hand saw comparable revision rates between obese (four revisions) and non-
obese (three revisions). Slight asymmetry of polyethylene space (less than 1 mm) 
between medial and lateral compartments was seen in six patients (four obese, two non-
obese) by Griffin et al. (1998) in their sample of 56 patients. There were significantly 
more non progressive radiolucent lines in the obese group compared to the non-obese. 
However, this did not have any implications on prosthesis survivorship in this study as all 
three knee replacements revised were in patients in the non-obese group. 
Some studies classified the result of TKA as ‘failure’ or ‘success’ based on need for 
revision or a combination of need for revision and clinical outcome scores. 
Vasques-vela Johnson et al. (2003) investigated the effect of patient demographics (BMI, 
age gender, diagnosis) in 559 TKA. They considered ‘failure’ as revision operation or 
prosthetic component removal. Prosthesis survival rate according to this study was 92.7% 
in obese compared to 98.5 % in non-obese showing good results were obtainable in obese 
patients but they are not as good as the ten year survival rate in the non-obese. In this 
study survival rates were seen to be lowest at 35.71% in obese patients with age less than 
60 years. Bordini et al. (2009) considered revision of at least one component or exchange 
of polyliner as the end point for prosthesis survival, in a retrospective review of a large 
database with 6532 non-obese patients and 3203 obese patients. They did not find any 
influence of BMI on the survival of prosthetic implant at five years follow up with similar 
failure rates across BMI groups. In contrast to these findings, On the other hand, Mulhall 
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et al. (2007) assessed the patient reported time between primary TKA and revision 
surgery in 291 patients undergoing revision TKA and found that the average survivorship 
time was significantly lower in obese compared to non-obese (6.6 years in obese vs. 8.3 
years in non-obese). Failure of TKA as described by a fair/poor post-operative KSS score 
or revision surgery or radiographic failure was of a significantly higher rate in obese 
compared to non-obese in the study by Foran et al. (2004b). Eighty eight percent of knees 
were considered to have a successful outcome in the obese group with four patients 
undergoing revision surgery while 99% of the non-obese patients had a successful 
outcome with no revisions in the group (at an average follow up of 6.6 years). 
Survivorship curves to analyze the differences in time to prosthetic failure showed similar 
rates of prosthetic survival between the obese and non-obese, until between 5 and 6.6 
years after which failure rate became more apparent in obese patients. In  a similar study 
by Foran et al. (2004a) with a longer follow up duration of 15 years, the failure rate in 
obese patients at the last follow up at 15 years post TKA was higher than non-obese 
patients but not statistically significant (9 vs 3 of 30 knees). Survival analysis revealed 
similar rate of prosthetic failure between obese and non-obese however, lower survival 
rates became apparent in obese patients by 15 years. Rate of polyethylene spacer change 
was also greater in non-obese than obese (though not statistically significant). However, 
it was noted that the overall activity level of patients undergoing polyethylene spacer 
change was higher compared to those not undergoing a polyethylene spacer change.  
 
4.5.1. Prosthesis survival in morbidly obese patients (BMI ≥ 40 kg/m2) 
Amin et al. (2006b) compared the results of TKA between 38 morbidly obese patients 
and 38 non-obese controls matched with a mean follow up of 3.2 years. In the morbidly 
obese group, apart from lower KSS scores and significantly higher rate of overall 
complications (superficial wound infection, deep joint infection, deep vein thrombosis, 
peri-operative mortality), higher rate of radiolucent lines around the implants were seen. 
Five year survivorship using revision as end point was 74.2% in morbidly obese and 
100% in non-obese (BMI < 30 kg/m
2
) and when using revision and pain as end points, 
was 72.3% in morbidly obese and 97.6% in non-obese. Both five year survivorship rates 
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were statistically different between the two groups. At an average follow up of 7.5 years, 
though higher revision rates were seen in morbidly obese compared to the control groups 
with BMI < 30 kg/m
2
 (2 vs. 0), the difference, however, did not reach a statistically 
significant level (Krushell and Fingeroth  2007). Differences in revision rates between 
morbidly obese (BMI > 40 kg/m
2
), obese (BMI = 30-39 kg/m
2
) and overweight (BMI = 
20-29 kg/m
2
) also did not reach statistical significance at 5.4 years (Dewan et al. 2009). 
With regard to radiolucencies, three studies (Winiarsky et al. 1998, Mont et al. 1996 and 
Krushell and Fingeroth  2007) did not report significant differences between morbidly 
obese (BMI > 40 kg/m
2
) and non-obese (BMI < 30 kg/m
2
) or non-morbidy obese (BMI < 
40 kg/m
2
) at follow ups of five, seven  and 7.5 years respectively.  
 
4.5.2. BMI and prosthesis survival: Summary 
A summary of the findings of the key studies are shown in Table 7.  
Prosthesis survival is one of the important measures of long term results of total knee 
replacement. The effects of obesity on implant survival assessed by the above studies use 
different end points to describe survival. While some studies use survivorship analyses, 
many studies use revision rates and/or radiographic analysis and/or poor clinical scores to 
determine the success and failure of the procedure. Many studies showed a lower survival 
rate in obese patients (BMI > 30 kg/m
2
) in comparison to that in non-obese patients 
(Vasquez Vela Johnson et al. 2003; Foran et al. 2004a; Foran et al. 2004b; Mulhall et al. 
2007). On the other hand, some studies found equal survivorship in obese and non-obese 
(Griffin et al. 1998; Amin et al. 2006a; Bordini et al. 2009; Jackson et al. 2009). Evidence 
from the studies reporting decreased survivorship in obese patients has supported the 
hypothesis that increased body mass and therefore increased mechanical loading on the 
prosthesis during weight bearing activities can lead to increased wear and tear with time. 
This is further supported by the evidence of the lowest 10 year survival rate in the 
younger obese patients (BMI > 30 kg/m
2
and age < 60 years) in one study (Vasquez Vela 
Johnson et al. 2003). The assumption of greater activity levels in younger patients 
highlights the compounded effect of increase loading with addition body mass and 
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repeated loading activities on the durability of prosthesis. Revision due to prosthetic 
infection could be suggestive of a higher rate of prosthetic infection at mid - term (5 
years) or long term. Based on this hypothesis of increased loading, more obvious and 
consistent evidence of decreased prosthetic survival can be expected from studies 
comparing morbidly obese and non-obese/non morbidly obese. However, as inferred 
from the section above, this is not the case and that differences in results still persist even 
with the morbidly obese group. Similar prosthetic survival or revision rates between 
obese/morbidly obese and the non-obese patients gives support to an alternate hypothesis 
by authors that because wear and tear of prosthesis is a function of use, lower activity 
levels in higher BMI patients would compensate for the additional load on the joint.  
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       Table 7 Radiograhic Evaluation and Prosthesis survival 
Study  
 
Sample (obese 
vs. non-obese) 
and 
Duration  
Independent  
Variable(s) 
Results 
Foran et al. 
2004 
27  vs 27 control 
15 years 
BMI>30  
BMI<30  
Polyethylene spacer revision in 33% obese compared to 60% non-
obese,p = 0.069 
 
Success rate (KSS>79, revision due to aseptic loosening, radiographic 
signs of failure) = 70% in obese vs. 90% in non-obese, p 0.102 
Griffin et al. 
1998 
22 vs 34 
10.5 years 
BMI>30  
BMI<30  
3 (9%) revisions in non-obese vs. 0 in obese 
Vasques-vela 
Johnson et al. 
2003 
138 vs. 301 
10  years 
Age  
Gender 
BMI 
Overall survival rate at 10 years in obese 92.7% vs 98.5% in non-obese, 
p < 0.01 
66% of  failed knee in obese group 
Spicer et al. 
2001 
285: vs 371:  
10  years 
BMI>30:  
<30: control 
Rev rate higher in obese (5.6% vs. 3.5%), p = 0.25,  
Radiographic osteolysis in obese = 13 vs 5 in non-obese, p <0.05 
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Foran et al. 
2004 
68 vs. 68 
(matches) 
 
5-7 years 
BMI>30:  
<30:  
4revisions in obese = 4 vs 0 in non-obese 
After 6.6 years, prostheric survival rate of 87,7% vs. 98.7% in non-
obese (re operation, clinical failure, radiographic failure as end points) 
Bordini et al. 
2009 
8892 
18 months – 5 
years 
BMI<25 
25-30 
30-35 
>40 
Failure/revision due to any reason was similar across groups 
1.9%, 2.3% (>30) vs. 2% 1.9% (< 30) 
Mulhall et al. 
2007 
291 undergoing 
revision surgery 
BMI Avg survivorship time for primary prosthesis  significantly lower in 
obese (77.2 vs 99 months), p = 0.036 
Amin et al. 
2006a 
125 vs 158  
5 years 
BMI: BMI>30:  
<30:control 
2.5% revision in obese vs. 1.4%, not statistically significant 
Amin et al. 
2006b 
38 vs 38 
5 years 
BMI>40: 
<30 control 
Overall results for morbid obese inferior compared to non-obese 
Krushell and 
Fingeroth (2007) 
39 vs 39 
5 – 14years 
BMI>40: 
<40 control 
Most M.ob have long term improvement in pain, function but less 
frequently than non-obese 
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4.6. Other influences 
 
Apart from the various differences in the literature assessing obesity and outcomes after 
TKA such as study design, outcome measure and obesity classification, there are other 
influences on the outcomes of the surgery, which may overlap with the effect of obesity 
or independently affect the patient resulting in a good or poor outcome. In the section 
below, the influence of weight change after surgery, activity levels, previous and 
subsequent contralateral TKA and personal factors will be discussed to understand the 
relation between these factors and obesity and their effect on the overall outcome of 
TKA.  
 
4.6.1. Physical activity 
Prosthetic wear is a function of use i.e., greater the use (measured as physical activity) of 
the implant knee, faster is the rate of wear (McClung et al. 2000). Laboratory studies 
have shown that greater wear is proportional to the load. Therefore it is suggested that in 
obese TKA patients since there is a greater load due to the higher body mass, wear could 
be greater with use when compared to non-obese (Gillespie &Porteous 2007). However 
no consistent relationship between body mass of patient and polyethylene wear has been 
seen in the literature. In general, obesity is associated with lower physical activity i.e., 
lower energy expenditure during leisure time (Gonzalez et al. 1999). Specific to the TKA 
population, only a few studies have investigated the association of obesity and activity 
and relation to outcomes. McClung et al. (2000) saw a significant negative association of 
obesity (p = 0.008, r
2
 = 0.79) with physical activity as measured by pedometer, after 
adjusting for age, gender and Charnley class in knee arthroplasty patients. Schmalzried et 
al. (1998) on the other hand did not correct for age and gender and did not see any 
significant association of body weight with the number of steps taken in their total sample 
of knee and hip arthroplasty patients (p = 0.75). However on separating gender, they 
noticed a stronger association of decreased walking activity with increasing weight 
(adjusted for height) in women though not statistically significant (p = 0.09, ‘r’ values for 
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this study were not given). McClung et al. (2000) also saw lower activity levels and 
higher body mass in their TKA patients compared to THA patients thus suggesting some 
association of obesity and physical activity levels after a total knee replacement. One of 
the suggestions of the studies showing no effect of BMI on TKA outcomes is that the 
lower activity levels in obese patients compensates for the functional difficulty due to 
increased loads. However, with no association seen  between weight and physical activity 
after arthroplasty by Schmalzried et al. (1998) and no difference in the activity levels 
between obese and non-obese TKA patients in the study by Foran et al. (2004a), lower 
activity level in obese TKA patients cannot be concluded. Participation in physical 
activity is influenced by a number of other factors which may have a stronger association 
than obesity such as pain, age (Sequeira et al. 1995; Schmalzried et al. 1998) and gender 
related differences related barriers to participation (Ball et al. 2000). In addition, 
generalized arthropathy and patient’s impression of their perceived performance ability 
may also affect their actual performance. Moreover in short term, it had been seen that 
activity participation improves from three months after surgery (Davis et al. 2011) 
probably due to initial phases anxiety and kinesiophobia related to wound healing and 
damaging the replaced knee.  
Naal and Impellizzeri (2010) in their systematic review of physical activity in TKA 
patients conclude that the physical activity levels are less than the recommended activity 
levels for health enhancement. But when compared to controls with osteoarthritis (being 
treated medically), TKA patient have been reported to have a higher activity level and 
better cardiovascular health (Reis et al. 1996). The main purpose of TKA is pain relief 
and restoration of joint function and because it is an elective procedure, the patient’s 
perception of success of the surgery will depend upon the individual goals of post-
operative function and activity. Reflecting this assumption, Weiss et al. (2002) found that 
TKA patients participate in a wide range of therapeutic and recreational activities and 
their participation ability depends on specific activity which may impose different loads 
and motions on the knee than that judged by walking. Thus, the physical activity levels in 
TKA patients after surgery is varied and is dependent on various factors including 
patients preference of the type of activity, however, despite the link between obesity and 
lower activity in the general population, if physical activity levels after TKA are 
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particularly less in obese is unclear and is confounded by a number of other patient 
characteristics.  
 
4.6.2. Weight change after TKA 
Some surgeons recommend weight loss prior to TKA when obesity is seen as a risk for 
complications and difficulty in procedure. While exercise participation is one of the 
primary methods recommended for weight loss, pain and symptoms of arthritis are most 
commonly cited by patients as barriers to exercise participation and that relief of 
symptoms is a potential motivating factor for exercise participation (Wilcox et al. 2006). 
Hence there is an expectation that symptom relief after TKA would enable exercise 
participation and subsequently weight loss. However studies assessing weight change 
after TKA do not support this conclusion. With follow up ranging from one to two years, 
studies did not find a significant loss in weight after TKA (Woodruff and Stone 2001; 
Heizel et al. 2005;  Donovanet al. 2006; Lachiewics and Lachiewics 2008; Dowsey et al. 
2010; Zeni and Snyder-Mackler. 2010). In fact, some studies saw a higher proportion of 
patients gaining weight after surgery. Twenty one percent gained > 5% pre-operative 
weight versus 14% who lost >5% pre-operative weight in the study by Dowsey et al. 
(2010)and this proportion were 23% (gained) versus 17% (lost weight) in the study by 
Lachiewics and Lachiewics (2008) and 66% (gained) versus 34% (lost) was seen by Zeni 
et al. (2010). Increase in weight especially in the obese would be a cause for concern as it 
would put them at a higher health risk and greater asymmetrical loading on the knee 
joints. Pre-operative BMI was not seen to influence weight change after TKA (Dowsey et 
al. 2010; Zeni et al. 2010). Pre-operative function level also did not have an effect on 
weight change (Dowsey et al. 2010; Zeniet al. 2010) but age was found to be significantly 
associated with weight loss ≥ 5% pre-operative weight (Dowsey et al. 2010) Thus from 
the literature it seems that mobility achieved after TKA does not result in weight loss and 
greater BMI does not mean a greater weight gain or loss after TKA. Since loss of weight 
appears to be independent of functional recovery and activity after TKA therefore; 
expectations of some patients regarding weight loss as a result of surgery may not be 
realistic.   
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4.6.3. Contralateral knee disease and other joint disease 
Hawker et al. (1998) in their survey saw a poorer WOMAC score in those with 
contralateral knee disease. Poorer performance in 15 minute walk test, slower recovery in 
the stiffness and function domain of WOMAC and physical function domain of SF36 
after knee or hip arthroplasty was seen in patients with severe other joint disease (Naylor 
et al. 2008). However, the pain and global improvement was significant irrespective of 
the presence of other joint disease. The ten year risk of a contralateral knee replacement 
is also observed to be as high as 37-63% (McMohan and Block 2003). Thus, clearly the 
presence of other joint disease will affect the recovery and outcomes after TKA. Patients 
with other joint disease would also tend to have lower pre-operative functional status, 
however, the study by Naylor et al. (2008) did not see significant differences in baseline 
WOMAC scores between those with and without other joint disease.  
Functional performance after TKA is strongly related to muscle strength in both operated 
and non-operated limb but more strongly to that in the non-operated side (Mizner and 
Snyder-Mackler 2005). It was reported that during sit to stand activities, patients tend to 
shift weight away from the operated side to the non-operated and the asymmetry in 
quadriceps strength also show that the non-involved limb is used more for loading during 
post-operative recovery (Mizner and Snyder-Mackler 2005).  
Therefore, the presence of disease in the non-operated knee and other lower limb joints 
may cause increased difficulty during weight bearing activities, compromised recovery of 
function in the operated side, thus also reflected in the self-report outcomes (Hawker et 
al. 1998; Naylor et al. 2008). Moreover, when interpreting self-report score even though 
joint specific, patients may be unable to isolate the effect on the particular joint from the 
debilitating effect of the disease in other joints.  
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4.6.4. Personal factors 
Mental health in TKA patients was not seen to be affected by BMI when measured as 
mental health component summary of SF36/SF12 pre-operatively or post-operatively 
(Stickels et al. 2001; Rajgopal et al. 2008; Nunez et al. 2010). However, pre-operative 
mental health scores have shown to have an effect on the outcomes in other studies (Heck 
et al. 1998; Fisher et al. 2007).  
Patient expectations of improvement and optimism have been shown to have certain 
degree of influence on pain and functional outcomes in arthroscopy patients (Moseley et 
al. 2002). Patient’s expectations and optimism would be reflected in their level of 
motivation and active participation in the post-operative rehabilitation which is 
considered important for recovery (Fisher et al. 2007) and in turn various psychological 
determinants both affective and cognitive will affect the patient’s expectations from the 
procedure and expectations of their own self efficacy. Pain coping, recovery locus of 
control i.e., recovery is self-dependent or on others (doctors, healthcare workers, fate), 
and level of pain coping or pain catastrophizing is associated with avoidance of pain 
inducing activity which can affect the achievement of functional goals after TKA 
(Kendall et al. 2001). Jones et al. (2007) in their review acknowledge that while the 
evidence on the effect of psychological variables on pain and function is sparse, early 
evidence in fact suggests that psychological determinants have a greater influence than 
medical or baseline variables on pain and function after TKA.  
 
 
4.7. Conclusion 
 
Increased risks of post-operative complications and deteriorating effects of obesity on 
post-operative health have been well documented for obese patients. However, this could 
not be clearly concluded for TKA patients from the literature because of discrepancy in 
the reported evidence. The comparison of results of the studies was difficult due to the 
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differences in the methodological approach, differences in the stratification of the levels 
of obesity and also the different approaches applied in the literature to define and classify 
outcomes.  
Overall, the results of the studies show that the effect of obesity as measured by BMI is 
unclear and it is difficult to indicate a specific cut off point, the BMI beyond which is a 
definite risk of poor post-operative health. However, a negative effect of BMI on 
outcomes has been detected more consistently when morbidly obese (BMI ≥ 40 kg/m2) 
are compared with non-obese (BMI < 30 kg/m
2
). Though an association of increased 
post-operative health risk after a surgical procedure with increasing BMI has been 
established, it not as striking as one would expect in the TKA population. TKA is an 
elective orthopaedic procedure and patients with considerable existing comorbidity and 
therefore possessing significant health risks post-operatively are typically screened for 
evaluation and treatment before proceeding to surgery which could work to decrease the 
complication rates in all patients.  
At 10-15 years after TKA, evidence has been reported for poorer function in patients with 
BMI > 30 kg/m
2
. This would suggest an adverse effect of obesity developing in the 
longer term. However, the time point after which obese patients are predisposed to these 
adverse outcomes is inconclusive as only two studies in the review have evaluated the 
effect of BMI on outcomes (KSS) at long term follow up (Griffin et al. 1998, 10 years; 
Foran et al. 2004, 15 years after surgery). The evidence is further limited by the 
differences in study design (matched control vs. non matched design), lack of baseline 
KSS data in one study (Griffin et al. 1998) and small sample size (27 obese and non-
obese vs. 22 obese and 34 non-obese). Evidence for the effect of BMI at midterm (5-9 
years follow up) and short term (one year follow up), remain inconsistent and therefore 
difficult to conclude.  
Poorer knee function scores have been observed in studies finding a negative effect of 
BMI on outcomes (Griffin et al. 1998; Foran et al. 2000b; Jackson et al. 2009; Dowsey et 
al. 2010). The lower function scores in obese compared to non-obese according to some 
authors is due to lower ability in stair ascending and descending and patello-femoral pain 
during certain activities (Griffin et al.1998; Stickles et al. 2001). Patello-femoral joint 
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reaction forces during activities like stair climbing is  about 3.3 times body weight and 
reach up to 8 times the forces produced during walking (Reilly &Marten 1972, Costigan 
et al. 2002) . The resultant forces produced could reach pain threshold for some obese 
during stair ascending and descending who otherwise have comparable walking ability. 
In addition, poor cardio-vascular status, respiratory disease and other joint 
disease/disability which assumed to be more likely in obese could also influence 
performance in these activities. 
Little or no adverse impact of obesity on self-report knee function (WOMAC) or self-
reported general quality of life (SF36, SF12) has been reported more consistently in the 
literature. Similarly, satisfaction with surgery has been seen to be comparable between 
obese and non-obese. These suggests that while objective measures based on clinical 
parameters, measured by an examiner may or may not be poorer in obese and morbidly 
obese patients, the perception of function at knee and quality of life and satisfaction with 
a knee replacement surgery is significant in all patients irrespective of their BMI.  
It is hypothesized that with increasing body mass, greater load is put on the prosthesis 
which over a period of time causes wear and tear of the prosthesis or prosthetic 
loosening. Several studies in the review show a lower prosthesis survival rate in obese 
when compared to non-obese patients (Winiarsky et al. 1998; Vasquez Vela Johnson et 
al. 2003; Foran et al. 2004a; Amin et al. 2006; Mulhall et al. 2007). However, some 
studies show equal implant survivorship (even at 10 years follow up) between the obese 
and non-obese groups (Griffin et al. 1998; Amin et al. 2006; Bordini et al. 2009). This 
was reasoned by the lower activity level in obese as wear and tear of the prosthesis had a 
direct association with activity levels. Obese patients with added stress on the prosthesis 
but with lower activity levels might have the same degree of prosthetic wear and tear as a 
non-obese patients assumed to have higher activity levels. Also, the additional weight in 
obese may be less than the level of stress which would predispose an early failure. This 
again highlights the lack of uniformity due to differences in the cut off value of BMI used 
for stratification of obese and non-obese.  
In studies specifically assessing patients with BMI > 40 kg/m
2
, consistency in evidence 
may be suggestive of poorer outcomes compared to non-obese. However, the sample 
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numbers for morbidly obese are less in many studies for the results to reach a statistical 
significance. At long term, outcomes for patients with BMI greater than 30 kg/m
2 
seem to 
be less favorable. However, there is very limited evidence for this. With the increasing 
numbers of TKA performed, prevalence of obese patients in the TKA population and the 
consequent implication of increasing health costs, it is important to establish if obese 
patients have results comparable with non-obese TKA or have to live with compromised 
results after TKA. 
 
 
4.7. Chapter summary 
 
This chapter described the findings of the literature review undertake to evaluate the 
effect of BMI on outcomes after TKA. Findings of the effect of BMI on post-operative 
complications, functional outcomes and prosthetic longevity was discussed which 
revealed the inconsistencies in the evidence due to differences in methodological 
approach and classification of BMI and outcomes. The present evidence from literature 
shows that it is difficult to confirm an effect of BMI which would result in failed or 
compromised results. While differences were largely seen in studies using a BMI cut off 
value of 30 kg/m
2
, more consistent evidence was seen for a negative effect of higher BMI 
values (BMI > 40 kg/m
2
) on outcomes. 
Considering the disparities existing in the reviewed studies, the following chapters in this 
thesis aim to evaluate the effect of obesity on TKA outcomes in the following two 
studies: 
1. A retrospective review of the effect of BMI on the self-report outcomes at up to one 
year following TKA. 
2. A prospective evaluation of the effect of obesity as measured by five body 
composition methods on the self-report outcomes at up to one year following TKA.  
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CHAPTER 5: RETROSPECTIVE REVIEW OF THE EFFECT OF BMI ON TKA 
OUTCOMES 
 
 
5.1. Chapter overview 
 
This chapter presents the retrospective evaluation of the effects of BMI on outcomes one 
year following TKA. The rationale and aims for the study are presented after which the 
protocol followed for the study has been detailed. The results of the study have then been 
reported followed by a discussion of the findings of the study. Finally, a summary of the 
chapter is presented. 
 
 
5.2. Introduction 
 
Obesity has been defined according to the Body Mass Index (BMI), where a BMI above 
30 kg/m
2
 is considered obese (World Health Organisation. 2000). It has been seen that 
BMI increases with age reaching a peak incidence in the age group of 60- 69 years 
coinciding with the average age range for primary joint replacement (Crowninshield et al. 
2006). The global increase in the prevalence of obesity in the total knee arthroplasty 
population has led to concerns regarding the outcomes of the surgery in obese patients. 
Obesity is considered as a risk factor for a number of surgical complications and there 
also remain concerns about the impact of the added stress on the underlying bone and 
implant material in obese patients thereby affecting the prosthetic longevity and 
functional gain (Winiarsky et al. 1998; Miric et al. 2002; Mulhall et al. 2007.). The 
question whether obese total knee arthroplasty patients are predisposed to adverse 
outcomes, has been researched previously with conflicting results. On defining obesity as 
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BMI greater than 30kg/m
2
, several studies reported no significant difference in the 
outcomes in obese and non-obese patients (Spicer et al. 2001; Stickles et al. 2001; 
Deshmukh et al. 2002; Amin et al. 2006a), while other studies show obese patients with 
inferior outcomes in terms of post-operative complications, function and revision rates 
(Griffin et al. 1998; Foran et al. 2004a; Foran et al. 2004b; Namba et al. 2005).  
Most of the previous literature on obesity in TKR is centered on surgical aspects and 
surgeon/investigator measured outcomes. The Knee Society Score (KSS) has been most 
commonly used outcome measure in these studies (Griffin et al. 1998; Winiarsky et al. 
1998; Spicer et al. 2001; Deshmukh et al. 2002; Foran et al. 2004a; Foran et al. 2004b; 
Amin et al. 2006a; Amin et al. 2006b; Krushell and Fingeroth 2007). Few studies 
assessing the impact of obesity on total knee replacement outcomes have focused on the 
use of patient administered outcomes. Patient’s perception of their functional difficulties 
specific to their health problem and their perception of their general quality of life can 
provide a complete evaluation of their perceived benefits of the intervention. In the 
review of the literature in Chapter 4, it was found that comparison of the short term 
follow up (one year) of self-report questionnaires specific to knee function such as the 
WOMAC, between obese and non-obese patients was undertaken by a few number of 
studies with different BMI classification of obesity (Stickles et al. 2001using a five 
groups comparison, Nunez et al. 2010 using BMI <35 kg/m
2
 vs. BMI >35kg/m
2
 and 
Rajgopal et al. using BMI >40 kg/m
2
vs. BMI < 40kg/m
2
). No study has assessed self-
reported knee function using the Oxford Knee Score (OKS) which is a questionnaire 
specific to TKA patients.  
Furthermore, most previous studies have assessed patients from the databases or registers 
of different surgeons, adding to the heterogeneity of the sample and thus making it more 
difficult to find an effect of obesity.  
Therefore, the purpose of this retrospective epidemiological evaluation is to assess the 
influence of Body Mass Index (BMI) on the patient perceived outcomes of TKR in 
patients undergoing total knee replacement under the care of a single surgeon The current 
study assesses patients’ perception of their functional ability specific to their knee 
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replacement, as measured by Oxford Knee Score (Dawson et al. 1998) and also their 
quality of life as measured by Short Form 12 questionnaire (SF12) (Ware et al. 1996).  
 
 
5.3. Aim of the study 
 
The aim of the study is to retrospectively evaluate the effect of BMI on self-reported 
patient outcomes at six months and one year after surgery in patients who underwent 
primary TKA at the Royal Infirmary of Edinburgh between the years 2005 and 2008.  
The null hypothesis for this study was that there is no effect of BMI on the self-reported 
patient outcomes at six months or one year after TKA.  
 
 
5.4. Material and methods 
 
5.4.1. Ethics 
Ethical approval was sought and granted from the NHS Lothian Board Research Ethics 
Committee of the prior to the commencement of the study. 
 
5.4.2. Participants 
The number of participants was based on the availability of data of patients who had 
undergone primary total knee replacement surgery from January 2005 up to and 
December 2008 under the care of a single surgeon at the Royal Infirmary of Edinburgh. 
A total of 211 was case notes were available from the medical records library, of which 
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171 patients’ data was included in the study (160 with osteoarthritis and 11 with 
rheumatoid arthritis). Forty cases were excluded from the evaluation for the reasons of 
diagnosis other than osteoarthritis/rheumatoid arthritis, missing pre-operative BMI data in 
case notes and relocation of files to other hospitals. Patient data included in the analyses 
satisfied the following inclusion criteria:  
a. Primary TKA under the care of Mr. R Burnett (Consultant Orthopaedic Surgeon, 
Royal Infirmary of Edinburgh) between January 2005 up to and December 2008. 
b. Underlying diagnosis of osteoarthritis or rheumatoid arthritis of the knee. 
c. Availability of patient’s medical files with complete data regarding medical details, 
pre-operative BMI and post-operative care. 
 
5.4.3. Surgery 
All patients included in the study were operated using a similar surgical approach by a 
single surgeon with a medial parapatellar approach. Kinemax plus or Triathlon total knee 
replacements were used. Post-operative care and rehabilitation in the hospital is based on 
an integrated care pathway and was identical for all patients.  
 
5.4.4. Data access and extraction 
List of patients, who had undergone TKR under the care of the surgeon between January 
2005 and December 2008, was obtained from the formic data collection system, Royal 
Infirmary of Edinburgh along with their gender, date of birth, SF12 scores, and OKS 
scores. The patient list was then given to the medical records library of the hospital with 
request for access of patient records. 
The formic data collection system at the Royal Infirmary Edinburgh which was accessed 
to collect the questionnaire data (OKS and SF12) is a database that holds information on 
self-report questionnaires of patients who are admitted to the Royal Infirmary Edinburgh 
for elective orthopaedic surgery. For total knee replacement surgeries, the OKS and SF12 
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questionnaires are administered routinely to the patients prior to surgery; six months and 
one year after surgery as postal questionnaires. The scores obtained are stored in this 
database along with patient date of birth, gender, consultant and hospital number. 
From the medical records accessed, BMI and demographic information (age, sex and 
initial diagnosis), date of surgery, date of discharge and previous medical history was 
extracted from the pre-operative assessment document. Any complications post-
operatively were noted from the multidisciplinary clinical care pathway records and 
follow up case notes and grouped under local complications (wound leakage, wound 
hematoma, post-operative infection, local orthopedic complication) systemic 
complications (cardiac, respiratory, circulatory, neurological, gastro intestinal, genito-
urinary complications and septicemia) and incidence of revision surgery (if patient has 
further undergone or been referred for a revision surgery). 
 
5.4.5. BMI groups 
BMI is defined as the body weight in kilograms divided by the square of the height in 
meters. Using the World Health Organization definition of obesity (WHO 2000), patients 
were divided into BMI groups of non-obese (BMI<30 kg/m²) and obese (BMI≥30 kg/m²).  
 
5.4.6. Outcome measures 
Pre-operative (one week prior to surgery), six months and one year follow up data was 
obtained for the Oxford Knee Score and Short Form 12 data. 
 
Oxford Knee Score  
Oxford Knee score (Dawson et al. 1998) is an assessment tool specific to the total knee 
replacement. It has been tested by its authors for internal consistency, test retest 
reliability, its construct validity with Knee Society Score, SF36 and Health Assessment 
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Questionnaire (HAQ) and sensitivity to change (Dawson et al. 1998). The authors 
describe the involvement of TKA patients in the derivation of the questionnaire’s content 
in order to draw patient views on how their knee problems affect their lives to 
satisfactorily address patient concerns which they believe is essential for the instruments 
content validity. The questionnaire is considered sort and simple and has been shown to 
have a high completion rate compared to other self-report knee questionnaires including 
WOMAC and Lequesne Index of Severity- Knee (Dunbar et al. 2001). 
The original scoring system for OKS consists of 12 equally weighted questions 
addressing patients’ assessment of their knee function and its effects on their quality of 
life. Each question is scored from 1 to 5 with a minimum total score of 12 indicating least 
difficulty and a maximum score of 60 indicating most functional difficulties. The OKS 
data recorded in the hospital database were based on this system of scoring. This system 
of scoring has been criticized and unintuitive and several modifications to scoring by 
users have led to confusion (Murray et al. 2007). The developers of OKS recommend the 
use of a standard form of new scoring system where each question is scored from 0 to 48, 
with a minimum total score of 0 indicating most functional difficulty and a maximum 
score of 48 indicating least functional difficulty. Once scores were obtained from the 
database, they were converted into the new scoring system by subtracting each score 
from 60 as recommended by the authors. 
No specific categories of the score are given to indicate levels from best to worst 
outcomes. However, it has been noted that like all outcome scores, the absolute score 
tends to decrease with age (Whitehouse et al. 2005). After a joint replacement, it is 
suggested that most improvement in function and in the OKS occurs within the first year 
after a TKA (Whitehouse et al. 2005). 
It has been shown that the pre-operative scores for the questionnaire is one of the biggest 
determinants of the post-operative score (Whitehouse et al. 2005). Therefore, the authors 
(Murray et al. 2007) suggest that change in score should also be analyzed in addition to 
post-operative scores.  
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Short Form 12 questionnaire 
The Medical Outcomes Study Short Form 12 Health Survey questionnaire (Ware et al. 
1996)is an instrument used to measure overall physical and mental health. It also consists 
of 12 questions. It was adapted from the Medical Outcomes Study Short Form 36 Health 
Survey (SF36) by the developers of SF 36 (Ware et al. 1996) and shows close and linear 
association with SF36. The purpose of development of the SF12 was to reduce the 
number of health dimensions measured by selecting 12 items from the original 36 items 
to produce physical component summary and mental component summary without 
substantial loss of information (Ware et al. 1996; Jenkinson et al. 1997).  
The SF12 has been tested for validity, reliability, responsiveness by its developers and by 
other authors for various conditions (Ware et al. 1996; Dunbar et al. 2001; Hurst et al. 
1998; Gandek et al. 1998).  
SF12 has been used widely for total knee replacement patients and like OKS has shown 
to have a higher completed questionnaire return compared to other generic health 
measures SF36, Nottingham Health Profile and Sickness Impact Profile with an average 
time of completion of 7.7 minutes (Dunbar et al. 2001).The total scores are shown as two 
meta scores, a physical component summary (PCS) and a mental component summary 
(MCS). The lowest score is 0, indicating worst possible health and the highest score is 
100, indicating the best possible health. 
 
5.4.7. Data Analysis 
Data was screened for normality using the Shapiro-Wilk test. Tables showing normality 
tests for the study are given in Appendix I. Differences between the groups in patient 
demographics and pre-operative outcome measures were analyzed using t test and Fisher 
Exact tests. Both post-operative scores and the differences between pre-operative and 
follow-up scores were analyzed for any effects of BMI classification. Differences 
between pre-operative and follow-up scores (change scores) were calculated from 
absolute scores by subtracting the baseline scores from the scores at the two follow up 
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assessments. This means that for both OKS and SF12 components, a positive change 
score indicates an improved knee function and improved quality of life respectively. 
Between group comparisons of the pre and post-operative scores, which were not 
normally distributed were carried out using Mann Whitney U test (BMI group effect) and 
Friedman’s ANOVA (time affect). Change scores which were normally distributed were 
analysed using independent t test to compare the improvement in outcome scores at six 
months and one year between the two BMI groups.  A Bonferroni correction was applied 
for multiple comparisons. 
Pearson’s correlation coefficients between BMI and absolute and change scores were also 
calculated. 
The level of significance was set at p < 0.05 for all statistical tests. All statistical analyses 
were carried out using SPSS version 19.0  
 
 
5.5. Results 
 
5.5.1. Baseline between group comparisons 
The pre-operative patient characteristics of the two BMI groups were as shown in Table 
8. The baseline data shown in the table is for a total of 171 (73 non-obese and 98 obese) 
cases for which complete baseline data was available. Complete OKS follow up data 
(both six months and on year) was available for 76 cases (31 non-obese and 45 obese) 
and complete SF 12 follow up data was available for 81 cases (36 non-obese and 45 
obese). This indicates a high attrition rate of 56% and 53% for OKS and SF12 
respectively.  
As shown in Table 8, the obese group consisted of more females (48.0% vs. 69.7%, 
p=0.002). Further, more patients in the obese group suffered from hypertension (72.2 vs. 
45.3%, p<0.001) and Diabetes Mellitus (18.3 vs. 6.6%, p=0.015).No statistically 
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significant difference was found for mean age between the two groups (65.0 years in 
obese patients vs. 65.7 years in non-obese patients, p = 0.089). . The Oxford Score at the 
pre-operative assessment was significantly lower, which means higher functional 
difficulties in the obese group compared the non-obese group (15.3+7.3 vs. 18.8+ 8, 
p=0.003).  Pre-operative SF12 components were not significantly different between the 
two groups. 
Average duration of hospital stay was similar for both groups; 6.5 days vs. 6.7 days for 
the non-obese and obese group respectively. 
 
5.5.2. Normality tests 
Absolute scores of both OKS and SF12 were non-normally distributed, except pre-
operative OKS score which was normally distributed. Change scores of both OKS and 
SF12 were normally distributed. Results of the tests for normality are listed in Appendix 
A. 
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Table 8 Mean (SD) of the demographics and number (%) of co-morbidities for the 
two BMI groups and the total sample. P-values of independent t test unless 
otherwise stated 
Variable Total sample 
(n= 171) 
Non-obese 
(n = 73) 
Obese 
(n = 98) 
p 
Age  (years) 66.7 (8.7) 68.0  (8.8) 65.7(8.4) 0.089 
BMI  (kg/m
2
) 31.4  (5.6) 26.6 (2.1)) 35.0(4.7) <0.001 
Female n (%)
¥
 105  (60.3) 36 (48.0) 69(69.7) 0.002 
R.A n (%) 11 (6.3) 5 (6.6) 6  (6.1) 0.24 
OKS (pre) (0-48) 16.7 (7.8) 18.8 (8.0) 15.3 (7.3) 0.003 
SF12 PCS (pre) 29.0 (6.7) 28.8(6.2) 30.0(7.0) 0.833 
SF12 MCS (pre) 49.4 (11.6) 51.1(10.6) 48.3(12.1) 0.118 
Diabetes Mellitus n (%)
¥
 23  (13.2) 5  (6.6) 18  (18.2) 0.015 
Hypertension n (%)
¥
 96  (55.2) 34  (45.3) 72  (72.7) <0.001 
Respiratory dis. (%) 33  (18.9) 15  (20) 18  (18.2) 0.16 
Cardiac disease n (%)
¥
 22  (12.6) 8  (10.7) 14  (14.1) 0.15 
Vascular disease n (%)
¥
 11  (6.3) 4  (5.3) 10 ( 10.1) 0.12 
Previous TKR n (%)
¥
 28  (16.1) 14  (18.6) 14  (14.1) 0.12 
Previous THR n (%)
¥
 22  (12.6) 8  (10.6) 14 (14.1) 0.15 
¥Fisher’s exact test, RA=Rheumatoid Arthritis, PCS = physical component summary of 
the SF12, MCS = mental component summary of SF12 
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5.5.3. Within group comparison of absolute scores, time effect 
The median and range of the absolute scores for the two BMI groups are given in Table 
9. Physical function, as measured by OKS and the physical component of the SF12 
showed significant improvement from pre-operative to both follow up assessments (p < 
0.001). However, the mental component of the SF12 did not show any significant 
difference between the three assessment points (p = 0.254). For the OKS and the SF12 
physical component the biggest improvement was seen from pre-surgery to 6 months 
with little or no change from 6 months to one year. This was the case for both BMI 
groups. 
 
5.5.4. Between group comparison 
Post-operative scores are given in Table 9. There were no statistically significant 
differences between the two groups in any of the post-operative outcome measures.  
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Table 9 Median (range) of the values of the outcome measures for the two BMI 
groups at 6 months and one year. Effect size, P-values of the group and time effect 
(pre surgery, 6 months and one year) 
 
Variable Non-obese 
(n=25) 
Obese 
(n=39) 
ES P – value 
(group) 
P-value 
(time) 
OKS 6 months 32 (40) 34 (35) 0.09 0.711  
< 0.001 OKS 1 year 36 (39) 36 (35) -0.01 0.664 
SF12 PCS 6 months 35.8 (33.4) 34.5 (38.2) -0.12 0.581  
< 0.001 SF12 PCS 1 year 42.8 (33) 36.9 (36.7) -0.44 0.091 
SF12 MCS 6 months 54.6 (44.2) 56.3 (42.1) 0.05 0.805  
0.254 SF12 MCS 1 year 54.9 (43.9) 54.9 (40.5) 0.02 0.827 
PCS = physical component summary of the SF12, MCS = mental component summary of 
SF12 
 
5.5.5. Between group comparison of change scores 
The mean and standard deviations for change scores for the two BMI groups are given in 
Table 10. On comparison between groups using change in OKS scores, no significant 
difference was seen between the BMI groups for change in OKS from pre-operative to 
six months follow up or from pre-operative to one year follow up. Similarly no 
significant difference was observed between groups for change scores (pre-operative to 
six months post-operative or pre-operative to one year follow up) for both physical and 
mental component of SF12. 
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Table10 Mean (SD) of the change score data for the three BMI groups, Means and 
Standard deviations 
Outcome Non-obese 
(n=31) 
Obese 
(n=45) 
ES p- value 
OKS (6mo-pre)  12 (11.2) 15.9 (8.7) 0.4 0.096 
OKS (1yr-pre)  14.1 (10.9) 16.8 (8.8) 0.28 0.229 
SF12 PCS (pre-6mo)  7.9 (12.8) 6.8 (10.5) -0.09 0.672 
SF12 PCS (pre-1yr)  10.9 (11.9) 6.5 (8.3) -0.44 0.063 
SF12 MCS (pre-6mo)  0.56 (11.1) 2.8 (11.9) 0.19 0.389 
SF12 MCS (pre-1yr) 0.74 (8.6) 2.8 (10.9) 0.21 0.370 
PCS = physical component summary of the SF12, MCS = mental component summary of 
SF12 
 
5.5.6. Correlations between outcomes and BMI 
Table 11 shows the strength of the relationship between the outcome measures and BMI 
value. Observing the relation between BMI and OKS, only the relationship between pre-
operative OKS and BMI showed a weak but statistically significant correlation (r= -
0.255, p<0.05).Thus indicating a lower score and hence more functional difficulty with 
increasing BMI value, pre operatively. On observing the relation between BMI and SF12 
scores, weak but statistically significant relation was seen between BMI and one year 
PCS scores (r = -0.270, p = 0.015) and between BMI and change score at one year (r = -
0.228, p = 0.041). The negative relation between BMI and PCS change score indicates 
that those with higher BMI improved less in their overall physical health quality of life.  
Fig 1, 2 and 3 show scatter diagrams of the outcomes which showed the strongest 
relationship with BMI; pre-operative OKS (r= -0.255), the physical component of the 
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SF12 at one year (r= -0.270) and the change in physical component score from baseline 
to one year (r= -0.228).  
 
Table 11 Pearson’s correlation coefficients between BMI and the outcome measures 
before surgery, at 6 months and 1 year after surgery and between BMI and the 
change scores 
 OKS - BMI PCS - BMI MCS – BMI 
Pre-operative -0.255* -0.071 -0.047 
6 months -0.039 -0.098 -0.004 
1 year -0.103 -0.270* -0.060 
6 months – Pre 0.157 -0.040 0.043 
1 year – Pre 0.093 -0.228* -0.004 
* Significant at p<0.05 PCS = physical component summary of the SF12, MCS = mental 
component summary of SF12 
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Figure 1 Scatter plot showing relationship between BMI (kg/m2) and pre-operative 
OKS 
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Figure 2 Scatter plot showing relationship between BMI (kg/m2) and SF12 (PCS) at 
one year post surgery 
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Figure 3 Scatter plot showing relationship between BMI (kg/m2) and SF12 (PCS) 
change score from pre-operatively to one year post surgery 
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5.5.7. Complications and revisions 
A total of 16 patients had a local complication (wound infection or wound leak) post-
surgery, of which, 5 (6.7%) were from the non-obese, 11 (11%) were from the obese 
group (Table 12).  A total of 18 patients had a post-operative systemic complication of 
which 6 (8%) were from non-obese, 12 (12%) from the obese group. A total of 6 (3.5%) 
patients underwent revision surgery post primary total knee replacement of which 2 (3%) 
were in the non-obese, and 3 (3%) in the obese group. The rate of above complications 
and revision were not statistically significantly different between the two groups.  
 
Table 12 Number (%) of post-operative complications and revisions in BMI groups 
 Non-obese 
(n=73) 
Obese 
(n=98)  
p- value 
Local complications 5 (6.7%) 11(11%) 0.13 
Systemic complications 6 (8%) 12 (12%) 0.14 
Revisions 2 (3%) 3 (3%) 0.30 
 
 
5.6. Discussion 
 
5.6.1. Summary of findings 
The null hypothesis of the study that BMI has no effect on outcomes was accepted as it 
was found that at short term (up to one year post surgery), the patient perceived benefits 
of total knee replacement was not different among two groups with different BMI.  
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It has been reported that most improvement in function after total knee replacement 
occurs up to 26 weeks after which little improvement is gained (Kennedy et al. 2008). 
The same was seen for this study sample, with improvement in knee related function 
from the pre-operative state to post-operative state (six months and one year) significant 
in all BMI groups of the study, while, there was little change in knee function from six 
months postoperatively to one year post-operatively. This again, was true for both BMI 
groups. 
The analysis of the self-report measures was carried out with both the absolute scores and 
the change scores. While the pre-operative absolute score for knee function was poorer 
for the obese compared to the other group, no significant difference was found in the six 
month and one year post-operative scores between the two groups. The change in knee 
function and quality of life from pre to six month and one year post surgery which was 
analyzed using change scores was also not significantly different between the groups. A 
lower pre-operative but comparable post-operative knee function scores and comparable 
change in knee function would imply that though pre-operative knee function was 
statistically significantly lower in obese, the difference was not large enough to affect the 
post-operative knee function or improvement in knee function. 
Correlation analysis both, numerically and as shown graphically in the scatter diagram 
indicated no or weak relationships between BMI values and both post-operative scores 
and change scores. Even though statistically significant, the relation between BMI and 
overall physical function at one year was weak (r = 0.27) and that between BMI and 
change in overall physical health from pre-operatively to 1 year after surgery (r = 0.23) 
was also weak. Moreover, scatter plot for the relation between these variables does not 
indicate a clear association, with the values largely scattered across the 25 kg/m
2
 to 35 
kg/m
2
 values of BMI. However, few extreme values indicating high BMI and low 
outcomes score (four in Figure 2) could have resulted in the in a statistically significant 
correlation.  
Finally, the rate of complications and revisions were not statistically significant between 
the two BMI groups. Therefore, the current study findings indicate similar degrees of 
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benefits as quantified by the OKS and SF12, complications and revision rates from the 
surgery irrespective of patient BMI group.  
 
5.6.2. Comparison of results with previous evidence 
In terms of differences between groups, the findings of our study are consistent with that 
of majority of the other studies investigating the effect of BMI on WOMAC (Stickles et 
al. 2001; Bourne et al. 2007; Nunez et al. 2011). Nunez et al. (2010), defining their BMI 
categories as those with a BMI ≥35 kg/m2 (n = 60) for severely obese and those with a 
BMI < 35 kg/m
2
 (n = 60) as the control group observed similar significant improvement 
in both groups for the total WOMAC at 12 months post operation. A larger study by 
Stickles et al. (2001) saw no significant difference in change scores for WOMAC 
between their five BMI groups (BMI <25kg/m
2
, n = 146, BMI = 25-29kg/m
2
, n = 304, 
BMI = 30-35kg/m
2
, n = 271, BMI = 35-39kg/m
2
, n = 149, BMI > 40kg/m
2
, n = 92) at  
one year follow up. In a separate rating of stair ascending and descending difficulty and 
satisfaction with surgery, Stickles et al. (2001), however conclude that despite finding 
greater difficulty with stairs, obese patients were as satisfied with the results of the 
surgery as other patients.  
Even at longer follow up of 5 -11 years, no difference in the improvement in WOMAC 
scores between BMI groups (BMI <25kg/m
2
, BMI = 25-30kg/m
2
, BMI = 30-35kg/m
2
, 
BMI = 35-40kg/m
2
, BMI > 40kg/m
2
) has been found (Bourne et al. 2007). Contrary to 
these findings, Hawker et al. (1998) in a community based study found that though BMI 
was not a significant predictor of pain; higher BMI was associated with worse physical 
function on the WOMAC at 2-7 years after surgery in 2 of their 3 stratified samples ( p = 
0.02 and p = 0.01). 
 The conflicting results in studies with longer term follow up is further seen in studies 
assessing investigator measured outcomes such as the Knee Society Score (KSS). KSS 
and radiographic outcomes were not found to be statistically different between obese 
(BMI > 30kg/m
2
) and non-obese (BMI < 30kg/m
2
) at a follow up ranging from 5 - 6 
years (Spicer et al. 2001; Amin et al. 2006a). In contrast, other mid-term to long term 
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studies have observed a poorer outcome in obese (BMI > 30kg/m
2
) (Griffin et al. 1998; 
Foran et al. 2004a; Foran et al. 2004b).  
Change in quality of life as from pre-operative state to six months and one year after 
TKA as assessed by the physical and mental component score of SF12 in this study, was 
also similar in all BMI groups in our study. Other studies using SF36 (Stickles et al. 
2001) and SF12 (Dowsey et al. 2010) also saw no effect of BMI (greater than or less than 
30 kg/m
2
) on change or improvement in quality of life.  The correlation analysis in this 
study however revealed a significant negative correlation between BMI and PCS scores 
of SF12. As mentioned above in section 5.6 (i), the relationship was not clear in the BMI 
range of 25-35 kg/m
2 
and though the relationship was weak, few values at the higher end 
of BMI (> 40 kg/m
2
) resulted in a statistically significant pull to a negative relation. A 
negative correlation of BMI with overall physical health (PCS of SF36) at one year after 
TKA (PCS of SF36) was also seen by Stickles et al. (2001). Dowsey et al. (2010) did not 
find significant differences between their obese and non-obese group for PCS score at 
one year but did see significantly lower PCS in morbidly obese. Therefore, some effect of 
higher BMI on overall physical function is implied from these findings, although, the 
BMI after which overall physical health declines cannot be concluded form the study. A 
significantly higher number of patients with comorbidity such as type II diabetes and 
hypertension in the obese group in the current study could have affected the overall 
physical health at one year after TKA 
 
5.6.3. BMI and TKA outcomes 
Apart from the association of BMI with the overall physical function as seen in the 
current study, the literature review (Chapter 4) indicates a poorer function scores in other 
studies particularly in relation to activities such as stair climbing and descending. The 
suggested reason for this is the increased load the knee joint has to bear in obese patients 
and therefore greater joint stressed and muscular work could result in pain and difficulty 
during these activities. However, knee function in this study was not affected by BMI.  
108 
 
The assumption of increased stresses on the joint due to obesity is also enforced by the 
association of obesity as a causative factor of the progression of knee osteoarthritis 
towards symptomatic end stage osteoarthritis requiring a TKA (discussed previously in 
Chapter 3). There is consistent evidence that there is a positive link between weight/body 
mass and end stage knee osteoarthritis. 
 Obesity, strictly, is defined as accumulation of body fat (Prentice and Jebb 2001). 
Applying this differentiation of body composition to the above conclusion, obesity 
defined as increased adipose mass would add to the body mass causing the mechanical 
effects stated above on the joint. However, a purely mechanical effect of body mass 
causing the joint disease does not clarify the stronger association of obesity with OA in 
women, that all obese persons do not suffer from OA, similar strength of association of 
obesity and OA is not seen with all weight bearing joints and the evidence of association 
of obesity with non-weight bearing joints such as joints of the hand.  Mechanical effect of 
obesity has been proposed to cause poorer functional outcomes after TKA in obese. The 
assumption of a negative effect of obesity as measured by BMI on the premise of 
increased mechanical loading and therefore greater functional difficulty in obese patients 
by virtue of their higher body mass is also not supported by this study. Moreover, the 
conflicting results in the literature are again not clarified by the sole effect of a 
mechanical nature on the joint by obesity. 
Aging is associated with both increase in body fat and decrease in the muscle mass which 
implies decreased muscular support at the joint to maintain its stability (Messier et al. 
1994). In addition, there is a known association of adiposity and disability and poor 
health outcomes (Ramsay et al. 2006). Body mass index being the most commonly used 
measurement of obesity in the study of obesity and knee osteoarthritis and the only 
method used for defining obesity in the study of outcomes after TKA, though gives 
evidence of the effects of body mass on the joint in some studies, its limitation in not 
differentiating fat and lean mass does not allow it to clarify the above effects of adipose 
tissue and muscle tissue. The distribution of fat has been suggested to play a role in this 
mechanical effect of obesity. While trunkal fat has effect on hip and knee joint, the hip 
and thigh fat has its effect on knee and little on the hip (Sturmer et al. 2000). The effect of 
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regional distribution of fat on the knee is again unclear with BMI as a measure of obesity. 
For a better understanding of the effect of true obesity on total knee replacement 
outcomes, it would therefore be justified and worthwhile to explore the use of other body 
composition measurement methods in addition to BMI in understanding the influence of 
obesity in the TKA population. 
 
 
5.7. Chapter Summary 
With the increasing prevalence of obese patients in the TKA population, it is important to 
establish if these patients have results comparable with non-obese TKA or have to live 
with compromised results after surgery. This chapter presented a retrospective study 
assessing the effect of BMI on patients’ perception of their outcomes which are important 
in clinical decision making as patients’ concerns and priorities may be different from that 
assessed by health providers. The findings indicated that the patients perceived 
improvement in function and quality of life is not different between BMI groups based on 
a cut-off point of 30 kg/m
2
. However a negative effect of BMI used as continuous data 
was observed on overall physical function one year after TKA. The above retrospective 
study has been accepted for publication as a journal article in the journal titled ‘Arthritis’. 
Copy of the accepted manuscript has been attached in Appendix E.  
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CHAPTER 6: A PROSPECTIVE STUDY OF THE EFFECT OF BODY 
COMPOSITION ON TKA OUTCOMES: STUDY METHODS 
 
 
6.1. Chapter overview 
 
This chapter presents the protocol used to assess the effect of body composition on 
patient reported outcomes for up to one year following TKA. The chapter begins with an 
introduction to the study and its aim. The choice of methodological approach for the 
study has been justified followed by a description of the study procedures. Methods of 
assessment of body composition and outcomes measured in the study are then described. 
Finally, the methods used to extract and analyse the measured data have been described.  
 
 
6.2. Introduction 
 
The results and conclusions from the literature show a lack of uniformity regarding the 
effects of BMI of total knee replacement outcomes, thus, making it difficult to suggest a 
cut off point for clinical obesity which may be the critical point which predisposes to 
complications of failed outcome. While a poorer outcomes on obese patients is expected 
due to increased stress on prosthesis and association of obesity with other comorbidity, 
the previously discussed retrospective study and other studies evaluating the effect of 
BMI on TKA outcomes do not show any difference between obese and non-obese groups 
in terms of functional gains. Obesity is defined as excess accumulation of fat in the body. 
Body mass index as a measure of obesity though widely used has its limitations in 
measurement of obesity and its distribution. To understand the true effect of obesity on 
the outcomes of TKA and the underlying mechanisms through which obesity may or may 
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not affect outcomes after TKA, this study explores the effect obesity measured by other 
clinically viable body composition methods including Bioelectrical Impedance Analysis 
(BIA) of body fat percentage, ultrasonographic measurement of regional fat, waist 
circumference and waist to hip ratio in addition to BMI on the outcomes following TKA.  
 
 
6.3. Aim of the study 
 
The study aims to assess the effect of body composition as measured by Bioelectrical 
Impedance Analysis (BIA) of body fat percentage, ultrasonography measurement of 
regional fat, waist circumference, waist to hip ratio and BMI on the patient-reported 
outcomes for up to one year following TKA. 
 
 
6.4. Methodological approach 
 
Randomised controlled trials (RCT) are considered the gold standard for testing 
hypothesis (Mann 2003; Thadhani and Tonelli 2006). However, in some areas of 
research, observational studies are more suitable or even viable than RCT. Research 
assessing the association of obesity with TKA requires an observational design as 
patients cannot be randomised into obese and non-obese group. A prospective cohort 
study as that used in this study has been described by Grimes and Schulz (2002) as ‘…the 
experience of a group exposed to some factor with another group not exposed to the 
factor. If the former group has a higher or lower frequency of an outcome than the 
unexposed then an association between the exposure and outcome is evident’. The 
‘exposure’ described here is obesity in this study. 
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One of the main advantages of an observational design is that it does not interfere with 
patient or surgeon choices. Observing a broader range of patients without rigorous 
controlled conditions would be more representative of clinical practice and thus add to 
study relevance i.e., whether the study results can be applied to common clinical 
situations.  
The relevance of the study to practice is also influenced by specifics such as the treatment 
implementation, adequate reporting of patient characteristics and appropriate choice of 
outcomes measures (Hartz and Marsh 2003).Cohort studies can also be advantageous in 
investigating potential multiple outcomes resulting from the exposure, however, while 
testing of the association of exposure with many outcomes, misleading interpretation can 
arise if only significant results are reported (Grimes and Schulz 2002). Therefore it is 
suggested that primary and secondary outcomes to be examine should be planned 
beforehand as has been done for the current study. Another important consideration is the 
sufficient time period between the measurement of exposure and outcomes to occur or 
change. It has been reported that the greatest improvement in the functional recovery 
after TKA occurs in the first 12 weeks after surgery which then continues up to 26 weeks 
(Kennedy et al. 2008). Assessment of patient reported outcomes after TKA have been 
reported to have shown significant improvement at two and four months compared to the 
pre-operative status (Parent and Moffet 2002). Therefore, a follow up of one year in this 
study would allow sufficient time to assess the effect of obesity on immediate surgical 
outcomes and also the patient perceived functional outcomes.  
Bias or systematic error is one of the main threats to the internal validity of an 
observational study such as the current study. A bias due to dissimilarity between the 
exposed and the non-exposed groups other than the exposure itself reduces the 
comparability of the groups (Grimes and Schulz 2002). Alternatively, a bias can also 
occur when follow up information is less likely to be collected from patients who have a 
worse outcome, as had been observed when using patient reported outcomes in TKA 
patients (Kim et al. 2004). As opposed to bias, confounding (a third variable which 
affects outcome) can be corrected before or after the study to achieve homogeneity of 
between groups and has been attempted in this study by using appropriate statistical 
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models. Bias and confounding which affected this study has been detailed as study 
limitations in Chapter 9.   
 
 
6.5. Study procedures 
 
6.5.1 Ethics 
Approval for this research study was obtained from the NHS Lothian Research Ethics 
Committee. Main ethical issue presented to the committee was the careful wording of the 
participant information sheet to ensure sensitivity towards participants’ body image and 
create no misunderstanding of their perception of their body weight and outcomes of their 
forthcoming surgery. The information sheet was approved by the ethics committee. 
Appendix C contain copies of  participant information sheet and patient consent forms 
that pertain to this study. 
 
6.5.2. Participants 
All patients under the care of six surgeons undergoing elective primary TKA at the Royal 
Infirmary of Edinburgh were eligible to participate, provided they did not have the 
following exclusion criteria: 
a. Infective arthritis 
b. Minimally invasive total knee replacement 
c. Simultaneous bilateral total knee replacement 
d. Neurological or cognitive impairments affecting movement or understanding of 
instruction/ questionnaires. 
e. Inability to give informed consent 
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Patients with neurological/ cognitive impairments or inability to give informed consent 
were excluded due to ethical issues. The other exclusion criteria were followed because 
of their influence on the outcomes. Other factors such as age, previous hip or contra 
lateral knee surgeries were not excluded so that the sample was as representative of the 
TKA population as possible. Patient with surgically fitted devices such as pacemakers 
were excluded from BIA measurements. 
Potential participants were identified from the patients on the waiting list for TKA. 
Patient list of six surgeons (of the Orthopedic Department, Royal Infirmary of Edinburgh) 
were included for recruitment.  Potential participants were sent letters of invitation for the 
study and participant information sheet with the contact details of the researcher by post. 
Consenting participants were then contacted by the researcher by phone or e-mail and 
recruited prior to their pre admission clinic appointment. Participants were assessed pre-
operatively (baseline) at the time of their pre admission. The pre-operative assessments 
were carried out at the Clinical Research Facility at the Royal Infirmary of Edinburgh, on 
the same day as the patients’ pre admission clinic appointment. For the post-operative 
assessment, the questionnaires were sent to the patients address via post at six weeks after 
surgery. Further follow up questionnaire data for six months and one year after surgery 
was obtained from the hospital database.  
 
6.5.3. Pre-operative assessments 
The baseline (pre-operative) assessment included (details in the following sections): 
a. BMI: weight and height of the participant was measured from which BMI was 
calculated as body mass (kg) divided by the height squared (m
2
).  
b. Waist to hip Ratio: with the patient in standing, the waist and hip girth was measured 
using a measure tape and the ratio was calculated as waist circumference divided by 
the hip circumference. 
c. Ultrasonography: with the participant supine, the subcutaneous fat thickness above 
the knee undergoing total knee replacement was measured. Inter and intra-rater 
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reliability tests of the ultrasound measurement protocol were conducted before the 
commencement of the current study. 
d. Bioelectrical impedance analysis: with the participant supine, the multi segmental and 
multi frequency analyzer was used to assess body composition. Intra-rater reliability 
test of the BIA measurement protocol was conducted before the commencement of 
the current study. 
e. Comorbidity: Medical records of the participants were reviewed to note comorbidity 
present and history of previous surgeries. 
f. Patient characteristics: age, gender, date of birth, laterality, previous knee 
replacement, and hip replacements were noted. 
g. The primary outcomes measure, Oxford Knee Score, which is a self-report 
questionnaire, was completed by the participant at the baseline assessment. 
h. Secondary outcomes measures Short Form 12 questionnaire and the Visual Analogue 
Scales were completed by the patient at the baseline assessment. 
 
6.5.4. Surgery 
All participants received elective surgery and the post-operative care via the integrated 
care pathway used at the Royal Infirmary of Edinburgh. Each patient’s operation note 
was reviewed to note the surgical approach and the type of implant. Any complication 
during the hospital stay, number of days of hospital stay and any complications post 
discharge were noted from the patient medical records.  
 
6.5.5. Post-operative assessments 
The follow up (post-operative) assessments included: 
a. Oxford Knee Score, SF12 and the Visual Analogue Scale were posted to the patients 
at six weeks after their surgery. These were completed by the participants and sent 
back to the researcher.  
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b. Six month and one year follow up  OKS and SF12 data were obtained from the 
hospital database 
c. Post-operative complications: post-operative patient charts were reviewed to record 
any local and systemic complications. 
d. Referral for revision surgery: follow up notes were reviewed to note if the participant 
has been referred for a revision surgery during the period of the study. 
 
 
6.6. Measurement of body composition 
 
6.6.1. Bioelectrical Impedance Analysis 
Bioelectrical impedance analysis (BIA) is a widely used method by clinicians and 
researchers to determine body composition. The theory behind bioelectrical impedance 
analysis is based on the relationship between the impedance and water content of the 
body. A small electric current (of approximately 0.8mA) is introduced into the body via 
electrodes which generates voltage between different points in the body (Kyle et al. 
2004). The actual parameter which is measured by the BIA is the impedance which is 
given as the ratio of voltage upon the current. The total body water is then estimated from 
this measured electrical impedance of body tissues using established equations.  
The multiple frequency BIA uses different frequencies (0,1,5,50,100,200 to 500 kHz) of 
current to measure Total body water (TBW), (intra cellular water (ICW), extracellular 
water (ECW) and fat free mass (FFM). 
 
Machine specifications 
Maltron Bioscan 920-2 (Maltron International Ltd, Essex, U.K.) was used for 
bioelectrical impedance analysis. The Maltron Bioscan Analyser is portable and non-
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invasive equipment. It is a multi-frequency analyser testing impedance at frequencies of 5 
kHz, 50 kHz, 100 kHz, and 200 kHz.   
The hardware components of the analyser consists of the Bioscan 920-2 analyser, 
ME4000 disposable electrode pads, MEC1106-2 set of electrode cables. The Maltron 
USB software for Windows and XP and Maltron data export software was used to import 
all the data from the analyser. Regular calibrations (twice a week) of the analyser were 
performed using the MCR 1205 Calibration test rig, provided by the manufacturers.  
 
Standardisation of testing conditions 
 Standardisation of BIA testing condition was developed according to the manufacturer’s 
guidelines and the ESPEN (The European Society for Clinical Nutrition and Metabolism) 
guidelines. The measurement conditions for the participants were standardised as follows: 
a. All participants’ weight and height were measured in kilograms and millimeters 
respectively. This was done at the time of the BIA measurement.  
b. Standardised hydration conditions for participants: No alcohol consumption up to 24 
hours prior to testing, no exercise up to 24 hours prior to testing, testing at least 2-3 
hours after a meal and no consumption of large amount of water prior to testing. 
c. Site of electrodes on the body were checked to make sure there were no skin lesions. 
The area was then cleaned with alcohol.  
d. Testing was done with patients’ supine with limbs abducted. Arms were separated 
from the trunk by approximately 30 degrees and the legs were separated by about 45 
degrees. In patients with greater thigh/arm circumference, skin between thighs/arms 
was separated using a blanket.  
e. No contact with the metal frame of the bed. 
f. Assessment room free of strong electrical or magnetic fields. 
g. BIA measurements were not done in patients fitted with a pacemaker.  
The hydration conditions for participants were listed on the participant information sheet 
and were reminded to the participants at the time of confirmation of appointment.  
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Procedure for measurement 
Patient height in millimetres and weight in kilograms were measured. BIA measurements 
were done with patients in supine. Areas of electrode placement were tested for skin 
lesions. Before placing the electrode pads, the area of the skin was cleaned with alcohol. 
Once the adhesive electrode pads were firmly placed (Figure 4), the numbered electrode 
cables were clipped to the corresponding location on the body. With the electrodes in 
place and the patient resting in supine, patient data including the measured height, 
weight, age, sex, ethnic group were entered into the analyser. A ‘5 segment’ option was 
chosen for the BIA measurements. The parameter calculated by the machine including 
BMI, whole body fat mass, fat percentage (BF %) was noted into the data collection 
sheet.  
Once data was collected these were uploaded into the computer using the Maltron USB 
software for Windows and XP. 
 
 
Figure 4 Electrode placements for BIA measurement 
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6.6.2. Ultrasonography 
Ultrasonography is a non-invasive method of imaging anatomy. It consists of the 
ultrasound scanner instrument with display screen and ultrasound probe or the transducer. 
The ultrasound transducer (or probe) generates ultrasound waves which are sent into the 
body tissues. These ultrasound waves produce ‘echoes’ which are reflected back from the 
body tissues into the transducer  The ultrasound echoes are reflected at boundaries or 
interfaces of tissues with different acoustic properties. These reflected echoes are then 
processed by the ultrasound instrument and displayed as dots which form the anatomic 
image (Kremkau 2001). 
 
Machine specifications 
The ultrasound imaging system consists of the following components: Sonosite 
ultrasound system, C60/5-2 MHz 60-mm curved array transducer, Ultrasonic coupling 
gel and Sitelink image manager software. 
 
Procedure for measurement 
Measurements were taken from the affected side with the participant supine. A single 
copper wire was attached perpendicular to the probe with a tape. This copper wire 
displays a thin shadow on the ultrasound image which helps to identify the centre of the 
probe in the image and also to make the corresponding markings for structures on the 
skin. 
Once participant information was entered into the machine, live imaging mode was used 
to image the tissues. The ultrasound coupling gel was applied on the probe to allow for 
ultrasound transmission into the body tissue. 
With the knee extended, and the probe parallel to the femur, an image was obtained of the 
lateral femoral epicondyle. To identify the lateral epicondyle of femur, the probe was 
placed on lower thigh (lateral side) and then moved down to the outer (lateral) side of the 
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knee till sharp bony curvature was seen.  The highest point of the bony curvature was 
then marked as the lateral epicondyle of femur. Similarly, the medial femoral epicondyle 
was marked. For this, the probe was placed on the medial side of lower thigh and then 
moved down to the inner (medial) side of the knee and the highest bony curvature was 
marked on the skin as the medial femoral epicondyle. 
The knee calliper was then used to measure the distance between the medial and lateral 
femoral epicondyles. The mid-point of the distance between the epicondyles was marked 
on the knee anteriorly. Using a measure tape, a distance 7 cm proximal to this mid-point, 
on the anterior aspect of the thigh was marked. This site was used for imaging regional 
fat thickness. To relax the anterior muscles of the thigh, the knee was put in a position of 
slight flexion (maximum 40 degrees) using pillows for support. This point on the anterior 
aspect of the knee was then imaged in the sagittal plane. Imaging was done with the 
probe parallel to the length of the femur. Once imaging was completed, gel from the 
participant’s skin and from the ultrasound probe was removed. The skin area and probe 
surface was cleaned with a disinfectant spray. Using the measurement callipers on the 
ultrasound instrument, the depth of the tissue lying between the lower layer of the skin 
and the upper layer of the muscle tissue was measured. This layer contains the fat 
deposits. The distance from the lower end of the skin to the top layer of the quadriceps 
muscle, was measured and noted at 25%, 50% and 75% distance from the left of the 
screen. The measurements were noted in the data collection sheet.  
Images were uploaded using the Sonosite software and measurements were further 
analyzed using imaging software (Image J, NIH, Bethesda Maryland). 
 
6.6.3. Waist to hip ratio and waist circumference 
Waist to hip ratio (WHR) is essentially the waist circumference divided by the 
circumference of the hips. This is a commonly used method to distinguish central fat 
distribution from peripheral distribution. Waist circumference and WHR are significantly 
related to the actual anatomical distribution of adipose mass and volume as measured by 
cadaver assessment (Martin et al.2003).  Predominant central adiposity is considered a 
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strong risk factor cardio-vascular disease, hypertension, stroke, diabetes mellitus 
(Donahue et al. 1987) therefore a large waist circumference is also seen to predict greater 
morbidity. On the other hand hip circumference is suggested to be inversely associated 
with morbidity suggesting that lesser the hip circumference greater is the risk of 
morbidity (Snijder et al. 2006). Thus a large waist to hip ratio which might be due to a 
large waist circumference or a smaller hip circumference predicts greater health risks. 
One of the features of WHR is that it is partially independent of total adiposity and for a 
given value of WHR there may be variability in the total body adiposity thus it is a 
measure of the distribution and not total fat levels. Moreover, increases in adiposity 
including abdominal adiposity may not be detected by WHR if there is an increase in the 
hip circumference along with the waist circumference. 
Though a standardised site for the measurement of the waist circumference has not been 
established, the WHO (2008) recommends that waist circumference should be measured 
at the mid-point of the lower border of the lower rib and the upper border of the iliac 
crest. The hip circumference according to the WHO (2008) recommendation is to be 
measured around the widest portion over the buttocks. 
 
Standardisation and procedure 
During measurement, the patients were to stand with their outer garments off and breathe 
normally. Waist circumference was measured at a site mid-point between the lower rib 
and the upper part of the iliac crest. Hip circumference was measure around the widest 
portion of the buttocks as recommended by WHO (2008). All measurements were done 
with a single non stretchable measure tape.  
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6.6.4. Body Mass Index 
Body Mass Index (BMI) is calculated as the body mass in kilograms divided by height in 
meters, squared. BMI, also known as the Quetlet index was developed in the mid-19
th
 
century on the basis of the observation that body weight is directly proportional to height 
in individuals with a normal frame (Romero-Corral 2008). It has been widely used as a 
measure of obesity in epidemiological studies. BMI has shown to have an association 
with percentage body fat and it is assumed that increase in body fat is usually 
accompanied with increase in weight. Therefore, it is widely used in research and clinical 
practice enabling a quick and inexpensive method for prediction of health risks from BMI 
defined obesity levels. Most health guidelines including the WHO (2000) define 
‘overweight’ as BMI of 25.0 to 29.9 kg/m2 and BMI greater than 30 kg/m2 as ‘obese’. 
However, BMI does not distinguish fat from fat free mass and thus can lead to 
misinterpretation of total fat content (Snijder et al. 2006; Khaodiar and Blackburn 2001; 
Rothman 2008). Therefore in some cases, for example in athletes, have a very low fat 
mass but by BMI classification may still fall in the overweight or even obese category 
because of their high muscle (lean) mass. Moreover in elderly due to decrease in height, 
BMI tends to be overestimated (Snijder et al. 2006) and it has been seen that for a given 
BMI, older persons have greater body fat compared to a younger adult (Gallagher et al. 
1996). Despite these limitations, BMI greater than 30 kg/m
2
 shows excellent specificity 
and positive predictive value for diagnosing obesity measured as body fat percentage 
(Romero-Corral 2008). Moreover, the simplicity of the measurement makes it a preferred 
method in large epidemiological studies examining obesity and its effects or in clinical 
practice when systematic and repeated collection of a measure of obesity is required 
(Frankenfield et al. 2001 Snijder et al. 2006) 
 
Standardisation and procedure 
Before measuring weight and height, participants were asked to remove shoes and heavy 
outer clothing.  Weight of the participant was measured in kilograms on a weighing scale 
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and the height of the participant was measured in millimetres using a standiometer. The 
same weighing scale and standiometer was used for all participants.  
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6.7. Ultrasound protocol reliability 
 
Protocols described for body composition methods of BMI, WC, WHR and BIA have 
been previously established in the literature as valid and reliable (Section 3.5, Chapter 3). 
However, measurement protocol for the measurement of subcutaneous fat thickness 
above the knee as described in section 6.6.2 above has not been previously used in this 
context. Therefore in order to assess if the given protocol is reliable, the inter-rater 
reliability and intra-rater reliability of fat thickness measurements using the described 
ultrasound protocol were evaluated and are described in the sections below.  
 
6.7.1. Introduction 
 
Currently the most commonly used methods for measuring subcutaneous fat thickness are 
those using skin fold callipers and ultrasonography (US). Because of the limitations of 
the skinfold method, ultrasonography was proposed as an alternative to skinfold 
measurement. Compared to the skinfold technique, the ultrasonography method offers the 
advantages of avoiding tissue compression, no requirement for palpation of muscle tissue 
interface and is potentially a more valid measurement in obese subjects for whom 
skinfold measurement are often problematic. 
Early studies validating A- mode ultrasound with direct measurements such as needle 
puncture and electrical conduction saw high correlation between the subcutaneous fat 
thickness measurements by these direct measures and that by ultrasonography (Bullen et 
al. 1965, Booth et al. 1966). Quantification of subcutaneous tissue is now done 
commonly with the B- mode ultrasounds which have shown no significant differences in 
fat thickness measurement when evaluated against direct cadaver analysis (Maud and 
Foster 2006). In one study in morbidly obese persons (before gastric banding) and obese 
(after gastric banding), ultrasonography measurements of subcutaneous fat thickness was 
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shown to have a good correlation with that measured by CT scans, r = 0.78 and r = 0.72 
respectively (Pontiroli et al. 2002). 
Various studies have assessed reliability and reproducibility of US fat thickness 
measurement. Inter and intra-observer reliability assessment of US at 14 sites by Ishida et 
al. (1992) reported high reliability of US, their coefficient of inter observer variation 
(CV%) greater than 90% for 11 of the 14 sites measured for fat thickness. This high 
reliability was also confirmed by Bellisari et al. (1993) who observed CV% of 98% and 
94% for intra observer and inter observer reliability respectively.  
Although data show a reasonably high reliability and validity of US subcutaneous fat 
thickness measurement, there still exists some difficulties which affect measurement such 
as the pressure on the probe at the scan site which if not uniform and constant, may affect 
adipose tissue distribution and the standardisation of the scan site. Therefore, before 
applying the US technique on TKA patients in the prospective study, reliability of the 
measurements taken by the investigator were assessed. 
 
6.7.2. Aims 
The aims of the study were: 
1. Test the inter-rater reliability of measurement of fat thickness above the knee joint 
using ultrasound technique. 
2. Test the intra-rater reliability of measurement of fat thickness above the knee joint 
using ultrasound technique. 
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6.7.3. Method 
 
Participants 
The reliability testing involved participants from a pool of apparently healthy students 
and staff from Queen Margaret University, post TKA patients and members of a local 
weight loss group (Scottish Slimmers, Musselburgh) in order to test a wider range of 
body compositions. Individuals with injury or skin condition (e.g. active inflammation of 
the skin at the site of testing) which could interfere with the use of ultrasound probe were 
excluded from the study.   
 
Investigators 
The first investigator (VA) is also the principal investigator of the prospective study and 
therefore took part in both inter and intra rater reliability studies. Both the first (VA) and 
the second investigator (KJ) are physiotherapists with experience in musculoskeletal 
ultrasonography. 
 
Assessment Procedure 
Measurement of fat thickness above the knee joint using ultrasound technique was 
identical to that described in section 6.6.2  
Height and body mass of the participants were also measured and BMI was calculated. 
Height of the participants was measured in millimeters using a stadiometer and body 
mass was measured in kilograms using a calibrated weigh scale.  
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Assessment protocol 
To test intra-rater reliability, participants were tested by the first investigator (VA) twice 
(Scan day 1 and Scan day 2) with a minimum interval of 48 hours between assessments, 
to check for the intra-rater reliability. For inter-rater reliability, both investigators 
measured each subject on the same day with a 15 minute interval between the 
measurements (Scan VA and Scan KJ).  
Data upload and analysis for all measurement were done by VA according to the methods 
described below. 
 
Data Extraction and Analysis 
Reliability assessments were all conducted at the Queen Margaret University, after 
obtaining ethical approval from the Queen Margaret University Research Ethics 
Committee.  
Images from the ultrasound machine were further analysed and measured on imaging 
software (Image J, NIH, Bethesda Maryland). The average of the distance between the 
lower surface of the skin and the top layer of quadriceps muscle were calculated as the 
average of these distances at 25%, 50% and 75% distance from the left of the image. 
Following standard normality distribution checks descriptive analysis of data was 
conducted (to provide mean and standard deviations of the measurements. Inter rater 
reliability was assessed using intra class correlation coefficient (ICC 3, 1) equation based 
on a two way analysis of variance (ANOVA) as described by Shrout and Fleiss (1979). 
Intra rater reliability was assessed using ICC equation (1, 2)  described in another study 
which assessed appropriate statistical analyses for ultrasound reliability and had an 
identical between day scan repeatability design (Rankin and Stokes 1998). This equation 
ICC (1, 2) is equivalent to ICC (1, k) described by Shrout and Fleiss (1979) where k is 
the number of measurements (2 measurements for 2 days) instead of number of raters.  
Intra class correlation coefficient range from zero to one with the closer the value to one, 
greater is the assumed reliability. There is no universal standard for categorizing scores, 
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Nunnaly and Bernstein (1994) note that the effect of measurement error is minimal with 
ICC values greater than 0.80 while Chinn (1991) recommend an ICC of at least 0.60  for 
the measurement to be useful. 
As ICC’s give no indication of the magnitude of agreement between the ultrasound 
measurements (between day scans or between raters), Bland and Altman’s methods to 
calculate the limits of agreement were employed (Bland and Altman 1986). A graph was 
plotted (Bland and Altman plot) between the relation between the size of the differences 
and size of the means. The Bland and Altman method calculates the bias which was 
estimated by the mean difference and standard deviation. The 95% limits of agreement 
were calculated as mean difference ± two times standard deviation. All statistical 
analyses were carried out using SPSS version 19.0. 
 
6.7.4 Results 
 
Participant characteristics 
Participant characteristics of age, gender, weight, height, BMI and mean of the absolute 
differences are shown in Table 13. 
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Table 13 Sample characteristics (means ±SD and range)of the participants in the 
reliability studies 
 Intra rater reliability sample Inter rater reliability sample 
 
N 20 13 
Age [Range] 42.9 (10) [25 years-62 years] 39.5 (17) [25 years-77 years] 
Males (n)/Females (n) 11/9 5/8 
 Day 1 Day 2  
Weight [Range], kg. 83.3±13.7 
[61.8-108.4] 
83.5 ±13.6 
[62.2-108.1] 
73.4 ±16.9 [51.5-110] 
Height [Range], mm. 1709± 77 
[1600-1880] 
1709 ± 77 
[1600-1880] 
1668 ± 77.5 [1560-1772] 
BMI [Range], kg/m
2
 28.4± 4 [22.4-
40.3] 
28.5± 4 [22.5-
40.2] 
26.3 ± 5.4 [19.2-38.9] 
 
Intra rater reliability  
The ICC coefficient of the between day scans of subcutaneous fat thickness by 
investigator VA was high with a ratio of 0.94 as indicated in Table 14. The Bland and 
Altman’s plot between the differences between scans and means of scans is shown in 
Fig.5. The lack of relation between the differences and mean in the plot shows that there 
was no heteroscedasticity indicating that the measurement error was not dependent on the 
size of the measurement. The distribution shows that in all cases except two, the 
difference between scan on day 1 and scan on day 2 is less than 2 mm. The central line in 
the plot indicates a difference of -0.685 mm i.e., the mean of the differences. The dotted 
line in the plot represents two times the standard deviation of the differences (2 x 1.3) and 
thus indicates the limits of agreement which extend from -3.29 mm to 1.92 mm. 
However, there are two cases which lie outside the dotted line (two times the standard 
deviation of the differences). 
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Inter rater reliability 
The inter-rater reliability of fat thickness in this study was excellent with an ICC 
coefficient of 0.99 (Table 15). Compared to the differences in between day scans (intra-
rater reliability), the differences between scans of the two investigators were narrower 
with most cases having a difference less than 0.5 mm. the central line in the plot indicates 
the mean difference (-0.131mm) and the dotted line represent two times standard 
deviation of the differences between Scans VA and Scans KJ representing the limits of 
agreement which were between 0.9mm and – 1.0 mm (Fig. 6) 
 
Table 14 Intra-rater reliability Means ± SD, ICC with 95% CI and agreement 
(LOA)  
 Mean fat 
thickness 
(mm) 
Mean 
absolute 
difference 
(mm) 
 
ICC 
95% Confidence 
Interval 
Bland Altman 
Limits of 
agreement (mm) Upper 
Bound 
Lower 
Bound 
US (Scan 
day1-Scan 
day2) 
9.5±3.6 
(day 1) 
 
10.1±3.8 
(day 2) 
 
1.07 
 
0.94 
 
0.977 
 
0.860 
 
-3.3, 1.9 
 
Table 15 Inter-rater reliability Means ± SD, ICC with 95% CI and agreement 
(LOA)  
  
Mean 
(mm) 
Mean 
absolute 
difference 
(mm) 
 
ICC 
95% Confidence 
Interval 
Bland 
Altman 
Limits of 
agreement 
(mm) 
Upper 
Bound 
Lower 
Bound 
Scan 
VA 
11±5.6 0.034  
0.99 
 
0.988 
 
0.999 
 
0.9, -1.0 
Scan 
KJ 
11.2±5.6 
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Figure 5 Bland and Altman Plot of the differences between US Scan day1 and US 
Scan day 2 vs. mean of US Scan day1 and US Scan day 2 for intra rater agreement 
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Figure 6 Bland and Altman Plot of the differences between Scan VA and Scan KJ 
vs. mean of Scan VA and Scan KJ for inter rater agreement. 
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6.7.5 Discussion 
 
The current study aimed to assess the reliability of ultrasound measurement of 
subcutaneous fat thickness above the knee. A very good inter-rater (ICC = 0.99) and 
intra-rater (ICC = 0.94) reliability was observed for the ultrasound measurements. 
The high ICC of the US measurements (0.94 for intra-rater and 0.99 for inter-rater) 
compares favorably to previous studies assessing intra and inter-observer reliability of US 
for the measurement of subcutaneous fat thickness (Ishida et al. 1992, Bellisari et al. 
1993). In addition, Ishida et al. (1992) used the generalisability theory to assess the 
relative contribution of subjects, days, investigators and trials on the variance in the fat 
thickness measurements. Subjects accounted for 79-97% variation, subject by day 
interaction accounted for 2-12%   while investigators and trials accounted for less than 
1% variation. The greater variation accounted for by subject by day interaction than that 
due to investigator may explain the higher reliability parameters for the inter-rater test 
compared to the intra-rater reliability test.  
However, direct comparison of our measurements to that of previous studies is not 
possible due to differences in the site of measurement. There are no established sites for 
the measurement of subcutaneous tissue using ultrasound, but some previous studies use 
sites for skin fold measurement given by the International Society of Kinanthropometric 
Assessment guidelines (Marfell Jones 2006). For the thigh area, this is at the mid-point 
between inguinal crease and anterior patella. The site for ultrasound measurement in this 
study is more distal, on anterior thigh, 7cm above the marked midpoint of the knee. The 
reason for the choice of this site is the proximity to the knee joint. Anthropometric 
measurements of the operated limb (supra patellar index) has been shown to have some 
effect on surgical difficulties which may subsequently have implications on surgical 
recovery (Lozano et al.2008). A distance of 7 cm allows accommodation for tissue folds 
above the knee joint particularly in obese participants.  
Ultrasonography is proposed as an alternative method to skin fold measurement as it 
overcomes some of the limitations of skinfold measurements. Unlike skin fold 
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measurement, US can measure full subcutaneous fat tissue in persons with high fat mass. 
This was essential for the prospective study for measuring fat thickness in obese patients. 
In addition, ultrasound also allows screen display of adipose tissue for potentially more 
accurate measurements. Despite these advantages and the observed high reliability there 
are some limitations to the method. Firstly, constant and uniform pressure on the 
transducer is needed as there is a reduction of the subcutaneous fat thickness with 
increased force on the transducer which is suggested to have a ‘squeezing out’ effect on 
the water contained in the adipose tissue (Leahy et al. 2012). Differences in tissue 
thickness caused by differential pressure on the probe were also observed in this study. 
The second limitation is the difficulty in interpretation of images which may arise as 
tissue characterization is subjective and depends on experience (Bellisari and Roche 
1993).Subcutaneous fat tissue is interspersed with connective tissue. Visual interpretation 
of the fat boundary can be affected by the connective tissue such that connective tissue 
near the fat-muscle interface may make the boundary between fat and muscle layer 
unclear (Bellisari& Roche 2005). Use of generous amount of acoustic contact gel, 
maximum surface contact with transducer and constant monitoring of the real time image 
is essential to keep the compression on the transducer to a minimum and obtain as clear 
an image as possible to identify the muscle fat interface.  
In conclusion, the proved reliability in the current study for ultrasound imaging of 
subcutaneous fat thickness justifies the use of the procedure and standardization, as 
described in this study by the investigator, in an apparently healthy sample to obtain 
reliable and accurate US measurements. Furthermore, knowing the safety of the use of 
these body composition methods, these can be also be implemented in the prospective 
study on TKA patients to obtain valid measurements.  
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6.8. Outcome measures. 
 
6.8.1. Oxford Knee Score 
The Oxford Knee Score (OKS) is a self-report questionnaire which was specifically 
designed to measures the patient’s perception of their knee function after total knee 
arthroplasty (Dawson et al. 1998). The questionnaire contains 12 questions, with five 
categories of response for each question. In the original scoring system for the 
questionnaire (as described in Chapter 5), each question is scored from 1 to 5 indicating 
response from least to most difficulty/severity. The individual response score is then 
combine to produce a final score ranging from 12 (least difficulty) to 60 (most difficulty). 
The current study has used the new scoring system for the questionnaire recommended by 
the authors (Murray et al. 1997) in which each question is scored from 0 to 4, 4 being the 
best outcome. This produces an overall score ranging from 0 to 48 where 48 indicate least 
functional difficulties. The questionnaire has been tested for validity, reproducibility and 
sensitivity to change (Dawson et al. 1998; Garrat et al. 1993).  
For the postal questionnaires collected at six week after surgery, incomplete 
questionnaires were re sent to the participants after contacting them. When contact was 
not possible, missing data addressed as per recommendations by the authors. The 
questionnaire authors recommend that if only one or two questions have been 
unanswered, it is possible to enter the mean value representing all of their other responses 
in order to fill the missing data. However, if more than two questions are left unanswered, 
the overall score should not be calculated. If two answers were indicated for a single 
question, the worst response was chosen as recommended by the authors.  
The questionnaire being short and simple has a high completion rate compared to other 
self-report knee specific questionnaire such as WOMAC or Lequesne Index of severity – 
Knee (Dunbar et al. 2001).  
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6.8.2. Short Form 12 Health Survey 
Short for 12 health survey (also described in Chapter 5) is a 12 – item quality of life 
survey. SF 12 was derived from the Medical Outcomes Study Short Form 36 Health 
Survey (SF36) by the developers of SF 36 (Ware J et al. 1996). The purpose of 
development of the SF12 was to reduce the number of health dimensions measured by 
selecting 12 items from the original 36 items to produce physical component summary 
and mental component summary without substantial loss of information (Ware et al. 
1996, Jenkinson et al. 1997).  
The SF12 has been tested for validity, reliability, responsiveness by its developers and by 
other authors for various conditions (Ware et al., Dunbar et al. 2001, Hurst et al. 1998, 
Gandek et al. 1998).  
SF12 has been used widely for total knee replacement patients and has shown to have a 
higher completed questionnaire return compared to other generic health measures SF36, 
Nottingham Health Profile and Sickness Impact Profile with an average time of 
completion of 7.7 minutes (Dunbar et al. 2001). The SF12 generates two summary score, 
the physical component summary (PCS) assessing the overall quality of physical health 
and the mental component summary assessing (MCS) overall quality of mental health. 
Each summary score ranges from 0 to 100, 100 indicating the best possible health.  
 
6.8.3. Visual Analogue Scale 
The Visual Analogue scale has been used extensively to assess pain in the TKA 
population. It has also been shown to be valid and reliable in TKA patients (Boeckstyns 
and Backe 1989; Flandry et al. 1991)  
For the study a 100 mm scale was used on which the patient marked their level of pain. 
The left end of the scale indicated zero or no pain and the right end of the scale indicated 
100 or maximum pain. Pain levels were assessed for pain at the knee during rest, 
walking, ascending stairs and descending stairs.  
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6.9. Data analysis 
 
6.9.1. Data extraction 
Pre-operative assessment (BMI, Waist to Hip ratio, patient characteristics) were manually 
recorded in the data sheet simultaneously with the assessments. These were then recorded 
in to SPSS data sheets. All data from the BIA was imported using the Maltron USB 
software for Windows and XP and Maltron data export software analyser. This data was 
then transferred into SPSS data sheets for analysis. 
Images from the ultrasound machine were further analysed and measured on imaging 
software (Image J). The average of the distance between the lower surface if the skin and 
the top layer of quadriceps muscle was measured as the fat thickness.  
Patient medical history of existing comorbidity, previous surgeries, post-operative 
complications and operation note were recorded manually from the patient’s medical 
notes and entered into the data sheet.  
 
6.9.2. Data Analysis 
All data underwent descriptive analyses to describe the characteristics of the sample.  
Descriptive analysis for baseline characteristics and comorbidity were done for each BMI 
group using number and percentages for categorical variables and mean and standard 
deviation for continuous variables. Between group comparison for continuous variables 
was done using independent t -test and categorical variables were analyzed using chi- 
square or Fishers exact test (if count less than five).  
Complication were divided into five parts: 1) complications during hospital stay 2) 
complications between hospital discharge and six weeks after surgery 3) complications 
from six weeks to six months after surgery and 4) complications from six months to one 
year after surgery 5) non home bound discharge and further interventions post surgery. 
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Data for each complication was analyzed using counts and percentages. Chi square test 
and Fishers exact test (if count less than five) were employed to compare the total 
complication rates for each part between BMI groups.  
Each body composition measure was used to divide the sample into two groups. The BMI 
values were divided into 2 groups of ‘non-obese’ (BMI = 20−29.9 kg/m2) and ‘obese’ 
(BMI > 30 kg/m
2
), based on the WHO classification of obesity (WHO 2000). Group 
division of the sample for waist circumference, waist to hip ratio, body fat percentage and 
ultrasonography were based on a median split technique where the median value of each 
measure was used to divide the groups into ‘low’ or ‘high’ Correlations analysis of the 
body composition measures were done to assess their relationship with each other and 
check if they quantified obesity in the same direction. 
Baseline and follow up (six weeks, six months and one year) OKS, SF12 and VAS pain 
scale were analyzed for time effect  to assess the change from baseline to each follow up 
using Friedman’s ANOVA and post hoc test using Wilcoxon signed rank test where 
appropriate.  
Inferential analyses to check the null hypothesis were done in two ways: 
1. Correlation analysis with Pearson’s correlation coefficient and scatter plots to explore 
the relationship between body composition measures and OKS, SF12 and VAS pain 
scale. 
2. ANCOVA with baseline score as covariate to assess the difference between groups 
for normally distributed data and Mann Whitney test to assess for group differences 
for data which do not meet assumptions of ANCOVA.  
The level of significance was set at p < 0.05 for all statistical tests. All statistical analyses 
were carried out using SPSS version 19.0  
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CHAPTER 7: A PROSPECTIVE STUDY OF THE EFFECT OF BODY 
COMPOSITION ON TKA OUTCOMES: RESULTS AND DISCUSSION 
 
 
Chapter overview 
 
This chapter is presented in two sections. The first section (Section 8.1) reports the study 
assessing the effect of obesity (as defined by five body composition measurement 
methods) on self-report outcomes up to one year after TKA and section. The second 
section (Section 8.2) discusses the findings of the study and its implications  
 
 
7.1. Study results 
 
7.1.1 Section overview 
This section includes reporting of participant baseline characteristics, immediate and 
follow up complication rates followed by descriptive data for the independent variables 
and outcomes. Inferential statistics are then presented addressing the hypothesis, first by 
assessing the relationship between obesity and outcomes using independent variables as 
continuous data and then by group comparison for differences between outcomes 
measures. This section ends with a summary of the results. 
 
7.1.2. Baseline participant characteristics 
Participant characteristics at baseline are as shown the table below (Table 16). 
Differences in the distribution of age and gender across the pre-operative BMI groups 
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were assessed using independent t- test and chi square test respectively. As shown in the 
table neither age nor gender distribution was significantly different across groups. Of the 
total patients, 6.5% (n = 4) had rheumatoid arthritis, of which more were in the non-obese 
group (three of four). Majority of the patients (72.13%) were fitted with a Triathlon 
(Stryker Ltd.) knee replacement. Other types of prosthesis included the fixed bearing, 
PCL retaining, Sigma PFC (DePuy Int Ltd.) (19.6%) and a Kinemax (Stryker Ltd.) fitted 
in one patient. The values of the count of the number of osteoarthritis/ rheumatoid 
arthritis, laterality, prosthesis type are also given in the Table 16. 
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Table 16 Characteristics of the participants at  Baseline 
 
Participant 
characteristic 
Total 
sample 
 
N = 61 
Obese, 
BMI > 30 
kg/m
2 
N = 38 
 
Non-obese, 
BMI = 25-
29.99 kg/m
2
 
N = 23 
P value  
T-test
a
/ chi-square 
test
b
/fishers-exact 
test
c 
Mean age in years 
Standard deviation 
70.6 (8) 68.9 (8.4) 
 
73.4 (6.7) 
 
0.189
a 
Gender  
 Male 
 Female  
 
28 
33 
 
17 
21 
 
11 
12 
0.814
b 
Diagnosis 
 OA 
 RA 
 
57 
4 
 
37 
1 
 
20 
3 
0.129
c 
Laterality 
 Right 
 Left  
 
24 
37 
 
16 
22 
 
8 
15 
0.183
c 
Prosthesis  
 Triathlon 
 PFC 
 Kinemax 
 Not recorded 
 
44 
12 
1 
4 
 
27 
8 
1 
2 
 
17 
4 
0 
2 
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7.1.3. Comorbidities prior to surgery 
 
Two patients with a previous episode of atrial fibrillation had been fitted with a 
pacemaker. One of the patients was fitted with the pacemaker after their baseline 
assessment for the study was completed. The other patient had a pacemaker fitted before 
he attended the baseline assessment for the study and in this case, since the presence of a 
pacemaker is a contraindication for the use of BIA, body fat percent data was not 
collected.  
In total there were four morbidly obese patients. Participant with the highest BMI (49.1 
kg/m
2
) had a history of metabolic syndrome and had undergone gastric banding surgery 
previous to being placed on the waiting list for TKA. Three other morbidly obese patients 
had histories of atrial fibrillation and myocardial infarction.  
The list of medical conditions obtained from patient’s medical history previous to the 
TKA has been detailed Table 17.  
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Table 17 List of comorbidity previous to TKR 
Medical 
condition 
Total sample Obese, BMI > 30 
kg/m
2 
Non-obese, BMI = 
25-29.99 kg/m
2
 
No of 
participants 
/ total no of 
participants 
for which 
data was 
obtained 
% of the no 
of 
participants 
for which 
the data was 
obtained  
No of 
participants 
/ total no of 
obese 
participants 
for which 
data was 
obtained 
% of the no 
of obese 
participants 
for which 
the data was 
obtained  
No of 
participants 
/ total no of 
non-obese 
participants 
for which 
data was 
obtained 
% of the no 
of non-obese 
participants 
for which 
the data was 
obtained  
Previous 
pulmonary 
embolism 
2/61 3.3% 2/38 5.3% 0 0 
Cerebrovascular 
disease 
 TIA 
 Stroke 
 
 
1/61 
4/61 
 
 
1.65% 
6.6% 
 
 
0 
1/38 
 
 
0 
2.6% 
 
 
1/23 
3/23 
 
 
4.3% 
13% 
Ischemic heart 
disease 
 CAD 
 MI 
 AF  
 LVF 
 
 
3/61 
6/61 
6/61 
1/61 
 
 
4.95% 
9.9% 
9.9% 
1.65% 
 
 
2/38 
4/38 
3/38 
1/38 
 
 
5.3% 
10.5% 
7.9% 
2.6% 
 
 
1/23 
2/23 
3/23 
0 
 
 
4.3% 
8.7% 
13% 
0 
Hypertension 29/61 47.5% 21/38 55.3% 8/23 34.8% 
Type II Diabetes*
 
8/61 13.1% 8/38 21% 0 0 
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COPD 6/61 9.9% 3/38 7.9% 3/23 13% 
Breast cancer 4/61 6.6% 3/38 7.9% 1/23 4.3% 
Prostrate cancer 5/61 8.25% 3/38 7.9% 2/23 8.7% 
Hodgkin’s 
disease 
1/61 1.65% 0 0 1/23 4.3% 
Chronic 
lymphocytic 
leukaemia 
1/61 1.65% 1/38 2.6% 0 0 
Metabolic 
syndrome 
1/61 1.65% 1/38 2.6% 0 0 
Fatty liver 1/61 1.65% 1/38 2.6% 0 0 
Low back pain 4/61 6.6% 3/38 7.9% 1/23 4.3% 
Hip pain 2/61 3.3% 2/38 5.3% 0 0 
Ankle arthritis  2/61 3.3% 2/38 5.3% 0 0 
Chronic ankle 
swelling 
1/61 1.65% 1/38 2.6% 0 0 
THA 4/61 6.5% 2/38 5.1% 2/23 8.7% 
TKA 17/61 27.9% 10/38 25.6% 7/23 31.8% 
Ankle fusion 1/61 1.65% 1/38 2.6% 0 0 
*Significantly different between obese and non-obese, p <0.05 
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Previous Knee and Hip replacements 
Twenty eight percent of the total sample had undergone a previous TKA in the 
contralateral knee. Between the obese and non-obese groups, the non-obese group had a 
greater percentage with a history of a previous TKA than obese (31.8% vs. 25.6%), but 
this difference was not significant (two tailed p value for chi square test = 0.728) 
There were two previous THR in both obese and non-obese groups. However, percentage 
wise, the non-obese group had a greater proportion of patients with previous THR (but 
not statistically significant, two tailed p value for fishers exact test = 0.628). Both patients 
in the obese group with THR had bilateral replacements while the two patients in non-
obese group had unilateral THR.  
 
 
7.1.4. Complications post surgery 
 
The information on the reported complications obtained from patients and medical 
records were grouped in to those arising in the immediate post-operative period, from 
discharge till six weeks after surgery, from six weeks after surgery till six months after 
surgery and from six months after surgery till one year after surgery.  
 
Complications during hospital stay 
 
The details of significant complications seen during the patients’ hospital stay are listed 
in the Table 18. There were a total of five post-operative conditions complicating the 
post-operative recovery.  Of the six patients experiencing these complications, three were 
obese and two were non-obese. One patient in the obese category experienced two 
complications in the list, suffering from both a lower respiratory tract infection and an 
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onset of fast atrial fibrillation. The complications obviously increased the length of the 
hospital stay for the patient except in one case where a patient developed atelectasis and 
hypoxia but was discharged in four days once his stats were back to normal. The longest 
hospital stay of 15 days was recorded for the patient who developed pulmonary 
embolism. One patient with atrial fibrillation was discharged after six days, however, to a 
nursing home, for further recovery  
 
Complications between discharge and six weeks after surgery 
 
As shown in Table 19, of the 17 complications reported in 29 patients, 16 (42.1%) were 
obese and 13 (56.5%) were non-obese. One patient not listed in the table above had been 
readmitted because of chest pain and shortness of breath one week after discharge but on 
further investigation, no evidence of pulmonary embolism or any other condition was 
found to be reported.  
 
Complications between six weeks and six months after surgery 
 
Significant co-morbidities that developed in patients during this period included an 
episode of MI, prostate cancer, metastasis of breast cancer and duodenal ulceration 
(Table 20). Related directly to the operated knee, one patient developed early osteolysis 
and loosening under the tibial tray around six months after surgery. Further interventions 
for this were not immediate as the patient was undergoing aggressive chemotherapy and 
also antibiotic therapy for urinary tract infection post prostrate biopsy and therefore 
information regarding further interventions in this case was not present in the medical 
notes. Of a total of 13 participants with a complication during this period, 9 (23.7%) were 
observed on the obese and 4 (17.4%) were observed in the non-obese. 
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Complications between six months post operation and one year after surgery 
Details of the co-morbidities/ complications developed during this period are listed in the 
table below (Table 21).  One patient was deceased after a period of palliative care for 
multiple brain metastasis of her breast cancer. During this period, five (13.1%) obese and 
two (8.7%) non-obese had a complication. 
 
 
Non- home bound discharge and further interventions after surgery 
 
Details of non- home bound discharge, interventions and referrals are shown in the Table 
22. A patient aged 89 was discharged into a geriatric orthopaedic rehabilitation after 
discharge from the hospital. A patient was discharge to a rehabilitation ward while 
another patient who developed atrial fibrillation post-operatively was discharged to a 
nursing home for convalescence. Five patients were referred by the hospital or the 
arthroplasty practitioners to outpatient or domiciliary physiotherapy. Some patients may 
have accessed physiotherapy through self-referral, the information for which, however, 
we could not extract from the patient notes. One patient was referred to psychology and 
was under anti-depressant medication for depression related to bereavement in the family 
and social circumstances. This also hindered her motivation for recovery in the early 
post-operative stages. 
 
Post-operative complications: Summary of results  
The number of co-morbidities or complications developed after surgery decreased over 
the period from discharge to one year after surgery from 28 in the period between 
discharge and six weeks to six for that between six months and one year after surgery. 
Related to the knee, complications documented varied from superficial wound infection, 
wound leakage, wound inflammation and continued pain, stiffness and muscle spasm 
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around the operated knee. In two cases, continued knee pain and stiffness was reported 
even in the later stages of recovery between six months and one year. Increased pain in 
the contralateral knee was experienced in four cases, of which three were reported before 
six months and one was reported after six months after surgery. 
Major complications such as deep infection, prosthetic infection or prosthetic fractures 
were not documented for any case and neither was any requirement for a revision surgery 
in any case noted. As mentioned in previous section, there was a case with early 
osteolysis under the tibial tray for one patient although information on further 
interventions for this was not available.  
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Table 18 List of complications during hospital stay 
Complications 
during hospital 
stay (immediate 
post-operative 
recovery) 
Total sample Obese, BMI > 30 
kg/m
2 
Non-obese, BMI = 
25-29.99 kg/m
2
 
No of 
participants 
/ total no of 
participants 
for which 
data was 
obtained 
% of the no 
of 
participants 
for which 
the data 
was 
obtained  
No of 
participants 
/ total no of 
obese 
participants 
for which 
data was 
obtained 
% of the no 
of obese 
participants 
for which 
the data 
was 
obtained  
No of 
participants 
/ total no of 
non-obese 
participants 
for which 
data was 
obtained 
% of the no 
of non-obese 
participants 
for which 
the data was 
obtained  
Atelectasis 1/61 1.6% 0 0 1/23 4.3% 
Pulmonary 
embolism 
1/61 1.6% 1/38 2.6% 0 0 
Respiratory 
infection 
1/61 1.6% 1/38 2.6% 0 0 
Atrial 
fibrillation 
2/61 3.3% 1/38 2.6% 1/23 4.3% 
Anxiety and 
stress 
1/61 1.6% 1/38 2.6% 0 0 
Total number 
of 
complications
* 
6/61 9.8% 4/38 7.9% 2/23 8.7% 
*
Two tailed p-value for fishers exact test= 1 
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Table 19 List of complications from hospital discharge till 6 weeks post operation 
Complications 
(discharge to 6 
weeks post op) 
Total sample 
 
Obese, BMI > 30 
kg/m
2 
 
Non-obese, BMI = 
25-29.99 kg/m
2
 
No of 
participants 
/ total no of 
participants 
for which 
data was 
obtained 
% of the no 
of 
participants 
for which 
the data 
was 
obtained  
No of 
participants 
/ total no of 
obese 
participants 
for which 
data was 
obtained 
% of the no 
of obese 
participants 
for which 
the data 
was 
obtained  
No of 
participants 
/ total no of 
non-obese 
participants 
for which 
data was 
obtained 
% of the no 
of non-
obese 
participants 
for which 
the data 
was 
obtained  
DVT 1/61 1.6% 0 0 1/23 4.3% 
Lower 
respiratory 
tract infection 
1/61 1.6% 0 0 1/23 4.3% 
Wound 
infection 
2/61 3.3% 1/38 2.6% 1/23 4.3% 
Wound 
leakage 
2/61 3.3% 1/38 2.6% 1/23 4.3% 
Cellulitis 1/61 1.6% 0 0 1/23 4.3% 
Wound 
inflammation 
1/61 1.6% 0 0 1/23 4.3% 
Stiffness  4/61 6.5% 2/38 5.3% 2/23 8.7% 
Abdominal 
discomfort due 
to analgesia 
4/61 6.5% 2/38 5.3% 2/23 8.7% 
GI bleed due 
to analgesia 
2/61 3.3% 2/38 5.3% 0 0 
Ulceration due 
to analgesia 
2/61 3.3% 2/38 5.3% 0 0 
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Contralateral 
knee pain 
2/61 3.3% 2/38 5.3% 0 0 
Hip pain 1/61 1.6% 1/38 2.6% 0 0 
Foot pain 2/61 3.3% 0 0 2/23 8.7% 
Sciatica pain 1/61 1.6% 1/38 2.6% 0 0 
Depression 1/61 1.6% 1/38 2.6% 0 0 
Panic attacks 1/61 1.6% 1/38 2.6% 0 0 
Maculopapular 
rash 
1/61 1.6% 0 0 1/23 4.3% 
Total number 
of 
complications
* 
17 
29/61 47.5% 16/38 42.1% 13/23 56.5% 
*
Two tailed p-value for Chi square test = 0.275 
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Table 20 List of complications from 6 weeks to 6 months post operation 
Complications 
( 6 weeks post op to 
6 months post op) 
Total sample 
 
Obese, BMI > 30 
kg/m
2 
 
Non-obese, BMI = 
25-29.99 kg/m
2
 
No of 
participants 
/ total no of 
participants 
for which 
data was 
obtained 
% of the no 
of 
participants 
for which 
the data was 
obtained  
No of 
participants 
/ total no of 
obese 
participants 
for which 
data was 
obtained 
% of the no 
of obese 
participants 
for which 
the data was 
obtained  
No of 
participants 
/ total no of 
non-obese 
participants 
for which 
data was 
obtained 
% of the no 
of non-obese 
participants 
for which 
the data was 
obtained  
MI 1/61 1.6% 1/38 2.6% 0 0 
Metastasis of 
breast cancer 
1/61 1.6% 1/38 2.6% 0 0 
Duodenal ulcer 
and gastritis 
1/61 1.6% 1/38 2.6% 0 0 
Prostrate 
cancer 
1/61 1.6% 0 0 1/23 4.3% 
Decreased 
balance 
1/61 1.6% 1/38 2.6% 0 0 
Early osteolysis 
of tibial tray 
1/61 1.6% 0 0 1/23 4.3% 
Knee stiffness 1/61 1.6% 0 0 1/23 4.3% 
Continued knee 
pain + calf pain 
1/61 1.6% 0 0 1/23 4.3% 
Continued knee  
pain and 
muscle spasm  
1/61 1.6% 1/38 2.6% 0  0 
Contralateral 
knee pain 
+arthritis 
2/61 3.3% 2/38 5.3% 0 0 
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Continued knee 
pain and 
redness 
1/61 1.6% 1/38 2.6% 0 0 
Soft tissue knee 
injury due to 
fall 
1/61 1.6% 1/38 2.6% 0 0 
Total number 
of 
complications
* 
12 
 
13/61 21.3% 9/38 23.7% 4/23 17.4% 
*
Two tailed p-value for fishers exact test = 0.749 
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Table 21 List of complications from 6 months till 1 year post operation 
Complications 
( 6 months post op 
to one year post op) 
Total sample 
N = 61 
Obese, BMI > 30 
kg/m
2 
N = 38 
Non-obese, BMI = 
25-29.99 kg/m
2
 N = 
23 
No of 
participants 
/ total no of 
participants 
for which 
data was 
obtained 
% of the no 
of 
participants 
for which 
the data was 
obtained  
No of 
participants 
/ total no of 
obese 
participants 
for which 
data was 
obtained 
% of the no 
of obese 
participants 
for which 
the data was 
obtained  
No of 
participants 
/ total no of 
non-obese 
participants 
for which 
data was 
obtained 
% of the no 
of non-obese 
participants 
for which 
the data was 
obtained  
MI 1/61 1.6% 1/38 2.6% 0 0 
Subdural 
haematoma 
(recovered with 
IC surgery) 
1/61 1.6% 0 0 1/23 4.3% 
Stroke 1/61 1.6% 1/38 2.6% 0 0 
Continued pain 
and stiffness 
2/61 3.3% 1/38 2.6% 1/23 4.3% 
Contralateral 
knee pain 
1/61 1.6% 1/38 2.6% 0 0 
Total number 
of 
complications
* 
6 
7/61 11.5% 5/38 13.1% 2/23 8.7% 
*
*
Two tailed p-value for fishers exact test = 0.700 
 
155 
 
Table 22 List of non home bound discharges, further interventions and referrals 
Intervention Total sample 
 
Obese, BMI > 30 
kg/m
2 
 
Non-obese, BMI = 
25-29.99 kg/m
2
 
No of 
participants 
/ total no of 
participants 
for which 
data was 
obtained 
% of the no 
of 
participants 
for which 
the data was 
obtained  
No of 
participants 
/ total no of 
obese 
participants 
for which 
data was 
obtained 
% of the no 
of obese 
participants 
for which 
the data was 
obtained  
No of 
participants 
/ total no of 
non-obese 
participants 
for which 
data was 
obtained 
% of the no 
of non-obese 
participants 
for which 
the data was 
obtained  
Discharge to 
rehab/nursing 
home 
3/61 4.9% 1/38 2.6% 2/23 8.7% 
Discharge to 
observation ward 
(for mild 
cellulitis) 
1/61 1.6% 0 0 1/23 4.3% 
Contralateral 
TKR 
1/61 1.6% 0 0 1/23 4.3% 
Revision 
contralateral TKR 
1/61 1.6% 1/38 2.6% 0 0 
Revision THR 1/61 1.6% 1/38 2.6% 0 0 
Referrals  
Out patient 
physiotherapy 
5/61 8.2% 2/38 5.3% 3/23 13% 
Orthotics for foot 
pain 
1/61 1.6% 0 0 1/23 4.3% 
Psychologist 1/61 1.6% 1/38 2.6% 0 0 
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7.1.5. Measurement of body composition 
 
The average BMI of the total sample was 31.3 kg/m
2
 with a wide variation in the BMI 
values which ranged from 20.7 to 49.1 kg/m
2
 (Table 23). When grouped according to the 
established cut-offs for BMI (WHO 2000), a larger proportion of the sample were obese 
(62.3%). The average BMI for the non-obese group was 26.2 kg/m
2
 while for the obese 
group it was 34.4 kg/m
2
. There were four morbidly obese patients in the total sample with 
BMI ranging from 40.3 to 49.1 kg/m
2
. For statistical analysis, however, due to a low 
number the morbidly obese were grouped in the obese category.  
 
Waist circumferences were first grouped into low risk (< 40 inches for males and < 35 
inches for females) and high risk (> 40 inches for males and >35 inches for females) and 
Waist to hip ratio measurements were grouped into values of WHR >0.90 (males) 
WHR>0.85 (females). This classification was based on the WHO cut-off values for WC 
and WHR for classifying those with abdominal obesity (WHO 2008). A large majority of 
the sample (86%) fell into the ‘high risk’ or ‘abdominal obesity’ group while only 14 % 
were in the ‘low risk’ or ‘no abdominal obesity’ group. Similarly, there was marked 
disparity in the number of participants in the two groups for body fat percentage (BF %) 
when classed as obese (BF % > 42% for females and >30% for males) and non-obese (BF 
% < 42% for females and < 30% for males) (Gallagher et al. 2000) with a greater 
proportion of the sample (70.5%) classed as obese. Since the large variation between 
group sizes (WC: 14 vs. 47, WHR: 9 vs. 52, BF%: 13 vs. 43) would render the statistical 
analysis meaningless, these body composition measures were split into two groups using 
a median split technique. Since no established or proposed cut-off points to classify 
obesity by ultrasound measurement of fat thickness are known, the median was calculated 
for the ultrasound measurements as 11.167 mm and the fat thickness value of 11.167 mm 
was used to split the sample into two groups as was done for WC, WHR and BF% 
groups. 
Descriptive values of the baseline body composition groups are detailed in table 23 
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Table 23 Body Composition groups 
BMI groups 
using WHO 
classification 
 Non-obese<30 kg/m
2 Obese ≥ 30 kg/m2 
N 23 (37.7%) 38 (62.3%) 
Mean weight (kg),  
(SD) 
73.2(12.1) 92.5(17.7) 
Mean height (mm), 
(SD) 
1666 (96) 1636(94) 
Mean BMI (kg/m
2
),  
(SD) 
26.24 (2.7) 34.36 (4.4) 
WC (mm) median 
split groups 
 WC <1054 (41.5”) WC ≥1054 (41.5”) 
N 31 30 
Mean WC (SD) 37.3 (3.3) 45.9 (3.5) 
WHR median split 
groups 
 WHR < 0.95 WHR ≥ 0.95 
N 32 29 
Mean WC (SD) 38.9 (5.5) 44.4 (3.8) 
Mean HC (SD) 
 
43 (4.7) 43.5 (3) 
Mean WHR (SD) 0.9 (0.05) 1 (0.04) 
BF%  median split 
groups 
 BF % < 39.9 BF% ≥ 39.9 
N 30 30 
Mean fat % 
(SD) 
33.8 (4.8) 48.2 (5.6) 
US (mm) median 
split groups 
 Fat thickness < 
11.167mm 
Fat thickness 
≥11.167mm 
N 30 31 
Mean fat thickness 
(SD) 
7.6 (2) 
 
15 (4) 
BMI (Body Mass Index), WC (Waist Circumference), WHR (Waist to Hip Ratio), 
BF(Body Fat), US (Ultrasonography) 
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Correlations between body composition measures 
Correlation analysis was performed between the body composition measures to assess the 
relationships between these measures and to check if they all quantify obesity in a similar 
direction (Table 24). All of the five body composition measures showed a significant 
correlation with at least two of the other four measures. Correlation coefficient (r) values 
ranged from 0.319 to 0.866. Only WHR and BF% (r = -0.105, p = 0.424) and WHR and 
ultrasound (r = -0.118, p = 0.364) did not correlate significantly. The lack of relation 
between WHR and BF% and US values indicate the different aspects of obesity measured 
by these methods. While BIA and US methods measure the actual fat present in the body 
(BIA) and above knee region (US), WHR gives the ratio of fat distribution i.e., greater 
WHR giving indication of greater central or trunk mass. Therefore greater central mass 
(android obesity) may be indicated by a greater WHR and body fat percentage (BIA), but 
in patients with more equitable distribution of body fat at both waist and hip would or 
those with greater fat mass at hip (gynoid obesity) will have a lower WHR but a high 
body fat percentage and regional fat thickness 
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Table 24 Pearson’s Correlation between body composition measures 
  BMI WHR WC BF% US 
BMI Pearson Correlation 1 .415
**
 .866
**
 .596
**
 .510
**
 
P value  .001 .000 .000 .000 
N 61 61 61 60 61 
WHR Pearson Correlation .415
**
 1 .740
**
 -.105 -.118 
P value .001  .000 .424 .364 
N 61 61 61 60 61 
WC Pearson Correlation .866
**
 .740
**
 1 .373
**
 .319
*
 
P value .000 .000  .003 .012 
N 61 61 61 60 61 
BF% Pearson Correlation .596
**
 -.105 .373
**
 1 .619
**
 
P value .000 .424 .003  .000 
N 60 60 60 60 60 
US  Pearson Correlation .510
**
 -.118 .319
*
 .619
**
 1 
P value .000 .364 .012 .000  
N 61 61 61 60 61 
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7.1.6. Outcomes measurement 
Flow of participants in the study 
The flow of participants through the study is as shown in figure 7. Twenty four (25%) of 
the total respondents could not be assessed for the study. Of these ten were not assessed 
because they were removed from the TKA waiting list or deferred from surgery, either 
due to development of other medical conditions requiring more immediate attention or by 
patients own choice of not going ahead with the surgery. Knee arthroplasty patients are 
given a choice of being transferred to other hospitals as a part of the waiting times 
initiative by the NHS Scotland to reduce the waiting time between referral and treatment. 
Four respondent patients were transferred to the Golden Jubilee National Hospital and 
one was transferred to a private hospital in Murrayfield as a part of this initiative and 
hence could not be assessed at their pre admission appointment for the study. Further 
seven participants had their pre admission clinic appointment in 2011and therefore could 
not be assessed. Two potential participants changed their minds about participation in the 
study at the pre admission clinic. 
With 70 remaining respondents, the study had a dropout rate of 14% (n = 9). From the 
nine patients who dropped out of the study, six had their TKA surgery cancelled at or 
after the pre admission clinic appointment (due to cardiac condition, development of 
malignant bladder cancer and patient’s decision of not going ahead with the surgery). 
Three did not respond to the six week follow up questionnaires leaving 61 complete data 
sets at six weeks follow up. The six month and one year follow up was obtained from the 
hospital database and was available for 45 (six month OKS follow up), 32 (six month SF-
12 follow up) and 32 (one year OKS and SF-12 follow up). 
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Patients on TKR waiting list between March 2010-April 2011 meeting eligibility 
criteria and invited to participate in study
N = 284
Responded 
N = 94
Assessed at pre 
admission clinic
N = 70
Not assessed for study
N = 24
Removed from waiting list n = 10
Transferred to other/private hospital
 n = 5
Changed mind about study 
participation at pre admission clinic 
n = 2
Pre admission appointment after may 
2011 n = 7
Available for follow 
up
N = 64
Complete data set 
obtained 
N = 61
Did not respond at follow up n = 3
Surgery cancelled at pre 
admission clinic n = 6
Available at 6 
months follow up: 
OKS = 45
SF12 = 32
Available at 1 year 
follow up = 32For 
OKS and SF12
 
Figure 7 Flow of participants in the study 
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Normality tests 
VAS pain scale scores and MCS of the SF12 were significantly deviated from a normal 
distribution. Six month and one year OKS and PCS of SF12 also showed significant 
deviation from normality. Baseline and six weeks OKS and PCS of SF12 were normally 
distributed. All tests for normality have been shown in the Appendix B. 
 
Baseline primary outcomes measure 
 
Oxford Knee Score 
The Oxford Knee Score (OKS) calculated between 0 and 48 (48 as the best outcome) had 
a median score of 22 (IQR = 9). A wide variation was seen with scores as high as 36 to 
scores as low as nine. However, on removing the extreme values, the 5 % trimmed mean 
was 21 and close to the mean of the sample indicating little influence of outliers on the 
sample mean. The descriptive statistics for the pre operative OKS are shown in Table 25. 
 
Baseline secondary outcomes measure 
 
Short Form – 12 Health survey  
The average physical component score, PCS, in the sample was lower than the mental 
component score, MCS (31.3 vs. 51.46). Out of a score of 0 to 100 (100 indicating the 
highest level of health, the median value was 29.8 (IQR = 9.9) for PCS. Median score for 
the MCS was 55 (IQR = 20.7) indicating some difference in the mean and median for 
MCS. The descriptive statistics for the SF12 scores are as shown in Table 25. 
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VAS Pain scale 
 
The baseline scores for the pain scales were available for 59 participants of the total 61, 
and 55 of 61 for pain scale on stair descending. The highest average pain score was 
observed during stair descending (7.4+ 2.21) followed by stair climbing (6.97+ 2.15), 
walking (6.92+ 1.83) and then at rest (3.5+ 2.26). Larger standard deviations for pain 
scale values during stair mobility might indicate differences in the use of support, 
climbing or descending patterns used and larger standard deviation for pain at rest might 
indicate difference in the pattern of pain though the day/night. The descriptive statistics 
for pain scales are as indicated in Table 25. 
 
Follow up primary outcomes measure 
Oxford Knee Score 
Six weeks scores were obtained for all participants, but the six months and one year OKS 
were available for 45 and 32 participants respectively. Maximum score of 48 (which is 
the highest possible score on OKS) was also achieved by patients as early as six weeks 
post-operatively. The six weeks post-operative scores did not show a significant deviation 
from normal distribution. Multiple modes and a high degree of deviation to the right were 
observed for the six month score with 42% of the six month scores above 40. The one 
year score were also skewed to the right and 18.8% of the total one year scores were the 
highest score of 48. There was a decrease in sample size in the subsequent follow up 
periods (N = 61 at 6 weeks, 45 at 6months and 32 at one year follow up). 
Table 25 gives the means, standard deviations and participant numbers for the follow up 
scores. A steady increase in the mean score was observed from baseline to one year 
follow up (21.13, 30.86, 36.33 and 39.96). On performing a Friedman’s ANOVA, 
significant improvement was observed from pre operative to six weeks and from six 
weeks to six months, (p < 0.001). However, the change from six months to one year 
follow up was not statistically significant (p= 0.05) as indicated in Table 25. 
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Follow up secondary outcomes measure 
 
Short Form 12 (SF12) 
Means, standard deviations and number of participants for all outcome measures are 
given in table 25. On observing the means, an increasing trend is seen for both PCS and 
MCS indicating a shift to better quality of life from baseline to six weeks and six month 
follow up. However, on performing Friedman’s ANOVA (followed by post hoc test with 
Wilcoxon signed-rank test), it was observed that the MCS scores did not differ 
significantly across time points. There was a significant increase in the PCS score across 
the time points from baseline to one year (p <0.001), although this increase is not seen 
between six months and one year follow up (p= 0.85). As with OKS, the sample size for 
SF12 reduced at subsequent follow ups, from 60 at six weeks to 48 and 32 for six months 
and one year follow up respectively.  
 
VAS Pain scale 
All pain scale values (at rest, walking stair ascending and stair descending) showed a 
significant reduction from baseline to six weeks indicating reduction in pain during these 
activities from the baseline to six weeks after the operation (Wilcoxon signed rank test, 
all p< 0.001). Pain scores were collected only at baseline and six weeks post-operative 
time point. 
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Table 25 Mean/median, standard deviation/range and N values for all outcomes 
measures at baseline, 6 weeks, 6 months and 1 year follow up (time effect) 
Outcome 
measure 
 Baseline  6 weeks 6 months 1 year 
OKS Mean (sd) 
 
21.13 (6.23) 30.86 (9.32) *
 
36.33 (9.81)* 39.96 (7) 
N  61 61 45 32 
PCS Mean (sd) 
 
31.29 (7.34) 37.68 (9.68)
 
* 45.34 (15.5)
 
* 45.33 (9.33 
N  61 60 48 32 
MCS Median (IQ) 
 
55 (20.7) 55.6 (15.65) 57.68 (9.78) 58.33 (9.37) 
N  61 60 48 32 
Pain rest Median (IQ) 
 
3.2 (3.4) 1.3 (2.6)
 
* NA NA 
N  59 59 NA NA 
Pain walking Median (IQ) 
 
7.5 (2.6) 2 (3.1)* NA NA 
N  59 59 NA NA 
Pain stair 
ascend 
Median (IQ) 
 
7.5 (3) 1.9 (3.8)* NA NA 
N  59 59 NA NA 
Pain stair 
descend 
Median (IQ) 
 
8 (2.8) 2.2 (5.18)* NA NA 
N  55 58 NA NA 
*Significant at p <0.05 from baseline to six weeks and six weeks to six months  
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7.1.7. Effect of body composition on outcomes: Testing of hypothesis 
Null hypothesis: Obesity (body composition) does not have any effect on self-report 
outcomes (OKS, SF12 and Pain scores) following TKA. 
The hypothesis was tested in two ways. Firstly, correlation analysis and scatter plots were 
employed to explore the relationship between the body composition measures and the 
TKA outcomes (Section 7.1.8). Secondly, the sample was grouped according to each 
body composition measure followed by use of appropriate statistical method for group 
comparison (Section 7.1.9). Fig 9 below illustrates the different statistical methods used 
to address the hypothesis.  
 
Null hypothesis: Obesity (Body 
composition) does not affect TKA self 
report outcomes
Independent 
variables:
BMI
Waist C.
WH ratio
BIA
US
Dependent 
variables:
OKS
SF12 (PCS+MCS)
Pain (rest, walk, 
stair up, stair 
dwn)
Time points:
Pre op
6 weeks post op
6 months post 
op
1 year post op
Does obesity influence TKA self report 
outcomes?
Correlations 
Scatter plot
Is there a difference in the self 
report TKA outcomes between 
obese and non obese?
ANCOVA at each time 
point with pre op as 
covariate
Normally 
distributed data
Non Normally 
distributed data
Mann Whitney test at 
each time point
 
Figure8 Statistical analyses of data 
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7.1.8. Effect of body composition: Correlation 
 
Correlation analysis statistics for all follow up outcomes has been given in table 26. 
 
Body composition and OKS 
Correlation analysis between the body composition measures and outcomes indicated a 
significant negative relationship between BMI and follow up scores at six months (r = -
.34, p = .024) and one year (r = -.42, p = .018). Also a significant negative relationship 
was seen between waist circumference and OKS follow up scores at 6 months (r = -.33, p 
= .027) and one year (r = -.38, p = .033). These values therefore indicated that as BMI or 
waist circumference values increased, there was a decrease in score (poorer outcome). 
Waist to hip ratio, body fat percent and ultrasound fat thickness measures did not relate 
significantly to these follow up scores. None of the correlations between six week scores 
and any body composition measure were significant either. Correlation coefficients, p 
values and number of participants have been given in table 26 with significant 
correlations highlighted. 
Scatter plots are shown for significant correlations in Figures 10-16. The negative 
correlation can be seen in the scatter plot for BMI vs. OKS at six months (r
2
 = .11) (Fig. 
10). The majority scores appear to be between BMI of 25 and 35 kg/m
2
. In this BMI 
range (25 to 35 kg/m
2
), the negative association does not appear strong with scores 
widely spread out in this region. However, the lowest OKS score of 10 is seen in two 
cases and these lie between BMI of 30 and 35.   
Figure 11 shows the scatter plot for BMI vs. OKS one year (r
2
 = .17). Like for BMI and 
OKS at six months, most scores are between BMI range of 25 and 35 kg/m
2
 and appear to 
be largely spread out. Only two scores were below an OKS score of 30, while one was 
close to 30 at 29 (BMI = 33), another was an extremely low value of 21 (BMI = 49). 
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Scatter plots for WC vs. OKS at six months and one year are shown in Fig. 8.5. Again the 
majority of the scores for both outcomes lie between waist circumference of 35 to 45 
inches and as seen with BMI, the values are quite spread. For OKS at six months, two 
cases with WC greater than 40 inches had extremely low OKS value of 10. All values of 
OKS at 1 year were above 30 except one value of 29 (WC = 44.5 inches) and one 
extremely low value of 21 (WC = 52 inches).  
 
Body composition and SF12 
Correlation analysis between body composition measures and PCS scores revealed a 
significant negative relationship between BMI and PCS at one year (r = -.37, p = .04) and 
waist circumference and PCS at six months (r = -.29, p = .04). Scatter plots for the 
significant relationships have been shown in Fig. 8.3 -8.8. Majority of the PCS scores 
were between 30 and 60. An extreme low PCS score of 23.42 (BMI = 49) was seen in the 
scatter plot between BMI and PCS at one year. The scatter plot between waist 
circumference and PCS at six months shows two extremely high PCS scores of 99 (WC = 
38, 36). No significant relation was observed for any other body composition measure 
and PCS score. 
No significant relation was observed for any body composition measure and MCS scores 
at any time point, except for WHR which showed a significant negative relationship with 
MCS at six months (r = -.32 , p = .03). Here again, the scatter plot shows two extremely 
high MCS scores of 99 with WHR <0.90 
 
Body composition and Pain scores 
No significant relations were observed for the follow up pain scores with any of the body 
composition measures.  
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Table 26 Pearson’s correlation analysis between body composition measures and all 
outcomes 
Outcome  BMI WC WHR BF% US 
OKS 6 weeks R -.141 -.107 -.075 .132 -.086 
Sig .278    .414 .564 .315 .512 
N 61 61 61 60 61 
OKS 6 
months 
R -.337* -.330* -.202 .084 -.143 
Sig .024 .027 .183 .587 .350 
N 45 45 45 44 45 
OKS 1 year R -.416* -.378* -.116 -.147 -.287 
Sig .018 .033 .528 .423 .111 
N 32 32 32 32 32 
PCS  
6 weeks 
R -.145 -.220 -.188 .077 -.161 
Sig .268 .091 .150 .563 .218 
N 60 60 60 59 60 
PCS 6 months R -.203 -.292* -.264 .049 -.099 
Sig .167 .044 .070 .744 .503 
N 48 48 48 47 48 
PCS 1 year R -.365 -.325 -.114 -.086 -.265 
Sig .040 .070 .534 .640 .142 
N 32 32 32 32 32 
MCS  
6 weeks 
R -.089 -.028 -.067 .110 -.122 
Sig .496 .829 .610 .402 .348 
N 61 61 61 60 61 
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MCS 6 
months 
R -.016 .073 -.319* .173 -.061 
Sig .903 .581 .027 .191 .641 
N 48 48 48 48 48 
MCS 1 year R -.158 -.253 .070 .101 -.011 
Sig .283 .083 .703 .499 .940 
N 32 32 32 32 32 
Pain at rest 6 
weeks 
R .034 .026 .133 -.147 .126 
Sig .797 .846 .316 .272 .340 
N 59 59 59 58 59 
Pain walking 
6 weeks 
R .187 .176 .147 -.034 .080 
Sig .156 .182 .266 .801 .549 
N 59 59 59 58 59 
Pain stair 
climb 6 weeks 
R .185 .240 .255 -.161 -.023 
Sig .161 .067 .051 .226 .864 
N 59 59 59 58 59 
Pain stair 
descend 6 
weeks 
R .169 .191 .124 -.078 .073 
Sig .206 .152 .352 .567 .584 
N 58 58 58 57 58 
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Figure 9 Scatter plot showing relationship between BMI (kg/m2) and OKS at six 
months follow up 
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Figure 10 Scatter plot showing relationship between BMI (kg/m2) and OKS at one 
year follow up 
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Figure 11 Scatter plot showing relationship between WC (inches) and OKS at six 
months follow up 
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Figure 12 Scatter plot showing relationship between WC (inches) and OKS at one 
year follow up 
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Figure 13 Scatter plot showing relationship between BMI (kg/m2) and PCS of SF-12 
at one year follow up 
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Figure 14 Scatter plot showing relationship between WC (inches) and PCS of SF-12 
at six months follow up 
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Figure 15 Scatter plot showing relationship between WHR and MCS of SF-12 at six 
month follow up 
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7.1.8. Effect of body composition: Between group comparison 
 
The sample was divided into groups based on each body composition measure. Between 
group differences of outcomes after TKA for each body composition measure was 
investigated. Figure 8 shows the data analysis methods used to assess the differences.  
A high correlation between the baseline scores and follow up scores for the outcomes was 
observed. In order to control for baseline imbalance between groups, ANCOVA with 
baseline scores as covariate was used to analyse group differences. After testing for 
normal distribution of data within each group (normality tables given in Appendix B), 
ANCOVA was used with baseline score as covariate to assess the differences between 
groups for the normally distributed data. Non-parametric tests were employed to assess 
between group differences for data which did not meet the assumptions of ANCOVA. 
The analysis (ANCOVA) was repeated for each follow up score. Two- way ANOVA was 
not used because of fewer data in the six months and one year follow up.  
 
BMI groups 
The sample was divided into BMI groups based on the already established criteria of non-
obese with BMI < 30 kg/m
2
and obese with BMI > 30 kg/m
2
. 
Group differences for OKS and PCS scores for each follow up time point was tested 
using ANCOVA. Man Whitney U test was used for MCS and pain scores for each follow 
up time point.  
There seemed to be no effect of BMI on any of the follow up OKS or PCS scores. The 
covariate, baseline OKS score and baseline PCS score were significantly related to the six 
month OKS follow up score and six month PCS score respectively (p <.001, p = .002). 
Test statistics for ANCOVA for BMI groups have been given in table 27.  
Man Whitney test for BMI group comparison for MCS scores showed no significant 
differences between BMI groups for any follow up. Also, no significant differences were 
seen in pain scores between BMI groups before TKA or six weeks after TKA.  
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Waist circumference groups 
Median value of waist circumference (41.5 inches) was used to split the sample into ‘low 
WC’ and ‘high WC’ groups. Thirty one participants were in the low WC groups and 30 
were in high WC group.  
The six month OKS and PCS score were significantly affected by the covariate (baseline 
OKS, p < 0.001 and baseline PCS, p = 0.008). Man Whitney test revealed no significant 
differences between the low and high WC group for any follow up MCS or pain score 
(Table 28) 
 
Waist to hip ratio 
Median waist to hip ratio (0.95) was used to divide the sample into ‘low WHR’ group 
(WHR < 0.95, n = 32) and ‘high WHR’ group (WHR > 0.95, n = 29) 
As seen for BMI and WC, no significant effect of WHR was observed on follow up OKS 
and PCS scores. The six month post-operative OKS and PCS were significantly affected 
by the covariate i.e., the baseline OKS (p < 0.001) and baseline PCS score (p = 0.004). 
Mann Whitney test did not reveal any statistically significant different between groups 
for MCS or pain scores except, pain score during walking at six week post operation 
which was significantly greater (p= 0.02) in the high WHR group (Table 29) 
 
Body fat percentage groups 
The sample was split into two groups using the median BF% (39.9%). There were 30 
participants in both groups of ‘low BF%’ (BF< 39.9%) and ‘high BF%’ group (BF% > 
39.9%). 
No significant effect of body fat percentage on follow up OKS or PCS was revealed by 
ANCOVA. Baseline scores however, were significantly low in the ‘high BF%’ group (p 
= 0.003). Baseline OKS and baseline PCS (covariates) did have a significant effect on the 
six month OKS (p < 0.001) and PCS scores (p = 0.003). Man Whitney test for follow up 
MCS scores or pain scores did not show any significant differences between the BF% 
groups except for a significantly higher pain scores in the low BF% group for stairs 
descend at baseline (p = 0.003). Test statistics for each analysis is as shown in Table 30. 
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Ultrasound groups 
The sample was categorised into ‘low fat thickness’ with fat thickness values <11.167 
mm (n = 30) and ‘high fat thickness’ with fat thickness values > 11.167 mm (n = 31). 
As seen with previous body composition measures, there was no significant effect of 
ultrasound measured knee fat thickness on follow up OKS and PCS. The covariate 
(baseline OKS/PCS) did have a significant effect on the OKS (p < 0.001) and PCS scores 
(p = 0.002) at six months follow up. No significant differences were seen between the 
groups for MCS or pain scores. Test statistics have been given in table.31.  
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Table 273Between groups comparison for BMI groups 
  N BMI<30 BMI>30 Test ES Sig Test statistic 
OKS Pre op
 
61 22.9(6.5) 20.1(5.9)   -0.48   
6 weeks 61 31.6(8.4)  30.4(10)  ANCOVA -0.13 0.99 F=.00 
6 months 45 38.1(7.7)  35.3(10.9)  ANCOVA -0.29 0.89 F = .020 
1 year 32 40.9(5.9)  39.2(7.9)  ANCOVA -0.25 0.77 F = .087 
PCS Pre op 61 32(8.5)  30.9(6.6)   -0.15   
6 weeks 60 37.9(10.4)  37.5(9.3)  ANCOVA -0.04 0.96 F= .003 
6 months 48 46.8(16)  44.4(15.4)  ANCOVA -0.14 0.95 F= .004 
1 year 32 46.1(7.7)  44.8(10.6)  ANCOVA -0.14 0.82 F= .054 
MCS Pre op 61 55.4 (38.4) 54.85(42.2) Man Whitney -0.17 0.498 U=391.5 
6 weeks 60 54.2 (30.8) 56.7 (46.3)  Man Whitney 0.18 0.403 U =370.5 
6 months 48 57.82(61.62) 56.29(76.24) Man Whitney -0.33 0.171 U=210.5 
1 year 32 58.73(31.69) 58.3 (22.21) Man Whitney -0.38 0.676 U = 115 
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Pain rest Pre op 59 3.7 (9) 2.95 (8.2) Man Whitney 0.11 0.646 U =84.5 
6 weeks 59 1.35 (7.1) 1.2 (9.4) Man Whitney 0 0.838 U = 394 
Pain walking Pre op 59 7.5 (5.7) 7.45 (6.74) Man Whitney -0.27 0.437 U = 364 
6 weeks 59 1.5 (5.2) 2.2 (9) Man Whitney 0.39 0.149 U =315. 
Pain stair climb Pre op 59 6.8 (6.2) 7.5 (9.6) Man Whitney -0.34 0.405 U = 360 
6 weeks 59 1.35 (7.70) 2 (9.4) Man Whitney 0.23 0.419 U =  355 
Pain stair descend Pre op 55 8.55(7.2) 7.9 (8.4) Man Whitney -0.37 0.229 U =  293 
6 weeks 58 1.9 (9)  2.3(9) Man Whitney 0.12 .619 U =  365 
 
Mean (standard deviations) shown for OKS, PCS. Median (inter quartile range) shown for MCS and pain scores.  
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Table 28 Between groups differences for WC groups 
  N Low WC < 41.5 inches High WC > 41.5 inches Test Sig Test statistic 
OKS Pre op 61 22.7(6.3) 19.5(5.8)    
6 weeks 61 31.2(8.1) 30.5(10.6) ANCOVA 0.8 F=3.94 
6 months 45 38.5(7) 34(11.8) ANCOVA 0.66 F=0.20 
1 year 32 41.7(5.8) 37.4 (8) ANCOVA 0.15 F=2.19 
PCS Pre op 61 33(8) 29.5(6.2)    
6 weeks 60 38.3(10.1) 37(9.3) ANCOVA 0.85 F=0.04 
6 months 48 9.5(17.1) 40.5(12) ANCOVA 0.24 F=1.42 
1 year 32 47.8(7.3) 41.8(11) ANCOVA 0.16 F=2.08 
MCS Pre op 61 56.3(39.8) 54.6(41.2) Man Whitney 0.34 U=399 
6 weeks 60 53.4(30.8) 56.7(46.3) Man Whitney 0.32 U=382 
6 months 48 58(61.6) 55.9(39.3) Man Whitney 0.1 U=206 
1 year 32 59.6(31.7) 57.8(10.4) Man Whitney 0.94 U=121 
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Pain rest Pre op 59 3.7(9) 3(8.2) Man Whitney 0.55 U=394.5 
6 weeks 59 1.3(7.1) 1.3(9.4) Man Whitney 0.92 U=428.5 
Pain walking Pre op 59 7.3(7.6) 7.6(7.3) Man Whitney 0.89 U=425 
6 weeks 59 1.6(7.9) 2.4(9) Man Whitney 0.24 U=358 
Pain stair climb Pre op 59 7(7.8) 7.7(9.6) Man Whitney 0.69 U=408 
6 weeks 59 1.4(7.7) 2.4(9.4) Man Whitney 0.20 U=351 
Pain stair descend Pre op 55 8.2(8.1) 7.9(7.1) Man Whitney 0.69 U=351.5 
6 weeks 58 1.8(9) 3.5(9) Man Whitney 0.39 U=365.5 
 
Mean (standard deviations) shown for OKS, PCS. Median (inter quartile range) shown for MCS and pain scores. 
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Table 29 4Between groups differences for WHRgroups with mean (SD) for ANCOVA and median (range) for Mann Whitney 
tests 
  N Low W < 0.95  High WH > 0.95 Test Sig Test statistic 
OKS Pre op 61 21.8(5.7) 20.4(6.8)    
6 weeks 61 31.8(7.9) 29.8(10.7)  ANCOVA 0.51 F=.447 
6 months 45 37.4(7.2) 5.4(11.7) ANCOVA 0.9 F=0.02 
1 year 32 39.3(7.3) 40.7(6.8) ANCOVA 0.6 F=.28 
PCS Pre op 61 31.9(6.8) 30.6(8)    
6 weeks 60 40.1(8.6) 5.1(10.2) ANCOVA 0.85 F=.04 
6 months 48 48.4(17.4) 42.3(13) ANCOVA 0.24 F=1.42 
1 year 32 46.6(9.3) 44.3(9.5) ANCOVA 0.16 F=2.08 
MCS Pre op 61 55.3 (39.8) 54.7(41.2) Man Whitney 0.58 U=425.5 
6 weeks 60 54.2(29.8) 56.7(46.3) Man Whitney 0.19 U=360 
6 months 48 57.8(61.6) 56.7(40.9) Man Whitney 0.42 U=249 
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1 year 32 57.8(26.8) 59.2(31.1) Man Whitney 0.52 U=111 
Pain rest Pre op 59 3.5(9) 3(8.2) Man Whitney 0.9 U=425.5 
6 weeks 59 1(7.1) 1.4(9.4) Man Whitney 0.31 U=368.5 
Pain walking Pre op 59 7.4(7.7) 7.6(7.2) Man Whitney 0.95 U=430 
6 weeks 59 1.5(7.9) 2.8(9) Man Whitney 0.02 U=285 
Pain stair climb Pre op 59 7(9.6) 8(7.7) Man Whitney 0.81 U=418.5 
6 weeks 59 1.5(7) 2.5(9.4) Man Whitney 0.06 U=309.5 
Pain stair descend Pre op 55 7.8(8.1) 8(5.6) Man Whitney 0.09 U=274.5 
6 weeks 58 1.9(9) 3.9(9) Man Whitney 0.31 U=355.5 
Mean (standard deviations) shown for OKS, PCS. Median (inter quartile range) shown for MCS and pain scores. 
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Table 30 Between group comparison for BF% groups 
  N Low BF% < 39.9% High BF% > 39.9% Test Sig Test statistic 
OKS Pre op 61 20.2(6.7) 22(5.7)    
6 weeks 61 30.9(9.6) 30.8(9.3) ANCOVA 0.73 F= .117 
6 months 45 36.4(11.1) 36.2(9) ANCOVA 0.41 F=.702 
1 year 32 41.8(6.3) 38.7(7.4) ANCOVA 0.26 F=1.3 
PCS Pre op 61 29.7(7.2) 32.9(7.4)    
6 weeks 60 37.6(10.4) 38(9.2) ANCOVA 0.87 F=.029 
6 months 48 44(11.4) 46.4(18.8) ANCOVA 0.88 F=.024 
1 year 32 47.6(7.7) 43.8(10.2) ANCOVA 0.17 F=1.986 
MCS Pre op 61 54.5(38.40) 55.9(44.2) Man Whitney 0.53 U= 407 
6 weeks 60 54.2(37.9) 57.7(44.7) Man Whitney 0.54 U=395 
6 months 48 57.3(40.9) 57.8(64) Man Whitney 0.54 U=246 
1 year 32 58.8(31.1) 57.8(26.8) Man Whitney 0.86 U=119 
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Pain rest Pre op 59 3(9) 3.2(7.1) Man Whitney 0.91 U=413 
6 weeks 59 1.3(8) 1.4(9.4) Man Whitney 0.95 U=416.5 
Pain walking Pre op 59 7.8(5.9) 7.1(7.7) Man Whitney 0.11 U=316.5 
6 weeks 59 2(8) 2(9) Man Whitney 0.46 U=372.5 
Pain stair climb Pre op 59 7.5(7.7) 7.4(9.6) Man Whitney 0.42 U=369 
6 weeks 59 2.2(9.4) 1.9(9.3) Man Whitney 0.66 U=392 
Pain stair descend Pre op 55 9(7.5) 7.5(8) Man Whitney 0.003 U=190.5 
6 weeks 58 2.5(9) 2.3(9) Man Whitney 0.74 U=385 
Mean (standard deviations) shown for OKS, PCS. Median (inter quartile range) shown for MCS and pain scores. 
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Table 31 Between group differences for US groups 
  N Low fat thickness< 11. 167 mm High fat thickness> 11.167 mm Test Sig Test statistic 
OKS Pre op 61 21.7(7.1) 20.5(5.3)    
6 weeks 61 31.6(9.8) 30.2(8.9) ANCOVA 0.67 F= 0.18 
6 months 45 38.1(10.5) 34.8(9.1) ANCOVA 0.38 F=0.782 
1 year 32 42.5(6.7) 37.7(6.7) ANCOVA 0.13 F=2.383 
PCS Pre op 61 31.4(8.6) 31.2(6)    
6 weeks 60 39.1(11.1) 36.3(8) ANCOVA 0.25 F=1.323 
6 months 48 46.5(17.3) 44.2(14) ANCOVA 0.50 F=0.474 
1 year 32 48.1(9.2) 42.9(9) ANCOVA 0.19 F=1.832 
MCS Pre op 61 53.6(12.4) 49.4(11.3) Man Whitney 0.08 U=342.5 
6 weeks 60 52.6(9.3) 50.7(12.1) Man Whitney 0.73 U=427 
6 months 48 55.8(13.5) 54.9(12.5) Man Whitney 0.70 U=268.5 
1 year 32 55.7(8.8) 53.2(9.4) Man Whitney 0.64 U= 115 
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Pain rest Pre op 59 3.4(2.6) 3.7(2) Man Whitney 0.39 U =378.5 
6 weeks 59 1.7(2) 2.1(2.2) Man Whitney 0.35 U = 373.5 
Pain walking Pre op 59 7.1(1.5) 6.7(2.2) Man Whitney 0.81 U =  419 
6 weeks 59 2.5(2.2) 2.5(2.1) Man Whitney 0.73 U = 412 
Pain stair climb Pre op 59 7.1(2) 6.8(2.4) Man Whitney 0.84 U =  422 
6 weeks 59 2.9(2.9) 2.6(2.4) Man Whitney 0.99 U =  434 
Pain stair descend Pre op 55 8(1.9) 6.9 (2.4) Man Whitney 0.05 U =  261 
6 weeks 58 3.3(3) 3.3(2.7) Man Whitney 0.82 U = 405.5 
 
Mean (standard deviations) shown for OKS, PCS. Median (inter quartile range) shown for MCS and pain scores. 
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7.1.9. Section summary 
 
To assess the influence of obesity on TKA self-report outcomes, body composition of 
patients was measured before their TKA operation and self-report outcome data was 
collected  at baseline (pre operative), six weeks post-operatively, six months post-
operatively and one year post-operatively. The hypothesis was addressed in two ways, 
firstly, by exploring the influence of obesity on the TKA outcomes using correlation 
analysis and secondly, by assessing the difference in outcomes between body 
composition groups. 
The correlation analysis to explore the influence of obesity on TKA outcomes revealed 
that of the five body composition measures, BMI and waist circumference had a 
significant negative relationship with OKS score at six months follow up and also with 
OKS score at one year follow up. This indicated that at six months and one year after a 
TKA, patient perceived knee function was poorer as BMI increased. Similarly, increasing 
waist circumference also indicated a poorer knee function at six months and one year 
after TKA. The overall health related physical function measured by PCS was 
significantly related to BMI at one year and to wait circumference at six months after 
TKA.  
Between group comparison with ANCOVA (controlling for baseline score) revealed no 
significant group differences for knee function or overall physical health between obese 
and non-obese categorised by any of the body composition measures for any given time 
point. Non- parametric tests also revealed no group differences for overall mental health 
and pain scores for any body composition measures at any time point except pain during 
walking at six weeks follow up, which was greater in the ‘high WHR’ group than the 
‘low WHR’ group. 
The influence of BMI and waist circumference observed in the correlation analysis was 
not reflected when group differences were assessed. After controlling for baseline scores 
with ANCOVA, it was observed that there was no difference in the knee function or 
overall physical function between obese and non-obese group categorised by BMI values 
for any of the follow up times. Similarly, no differences were seen between the waist 
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circumference groups for these outcomes at any follow up period. Some explanation 
maybe offered by the scatter plots for these outcomes as the region before and at the cut 
off point for grouping show similarly spread values and therefore no clear relationship 
between variables. However, with greater BMI or WC, some extreme outcomes values 
pulled the relationship to a significant level.  
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7.2 Discussion 
 
 
7.2.1. Section overview 
 
This section discusses the methodology used and the findings of the study assessing the 
effect of obesity on TKA outcomes. The section begins with a summary of key findings. 
The measurement and findings of body composition methods is discussed followed by 
measurement of primary and secondary outcome measures. Findings of the current study 
have then been compared with those of previous studies assessing the effect of obesity on 
TKA outcomes. By illustrating the various theories behind a possible or no effect of 
obesity, the chapter then addresses the question: is it weight or fat that affects the 
outcomes? Finally, a summary of the section is presented.  
 
 
7.2.2. Summary of key findings 
 
The aim of the study was to assess the effect of obesity on self-report outcomes after total 
knee replacement. The alternate hypothesis for the study that obesity resulted in poorer 
outcomes after total knee replacement was rejected and the null hypothesis that obesity 
has no effect of self-report outcomes after total knee replacement was retained 
The hypothesis was tested using two different types of statistical analysis in order to 
answer the research question: Firstly, correlation analysis and scatter plots were used to 
address the influence of obesity on total knee replacement and secondly, statistical tests 
for between groups differences were used for group comparison of outcomes between 
various body composition groups. The key findings of the two analyses are given below. 
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Correlation analyses 
Obesity had no influence on any of the reported outcomes six weeks after surgery. For 
outcomes six months and one year after surgery a negative correlation was seen with 
BMI, WC and WHR. It was observed that increasing BMI corresponded to poorer patient 
reported knee function at six months and one year after surgery and also poorer overall 
physical function an year after surgery. Increasing WC corresponded to poorer patient 
reported knee function at six months and one year after surgery and also poorer overall 
physical function six months after surgery. The reported overall mental health was not 
affected by any of the body composition measure except a negative correlation with 
WHR six months after surgery. However, the scatter plots of these relationships showed 
that most data points were clustered around a small range of  body composition measures 
with a few extreme values resulting a significant correlation coefficient, For example, 
most values were clustered between the BMI values of 25 kg/m
2
 and 35 kg/m
2
 (between 
35 inches and 45 inches for WC and between 0.9 and 1.05 for WHR) with no clear 
association with the outcomes. However, after checking for outliers, few extreme values 
(one to four) at the higher end of the body composition measure indicating high obesity 
with poor outcome resulted in significant correlations. The significant correlation 
between WC and six month PCS and WHR and MCS at six months were observed to be 
because of two very high values of PCS and MCS with lower WC ( <40 inches) and 
WHR (<0.90). 
 
Analysis of between group differences 
The effect of body composition on the few outcomes as shown by the correlation analysis 
were not reflected in the between group comparisons. No differences were found between 
the body composition groups for patient reported knee function and overall quality of life 
after total knee replacement. Significant greater pain during walking six weeks after 
surgery in patients with WHR > 0.95 was observed, but no statistically significant 
difference were seen between any of the body composition groups for pain at rest, during 
195 
 
stair climbing or during stair descending. The between group values of stair climbing at 
six weeks  also showed  greater pain in the obese groups categorized by  WHR (with 
effect sizes of 0.64) but this was not seen to be statistically significant. Hence it likely 
that the current study was not appropriately powered to detect statistically significant 
differences between the body composition groups. 
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7.2. 3. Measurement of body composition 
 
As discussed in Chapter 6, five different methods of measuring body composition which 
measure different aspects of anthropometry were used in the study and these included: 
Body Mass Index (BMI), Waist Circumference (WC), Waist to Hip Ratio (WHR), 
Bioelectrical Impedance Analysis (BIA) and Ultrasonography (US) 
.  
Obesity classification and cut off values 
As seen in section 8.1 (results), the data from these measurement methods were analyzed 
both as continuous data and also by using cut off values to classify the data into obese 
and non-obese groups.  
In general the most widely reported method of measuring obesity in the orthopaedic 
literature is BMI and more specifically, with regard to the effect of obesity on total knee 
replacement outcomes, only the effects of body weight and BMI have been explored. 
Body mass index is extensively used not only in epidemiological studies but also in 
clinical practice. The BMI classification of obesity as recommended by the WHO (World 
Health Organization) 1995 report is now used as the reference criteria for classifying 
obesity. Classification of obesity based on BMI in this study has been based on this 
established reference criteria (BMI > 30 kg/m
2
 as obese). Apart from categorizing patient 
obesity based on an established reference, this also allowed comparison of the data from 
the current study with previous literature. Reference cut off values for obesity 
classification have also been recommended for WC, WHR and BIA, however, no known 
classification exists for regional obesity measured using ultrasonography. Therefore, a 
median split technique was employed on ultrasonography values to categorize patients 
into obese and non-obese. The 2000a WHO report recommends cut off values of WC > 
102 cm (men) and >88 cm (women) and WHR > 0.90 cm and > 0.85 cm for a 
substantially increased risk of metabolic complication. The rationale for these cut off 
points for WC and WHR were based the increased relative risk of metabolic disease 
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resulting from abdominal obesity observed in a study on a random sample of 2183 men 
and 2698 women in Netherlands (Han et al. 1995) and not on the methods’ prediction of 
the amount of abdominal adipose tissue (WHO 2000a report).  On applying these cut off 
values of WC and WHR to the current study data, it was found that of the 23 patients 
considered non-obese according to BMI (BMI <30 kg/m
2
), 10 (43%) of these 23 were at 
a ‘substantial risk of metabolic complications’ according to WC criteria (WC > 102 cm 
(men) and >88 cm (women) while 17 (74%) were at a ‘substantial risk of metabolic 
complications’ according to WHR criteria (WHR > 0.90 cm and > 0.85 cm).  While this 
could show underestimation of obesity by the BMI criteria, using the WC and WHR cut 
off to the current study’s data lead to a wide disparity between the group sizes (14 vs. 47 
for WC groups and 7 vs. 54 for WHR groups) making the results of statistical analysis 
clinically meaningless. So, instead a median split technique was used on WC and WHR 
data to form obese and non-obese groups for statistical analysis.  
At present  no evidence-based established cut off values for percentage body fat exist 
(Oreopoulos et al. 2011). Many studies have used a cut-off points of total body fat 
percentage > 25% in males and total body fat percentage > 30% in females with reference 
given to the WHO 1995 report. However it was noted in  published correspondence to the 
editor (Mayo journal proceedings 2011) that these values were not recommended by 
WHO 1995 report but the guidelines of the American Association of Endocrinology. 
However, no evidence-based rationale was actually provided for these cut off points (Ho 
Pham and Campbell 2011 ). Gallagher et al. (2000) considered the effect of age, sex and 
race on total body fat percentage and developed cut offs based on BMI classification as 
total body fat percentage > 31% (males) and > 43% (females) corresponding to BMI > 
30kg/m
2 
for the age range of 60-79 years. Using these cut offs on the current study’s data, 
ten patients with BMI <30 kg/m
2
 (non-obese) were above the total body fat percentage 
cut off thus indicating an underestimation of obesity by BMI as seen with WC and WHR. 
Or overestimation of obesity using these cut-offs of body fat. 
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Assessment of body composition 
Anthropometric measures of obesity which include BMI, WC and WHR remain the most 
widely used measures of obesity in epidemiological research and clinical practice because 
of their practicability and ease of use and their correlation with body fat. Several studies 
have shown a good correlation of BMI with body fat percent (Khaodiyar and Blackburn 
2001; Prentice and Jebb 2001; Frankenfield et al. 2001). WC and WHR being indirect 
measures of central obesity have shown to be correlated with abdominal fat (Chan et al. 
2003) although WHR is seen more as a measure of the type of body fat distribution.  
Being widely used for population studies, BMI has the advantage of having extensive 
reference data and established relations with body fat and morbidity and mortality (WHO 
1995 report). By its correlation to body fat, BMI givens indices of the level of obesity, 
but it does not distinguish between the fat and the lean mass which contribute to the body 
mass (Khaodiyar and Blackburn 2001; Prentice and Jebb 2001; Frankenfield et al. 2001). 
Moreover, the reference data (cut off points) for BMI are the same for all age, gender and 
race thus do not account for the influence of these factors on obesity (Jackson et al. 
2002). With increasing age, there is conversion of lean mass into fat mass and therefore 
for a given body mass, an older person will have a higher fat mass (Smalley et al. 1990; 
Prentice and Jebb 2001; Snijder et al. 2006). While a good correlation between BMI and 
BF% was seen in the present study data (r
2
 = 0.42, p<0.001), some effect of age and 
gender was seen leading to disparity between body fat and BMI. For example, a BMI of 
49.1 in a 63 year old female patient corresponded to a body fat % of 54.8% which was 
less than that of two other female patients of BMI 46.2 (age = 70 years) and 44.9 (age = 
69 years) had BF% of 57.25 and 55.08% respectively. For lower BMI’s, a female patients 
aged 89 years with a BMI of 21 corresponded to BF% of 33.5% while a male patient 
aged 74 years with a BMI of 23 corresponded to BF% of 19.6%. Effect of ethnicity on 
BMI as suggested by Jackson et al. (2002) is not applicable in this study as all patients in 
the study sample were Caucasians.   
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Measurement of body fat by BIA is considered more accurate than the above 
anthropometric methods (Gray et al. 1989). While its ease of use add to its advantages, 
the interpretation of highly obese subjects (BMI >34 kg/m
2
) is to be treated with caution 
as in these patients the total body water and extracellular water is relatively higher 
leading to an overestimation of fat free mass and underestimation of fat mass. (Kyle et al. 
2004).  
We estimated regional distribution of fat using WC and WHR for central obesity and US 
for measuring fat thickness above the knee. Echo patterns in ultrasonography images 
quantitatively differentiate tissue which allowed us to clearly see the muscle-fat interface. 
While there is evidence that ultrasound measurement of subcutaneous fat particularly 
over quadriceps can be used to predict total body fat in Caucasians (Weits et al. 1986; 
Fanelli and Kuczmarski. 1984), this was not attempted in this study.  
 
Practical considerations for measurement of body composition  
Anthropometric measurement errors are unavoidable and therefore the standardization of 
measurement method should be closely followed for this. While close attention can be 
paid to examine participants for research purposes with a limited number of observers, 
the standardization of measurement methods is more difficult in a regular clinical setting. 
In a review Ulijaszek and Kerr (1999) concluded that weight and height are most accurate 
and repeatable while waist and hip circumferences show inter observer differences. The 
ease of standardizing the measures of boy mass and body height makes BMI the most 
appropriate body composition measure in a clinical setting. Although change in scales, 
different rounding of numbers by different assessors may lead to some variation but not a 
drastic difference in BMI values as it would be with any other measurement.  
Various measurement protocols for waist circumference have been recommended by 
health authorities of which the three most common are: 1) at the level of umbilicus 2) 
minimal waist and 3) mid-point between lower border of ribcage and iliac crest. However 
there is no consensus regarding the optimal protocol for measurement and no rationale 
has been given for any recommendations (Ross et al. 2007). A systematic review of 120 
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studies conducted by an expert panel concluded that the measurement protocol had 
negligible influence on the relationship between waist circumference and morbidity and 
mortality (Ross et al. 2007). The panel recognized that protocols using bony landmarks 
would seem optimal as they would minimize measurement error, will be transferable to 
clinical practice and allow easy self measurement. The method recommended by WHO 
(2000) measuring waist circumference as mid-point between lower border of ribcage and 
iliac crest was chosen in this study as it allowed to better standardize the circumference 
measurement especially in obese patients with significant abdominal folds and use the 
WHO (2000) recommended cut offs for waist and hip circumference for assess data. 
Waist and hip circumferences was observed in this study to be simple to measure and 
standardize. Although a tendency for either pulling in abdominal muscles or forced 
expiration by participants during measurement was observed, this could be rectified with 
appropriate instructions to the participant. Standardization of the measurement was 
further ensured as only one observer was taking the measurements for the study although 
in a clinical setting where it is more likely that there is more than one observer, reliability 
may be more difficult.  
Standardization of measurement among the five methods used was most difficult for BIA. 
Maintaining the similar testing conditions for BIA is essential for accurate and reliable 
measurements. Lack of maintaining these conditions would affect the subsequent 
calculation from predictive equation resulting in differences in reading (Kushner et al. 
1996). Testing conditions prescribed by the manufacturer were followed for accurate 
calculation of predictive equations used by the manufacturer (Maltron Ltd.). Fasting 
condition required before BIA measurement (as described in Chapter 6) was the most 
difficult to maintain especially since the baseline assessment was at the time of the 
patient’s pre admission clinic appointment which in practice can take even up to three 
hours. While it was attempted to keep these conditions by adjusting assessment times, it 
would be impossible to manage these conditions in a busy clinic.  
The above measurement methods require no or minimal training, however, 
ultrasonography did require training and testing for reliability before application in the 
study. Position of the leg had to be considered carefully before measurements. It was 
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observed that keeping knee  in a slight flexion (approximately40 degrees) position 
allowed adequate relaxation of the quadriceps muscle so that the contraction did not 
compress other tissues and the thigh folds above the knee (especially in obese) did not 
hinder probe placement. Minimal compression of tissues due to the pressure applied by 
the ultrasound probe had to be considered. Consistency of probe placement and pressure 
applied was achieved with training.  
 
 
7.2. 4 Outcomes measure 
 
Oxford knee score 
Oxford knee score was originally developed for use in randomized controlled trials but 
since its development, it has been used extensively in cohort studies and audits. Its 
simplicity and brevity allows for a higher completion rate than other measures (Dawson 
et al. 1998; Dunbar et al. 2001). At baseline assessment, when the assessor was present 
during OKS completion, it was observed that patients found the questionnaire easy to 
complete. This was also reflected in the 95% response rate for a completed questionnaire 
at six weeks post-operatively. The completion rates at the longer follow up of six months 
and one year were considerably lower (70% and 50% respectively) than previous studies 
with completion rates ranging from 81% - 89% (Whitehouse et al. 2005; Dunbar et al. 
2001). The six weeks questionnaire were completed by patients either in the presence of 
an assessor or via post with telephonic reminders, whereas, the six months and one year 
scores were obtained from the hospital database. It is likely that this difference in the 
method of data collection affected the response rate at six months and one year.  
Patients in this study found the OKS simple but some did require clarification for item 7 
of the questionnaire ‘Could you kneel down and get up again afterwards?’ as they believe 
they should not or had never attempted to. This issue was also raised by Whitehouse et al. 
(2005) in their study where patients selected the last response (no impossible) even when 
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they scored well in other items and hence the item was criticized for being inappropriate. 
The authors of OKS have emphasized that the ‘Could’ in the question is highlighted to 
indicate a hypothetical situation of kneeling. Although this had to be clarified in some 
cases, it is believed that it did not affect the results of the study. 
The original OKS scoring system had total scores ranging from 12 (best outcomes), to 60 
(worst outcomes). With criticism of this scoring system as being unintuitive, these scores 
were later modified by the authors to a scoring system which produced overall scores 
ranging from 0 (worst outcome) to 48 (best outcomes) (Murray et al. 2007). Applying the 
new scoring system (0-48), the mean pre operative score for this study was 21.1+ 6.2, at 
six weeks was 31+9.3, at six months was 36.3+ 9.8 and at one year was 40+ 7. These 
scores were slightly better than those presented by Murray et al. (2007) (pre operative 
mean = 18+7.5 and one year mean = 34.2+ 10) and recently by Judge et al. (2012) (pre 
operative mean = 20+ 8 and one year mean = 34.5+ 9.1).  
According to Murray et al. (2007), due to the symptom severity pre operatively and 
milder symptoms at follow up, the OKS scores tend to be skewed, to the left i.e., lower 
scores pre operatively and skewed to the right post-operatively. In this study, normal 
distribution for pre operative scores was observed which indicate that some patients had 
only mild symptoms pre operatively.  The pre operative scores ranged from as low as 9 to 
36. This raises the question of why patients with mild symptoms were operated at all; 
however, there may be other baseline clinical characteristics to be considered such as 
radiological severity (Dieppe et al. 1999). O’Neill et al. (2007) in a qualitative meta-
synthesis further point towards the complexity of decision making involved in an elective 
procedure like TKA which are influenced by factors such as social and cultural 
circumstances and motivation.  
Finally, the measurement of outcomes goes beyond the assessment of the statistical 
significance of the change in scores to determining the real clinical and subjective 
meaning of the scores. One method of assessing a clinically meaningful difference is 
using the Minimal Clinically Important Difference (MCID) which is defined as the 
smallest difference in score which patients perceive as a meaningful change (Jaeschke et 
al. 1989). The MCID for Oxford scores is not yet established. Although the authors 
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suggest it between three and five points, it is cautioned that it could be lower than three 
points (Murray et al. 2007). In order to interpret the meaning of the scores as good or bad 
outcomes, attempts have been made to dichotomize or categorize data from patient 
reported outcomes measures. A recent attempt by Judge et al. (2012), describe how 
patient acceptable symptom state (PASS scores) can be used to create thresholds for 
change scores (pre-operative to six months) and absolute score at six months which relate 
to the patients satisfaction with the surgery or in other words, the minimal value of OKS 
beyond which patients consider themselves in a satisfactory state of wellbeing. They 
identified a threshold score of 11 for change score and 30 for absolute score beyond 
which patients achieved the highest satisfaction with surgery. However, external 
validation of these thresholds is required for its general implementation in practice. Judge 
et al. (2012) recognize that the threshold scores vary with the pre operative or baseline 
scores and that different threshold scores will be needed to define outcome according to 
baseline scores. Applying this threshold to six month follow up data of this study, 80% 
patients had a score >30, i.e., 80% of the study sample achieved the highest satisfaction 
levels with surgery. However, in this study, separate measurement of satisfaction data 
was not collected to compare with the results by Judge et al. (2012). 
 
Short Form 12 
Patients reported the same level of simplicity and brevity with completing SF12 as they 
did with OKS. This was reflected in the similar response rate of SF12 (93.8% at 6 weeks, 
75% at six months and 50% at one year post op). As with OKS, six month and one year 
follow up response was considerably lower than the 87.3% seen in a previous study with 
by Dunbar et al. (2001). 
In a SF12 cross validation study by Gandek et al. (1998), SF12 scores were obtained from 
national representative samples of nine countries  from which mean PCS and MCS scores 
obtained from UK population for the age range 65-74 years were 45.3+ 11.2 and 53.2+ 
9.1. They concluded that PCS scores declined with age while MCS scores remained 
stable or even increased with age. This was also seen true for this sample which was of a 
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higher age group (mean age = 70.6 years). PCS scores for our sample was lower than the 
population score (age 18 to 74 years) of 50.9+9.4 even at one year after surgery (at one 
year, mean = 45.3+ 9.3) while MCS scores were at par with that of the population and 
even better at follow ups (at one year, mean = 58.3+9.4). Comparing the current data with 
primary TKA population, scores were higher than that seen by Hartley et al. (2002) at six 
months (45.3 vs. 40.8) and one year (45.3 vs. 41.1) after surgery. The higher scores in 
this study sample for OKS and SF12 compared could be a resultant of the lower level of 
response to follow up in our study (50% at one year). A low level of follow up can be a 
limiting factor as it has been suggested that patients who do not respond to questionnaires 
have poorer functional outcomes (Kim et al. 2004) and are more dissatisfied with their 
TKA (Robertsson and Dunbar 2001) 
The influence of comorbidity and disease at other joint poses another challenge for all 
patient reported outcomes measures. Twenty three percent of the patients in this study 
suffered from other joint problems; four of these had previous total hip replacement 
(Table 17, Section 8.1.3) and 28% had had a previous TKR on the contralateral limb. 
Oxford knee score attempts to focus solely on function at the knee with specific questions 
related to the knee, in order to enhance specificity in the TKA population. On comparison 
with SF36, OKS was seen to be more sensitive to change than SF36 (Dawson et al. 
1998).To accommodate the complex nature of patients’ health problems, authors of OKS 
recommend the use of a validated generic questionnaire in addition to the knee specific 
OKS (Dawson et al. 2006). While the correlations between OKS and PCS for the 
corresponding time point were high (p<0.01), the greater effect size of OKS compared to 
that obtained with PCS (ES for the total sample for change from baseline to six months = 
2.45 vs. 1.9 and ES for change from baseline to one year = 3.14 vs. 1.9) indicates that in 
this study OKS was more sensitive to change at follow up than PCS. This highlights that 
OKS, as expected, was more sensitive to detect improvement or deterioration in this TKA 
sample while the generic SF12 could have been more susceptible to influences from other 
joints or comorbidity. 
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7.2. 5 Effect of obesity on patient reported outcomes: Comparison with previous evidence 
 
This study is different from previous studies in that it is the first study to assess the effect 
of four other measures of obesity along with BMI on patient reported outcomes following 
TKA. Furthermore, this is the only study using OKS questionnaire as a patient reported 
outcome assessing the effect of obesity. Therefore, in this section comparison has been 
attempted between the current study results of BMI groups with previous studies 
reporting patient reported outcome measures, although different from OKS.  
The knee specific patient reported outcome measure of choice for most studies seems to 
be WOMAC. Among the more generic patient reported outcome measures, SF36 was the 
questionnaire of choice in most studies. A few studies have assessed outcome using the 
SF12 questionnaire (Rajgopal et. al 2008; Dowsey et al. 2010). 
 
Knee function; Change scores 
The three studies assessing change/improvement in WOMAC from pre operative to one 
year after surgery between BMI groups observed no significant difference between BMI 
groups (Stickles et al. 2001; Rajgopal et al. 2008; Nunez et al. 2010). This concurred with 
the finding of no significant difference between the BMI groups for change in OKS from 
pre operative to one year post surgery in this study (mean = 16.6+ 5.4 for non-obese 
group and 17.7+9.3 for obese group). These studies used different cut off points to define 
BMI groups. While Stickles et al. (2001) used five BMI groups (< 25 kg/m
2
 as  healthy; 
25 to 29.9 kg/m
2
 as overweight; 30 to 34.9 kg/m
2
 as class I obese; 35 to 39.9 kg/m
2
 as 
class II obese; and ≥ 40 kg/m2 as class III obese BMI > 30 kg/m2 ), Nunez et al. (2010) 
defined BMI > 35 kg/m
2
 as ‘severely obese’ comparing it with BMI <  35 kg/m2 and 
Rajgopal et al. (2008) defined BMI > 40 kg/m
2
 as their ‘morbidly obese’ group 
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comparing it with BMI < 40 kg/m
2
. Thus, this lack of effect of BMI groups on patient 
reported knee specific function seemed to be irrespective of the cut off points used for 
BMI grouping. However, the change in KSS function scores (part of KSS scored by 
patients, it includes three questions each on walking ability, stairs and use of walking aid) 
was observed to be lower i.e., worse in patients with BMI >30 kg/m
2
 at one year after 
surgery by Dowsey et al. (2010). 
 
Knee function; Absolute scores 
On assessing absolute OKS score at one year after surgery, no differences were observed 
between groups (BMI >30 kg/m
2
or BMI <30 kg/m
2
) after controlling for pre operative 
OKS score. Conflicting results were however seen in the between group analysis of 
absolute WOMAC scores at one year after surgery between studies. A poorer KSS 
function score in obese (BMI >30 kg/m
2
) was seen at one year follow up by Dowsey et 
al. (2010). Rajgopal et al. (2008)  using BMI >40 kg/m
2 
or <40 kg/m
2
 classification for 
grouping reported lower one year post-operative WOMAC score in morbidly obese. Pre 
operative OKS score was not significantly lower in obese in the current study’s sample. 
Lower pre operative scores were also observed by Rajgopal et al. (2008) in their study. 
On the other hand using a classification of   BMI >35 kg/m
2 
or <35kg/m
2
, Nunez et al. 
(2010) saw no differences between groups in their post-operative one year WOMAC 
score. One of the factors affecting post-operative score considerably is the pre operative 
score. In the current study this has been controlled for by using the pre operative score as 
a covariate in the ANCOVA. Nunez et al. (2010) controlled for the pre operative measure 
by using a matched control group, however, the pre operative WOMAC stiffness scores 
in the study were poorer for the obese group. While the two above studies with lower 
absolute post-operative score at one year (Dowsey et al. 2010; Rajgopal et al. 2008) did 
not control for pre operative scores. 
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BMI as a continuous variable vs. Knee function 
 BMI as a continuous variable had a significant negative correlation with six month and 
one year post-operative OKS in this study (r = -0.34, r = -0.42 respectively). A significant 
negative correlation was also seen between BMI and one year WOMAC scores (p <0.01, 
no r value given) by Stickles et al. (2010). A negative effect of BMI > 40 kg/m
2
 on one 
year WOMAC was reported by Rajgopal et al. (2008) in their regression model (b coeff = 
-5.2, p = 0.027) and on the other hand, using regression models with BMI as one of the 
predictors, Escobar et al. (2007) concluded that BMI did not predict worse outcomes 
measured by WOMAC and SF36 six months after surgery. 
 
Overall physical health  
Change score for PCS showed no significant difference between BMI groups (mean = 
13.1 + 11 for non-obese and 13.5+10 for obese). This result was also observed by two 
other studies which assessed the SF12 as an outcome measure with follow up of up to one 
year after surgery (Rajgopal et al. 2008; Dowsey et al. 2010). However, the current study 
found no significant difference between the BMI groups for absolute one year PCS scores 
while controlling for pre operative scores. Dowsey et al. (2010) and Rajgopal et al. 
(2008) observed significantly poorer one year PCS score in their morbidly obese groups. 
Considering that SF12 is derived from SF36 and has similar domains and scoring system, 
comparison can also  be made between the SF12 results in this study with the results 
those assessing SF36 (Stickles et al. 2001; Steven-Lapsley et al. 2010). Change in SF36 
from pre operation to one year post operation was not different between five BMI groups 
(Stickles et al. 2001) which reflect the current study’s findings of no difference in the 
overall quality of life, specifically in the physical domain. 
 
BMI as a continuous variable vs. SF12 
Using BMI as a continuous variable for the analysis of PCS scores, this study observed a 
weak but significant negative relation between BMI and the one year PCS (r = -0.37, p = 
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0.04). This negative relation of BMI was also seen with PCS of SF36 (p = 0.02) in the 
study by Stickles et al. (2010). However when used in regression models as a predictor, 
BMI did not seem to account significantly to the variation in SF36 up to one year after 
surgery in other studies (Escobar et al. 2007, Steven-Lapsley et al. 2010). 
The current study found no significant relation between BMI and MCS of SF12 and 
neither any group differences in change of MCS from pre operative to one year after 
surgery or absolute MCS score at one year after surgery. Lack of an effect of BMI on 
MCS was also seen in Dowsey et al. (2010) and Stickels et al. (2001) (MCS of SF36). 
Poorer MCS absolute scores pre operatively and at one year for BMI > 40 kg/m
2
 were 
seen by Rajgopal et al.(2008), however, greater improvement (change score) was seen in 
MCS for these morbidly obese patients.  
 
Pain scores 
Pain at the knee (at rest, during walking, stair climbing and stair descending) measured 
on a VAS scale was not significantly different between BMI groups as absolute one year 
scores or as change scores from pre operatively to follow up. This was similarly seen by 
Naylor et al. (2008) who used a VAS pain scale on a sample including both knee and hip 
replacement patients. Nunez et al. (2010) also did not see a difference between their BMI 
groups (BMI > 35 kg/m
2 
and BMI < 35 kg/m
2
) for WOMAC pain scores. A ten point 
VAS pain scale used by Namba et al. (2005) indicated greater pain relief in obese (BMI 
>35 kg/m²) from baseline to one year after surgery.  
In summary, improvement in the knee related physical function and overall physical 
function as reported by patients was similar in all TKA patients irrespective of their BMI 
group or the classification used to categorize patients into obese and non-obese groups. 
Disparity in findings emanates from literature when analysis is done using absolute 
scores or when using BMI as a continuous variable.  
The current study did not see any difference in physical function scores between obese 
and non-obese at one year after operation and neither did studies by Stickles et al. (2001) 
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or Nunez et al. (2010) for their severely obese (BMI >35 kg/m
2
). In contrast some studies 
did observe significant difference in the knee related or overall physical function reported 
by patients either pre operatively or post-operatively up to one year or both (Rajgopal et 
al. 2008; Dowsey et al. 2010). However, a weak but significant negative relation of BMI 
with follow up knee function at six months and one year after operation and with overall 
physical health at one year after operation was observed in this study. This result was 
concurrent with another study which found a significant negative correlation of BMI with 
one year knee and overall physical function (Stickles et al. 2001), but contrasts with other 
studies which use regression models with BMI as a predictor variable and find 
insignificant association of BMI with physical function outcomes (Deshmukh et al. 2001; 
Escobar et al. 2007; Steven-Lapsley et al. 2010).  
Comparison of patient reported outcomes measures with investigator measured or 
performance measures to assess the effect of obesity within one year after surgery was 
also done. Poorer KSS knee and function score was seen for obese and morbidly obese at 
one year (Dowsey et al. 2010) and this was reflected in the greater patient reported 
difficulty in stair climbing and descending (Stickles et al. 2001). On the other hand, BMI 
did not have a significant association with timed up and go test, stair climb test and 6 
minute walk test as observed by Steven Lapsley et al. (2010). It must be noted that in the 
latter study (Steven Lapsley et al. 2010) the patient sample was limited up to a BMI of 40 
kg/m
2
 with no patient in the study having a BMI >40 kg/m
2
. On observing scatter plots of 
BMI vs. one year OKS/PCS of this study (section 8.1, figs 8.4,8.7), though the negative 
correlation is significant, it is not very strong and pulled to the poorer side by extreme 
values with particularly high BMI. This suggests a possibility that particularly poorer 
outcomes in very high BMI ranges could be pulling the overall outcomes in obese 
towards the poorer side in the correlation analyses  
In conclusion, the improvement in physical function was equal for all BMI groups in this 
study. While some effect of BMI was seen as a continuous variable, it could be the result 
of some extreme values in this study which was seen with BMI as high as 49 kg/m
2 
with 
corresponding low outcomes scores. Drawing conclusive evidence with comparison of 
studies is presently limited with variation among studies with regard to BMI cut off 
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values used, different outcomes measures used, statistical differences (use of change 
score or absolute scores or BMI as a continuous variable), control for pre operative scores 
and difference in study design (matched controls or non matched). 
 
 
7.2. 6 Is it weight or fat that affects outcome? 
 
From previous evidence in literature, the link between obesity and osteoarthritis has been 
suggested to be more complex than just a mechanical effect of increased loading of the 
joint in those with greater body mass. Whether this complexity in the relation between 
obesity and function is present after the affected joint has been replaced has not been 
explored. Thus, by defining obesity using five different methods of body composition 
measurement, this study attempts to explore if mechanical factors and/or other factors 
associated with obesity play a role in determining the outcome for up to one year after a 
total knee replacement. The current study results show that none of the body composition 
measures had any significant group differences for knee specific function and overall 
physical and mental health related quality of life. But statistically significant associations 
were observed between BMI, WC and follow up OKS and PCS. However, the association 
was weak and could be attributed to the outliers in the higher end of BMI/WC. In 
addition, patients in the higher WHR group felt greater pain during walking six weeks 
after surgery. Therefore total body mass and trunkal mass by increasing joint loading may 
have had an effect on pain on weight bearing and physical outcomes and that the level of 
fat (total body measured by BIA and regional measured by US) did not have any bearing 
on the outcomes.  In order to understand the link between obesity and TKA outcomes, 
this section discusses the various hypotheses surrounding the nature of association of 
obesity and the diseased knee joint and the mechanisms by which obesity may or may not 
affect the outcomes after replacement of the joint as proposed by the current and previous 
evidence. 
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There is an obvious link between obesity and the onset of knee osteoarthritis, progression 
of osteoarthritis and the progression of the condition to a severity requiring a total knee 
replacement (Felson 1998, Hartz et al. 1986, Strummer et al. 2000, Lohmander et al. 
2009, Wang et al. 2009). In order to understand the nature of link between obesity and 
knee OA, various studies have explored different markers of obesity other than body 
mass (WC, WHR, body fat, muscle mass) as risk factors for knee OA. While some 
studies did find a positive association of fat distribution and proportion of fat with knee 
OA (Abbate et al. 2006, Lohmander et al. 2009, Wang et al. 2009), others did not find a 
significant association (Hart and Spector 1993, Davis et al. 1990, Hochberg et al. 1995).  
The most accepted hypothesis is the mechanical effect of increased loading on the joint 
obesity has by virtue of increased body mass such that the prolonged overloading of the 
joint eventually causes cartilage destruction. The association of obesity with non weight 
bearing joint e.g. joint in the hand (Yusuf et al. 2010, Cicuttini et al. 1996), the fact that 
all obese have knee OA, gender disparity in the link between obesity and knee 
osteoarthritis (Felson et al. 1988; Davis et al.1988), stronger association of obesity with 
knee than other weight bearing joints such as the hip (Wang et al. 2009) point towards a 
more complex link of obesity on the knee joint rather than just a mechanical effect. 
Furthermore, there evidence that loss of body fat is more closely associated with 
symptomatic relief in knee OA than is loss of body weight (Toda et al. 1998). 
The definition of osteoarthritis as a joint disorder with cartilage destruction as the main 
feature has evolved to describe OA as a more systemic disorder which may affect the 
whole joint including bone, muscles, ligaments and synovium (Pottie et al. 2006). Recent 
advances in the adipose tissue physiology and the role of leptin in the development of OA 
has further strengthened the hypothesis that OA is a systemic disease with dysregulation 
of lipid homeostasis as one of the pathophysiological mechanisms leading to its 
development (Dumond et al. 2003). 
The effect of pre existing obesity on outcomes after TKR has been researched using body 
mass index as a parameter of obesity. This has been based on the hypothesis of the 
mechanical effect of obesity such that greater obesity by means of greater body mass will 
lead to greater loads on the prosthesis and poorer outcomes. The increased risk of 
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morbidity and mortality due to obesity which is defined as accumulation of body fat has 
been well documented in literature. Obesity by its effect, metabolic and systemic, puts the 
patient at a higher risk of surgical complications during operation and afterwards, during 
the recovery period. These complications during hospital stay and the early post-
operative period could in turn affect the rate and level of functional recovery especially in 
the short term. Because BMI cannot distinguish between fat and lean mass it can 
overestimate obesity in persons with greater musculature while underestimating obesity 
in persons with greater body fat for given body weight. Even if these differences in BMI 
are small, their effects in miscalculation of obesity may have a greater effect when using 
cut off points to define obesity by BMI. In TKA patients with greater musculature who 
have a history of high physical activity, BMI though high enough, will not measure 
obesity because of the high lean mass in the person. Pre operative muscle condition or 
higher muscle to fat proportion often predicts the post-operative functional ability after 
TKA (Mizner and Snyder-Mackler 2005). The higher muscle strength in these patients 
could therefore result in faster recovery in the muscle condition after surgery, lesser 
strength deficits and early return to activity. On the other hand patients with a lower BMI 
but higher fat in proportion to the body mass (for e.g. in women), would have less 
peripheral muscular support. Also higher chances of lower activity in the latter group 
would lessen the physiological stimulation for joint recovery and consequently, the 
benefit of a near normal joint mechanism. However, in this study, body fat (as total body 
fat percentage and regional fat thickness), distribution of trunkal mass in addition to BMI 
did not show an effect on the patient perceived knee and overall health. The statistically 
significant but weak association of higher BMI and WC with follow up knee and physical 
health outcomes and the trend of greater pain during weight bearing activities in patients 
with higher WHR six weeks after surgery would seem to indicate that these measures 
could have some influence on the physical outcomes. From this it can be speculated that 
total body mass and trunkal mass could by means of increased loading on the replaced 
joint affect function to some extent irrespective of muscle/fat proportion. However, future 
appropriately powered studies will need to be carried to confirm this. 
Our results obtained from BMI as a measure of obesity is consistent with other studies 
assessing patient perceived outcomes for up to one year after surgery, as has been 
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discussed in the previous section. Some deficits in function however were seen in obese 
by Stickles et al. 2001; Naylor et al. 2008; Dowsey et al. 2010, but these authors conclude 
that while there are some deficits in function in obese, the patient perceived benefit are 
high enough for obesity to not be a contraindication to surgery. While some of these 
studies did see a poorer function measured by lower function score in obese, the 
improvement in function was in obese was at par with the non-obese. Some of the poor 
function was seen in the form of poorer function score of KSS and difficulty during stair 
climbing and descending and increased use of walking aids (Stickles et al. 2001; Dowsey 
et al. 2010). The function score of KSS consists of patient answered questions regarding 
stair climbing, walking and use of walking aids. Peak forces at the knee during activities 
like stair climbing and descending are as high as 7-8 times body weight (Griffin et al. 
1998) and it is hypothesized that in activities involving higher joint forces a higher body 
mass will further add to the forces to reach a threshold inducing pain and difficulty 
performing these activities due to the greater muscular strength required. This hypothesis 
is supported by also by longer term studies assessing function by KSS scoring, Foran et 
al. (2004b) with a follow up of seven years, Jackson et al. (2009), follow up of nine years; 
Griffin et al. (1998), follow up of ten years; Foran et al. (2004a), follow up of 15 years. 
However other study results which do not support this hypothesis see no difference in 
KSS scores between obese and non-obese at five years (Amin et al. 2006; Dewan et al. 
2010) or at ten years (Spicer et al. 2001) and therefore suggestive of the alternative to the 
above hypotheses that the added body mass does not increase the load on the joint enough 
to reach the threshold for pain and discomfort or that if the load on the joint may be 
greater in the obese, the lower physical activity levels in the obese (McClung et al. 2000) 
may compensate the increased load on the joint. Consistently poorer results in morbidly 
obese seen in studies assessing morbidly obese with non-obese (Winiarsky et al. 1998; 
Amin et al. 2006; Krushell and Fingeroth 2007) has lead to these studies suggesting that 
perhaps the much higher body mass in this patient groups may not be compensated by 
lower activity levels. However, it must be noted that as opposed to McClung et al. (2000), 
Foran et al. (2004a) and Dewan et al. (2010) did not see lower physical activity levels in 
their obese groups.  
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Laboratory studies have shown increased wear and tear in polyethylene on metal 
prosthetic models with greater loads (Barbour et al., 1995; McKellop et al. 1995). 
Furthermore, the higher implant failure rates at long term in obese seen by Foran et al. 
(2004a) and Vasquez Vela Johnson et al. (2003). A review by Gillespie and Porteous 
(2007) suggests that laboratory findings may be equally relevant in a clinical setting 
where active and heavier patients compromise the longevity of the prosthetic implant.  
Despite the varied results for the effect of obesity on outcomes following TKA, majority 
of the studies conclude that the patients perceived benefits of pain relief and satisfaction 
obtained from the surgery is substantial. Even studies which did find poorer results in 
obese in some aspects of functional recovery acknowledge that the pain relief and 
satisfaction from surgery are substantial enough for obese to be equally eligible for TKA 
as non-obese. The current study measured different aspects of obesity including body fat, 
regional fat and fat distribution as obesity is not just a function of body mass and height 
and is associated with different metabolic and behavioral affection which may influence 
outcomes. The complication rates after the surgery and pre operative mental health of the 
patients in our study was not different between obese or non-obese and did not cause any 
difference in the overall outcomes between obese and non-obese. Using the standard cut 
off values of BMI and median split values for other measures (WC, WHR, BIA, US)  to 
divide the patients into groups also showed no effect of obesity on the outcomes.  
 
 
7.2.7 Section Summary 
 
This section explains the results obtained from the study and how it fits with the rationale 
behind assessment of body composition (WC, WHR, BIA, US) in addition to BMI to 
assess the effect of obesity and the various hypotheses behind any or no effect of obesity. 
This study is innovative in assessing influence of body composition (WC, WHR, BIA, 
US and BMI) on outcomes following TKA. 
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The alternate hypothesis that a higher level of obesity (higher BMI, WC, WHR, body fat 
percentage and regional fat thickness) will result in a poorer function outcome, poorer 
quality of life and higher levels of pain was rejected. The null hypothesis of this study; 
that obesity did not result in a poorer function outcome, poorer quality of life and higher 
levels of pain was accepted. 
However, the current study is underpowered as it was not able to detect statistically 
significant differences in measures which showed good effect sizes (Cohen’s d > 0.5) 
between body composition groups (WC, WHR, BIA, US and BMI). The study is 
especially low in participant number of morbidly obese patients thus not allowing for 
separate analysis. A negative correlation between BMI and WC and physical function 
levels at follow up was found but this was observed due to some extreme values at the 
higher end of the BMI/WC. A significantly greater level of pain during walking six 
weeks after surgery was observed for patients in the higher WHR group and a higher 
levels of pain in patients belonging to the higher WHR groups during stair climbing was 
also observed, though not statistically significant (Cohen’s d >0.5). No difference in the 
knee and overall health outcomes was found between obese and non-obese groups 
defined by any of the five body composition methods (WC, WHR, BIA, US and BMI) 
even after controlling for pre operative self-report function. This lack of effect on knee 
and overall health outcomes seen in the current study and previous studies suggests that 
as far as patient perceived benefits are concerned obesity (measured by WC, WHR, BIA, 
US and BMI) has little or no impact at short term (up to one year). 
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CHAPTER 8: GENERAL DISCUSSION 
 
 
8.1. Chapter overview 
 
This chapter presents the key finding of the thesis including the literature review, 
retrospective study, reliability tests for body composition measures and the prospective 
study. Comparison of the findings of the retrospective and prospective studies is then 
done to derive conclusions about the effect of BMI on patient reported outcomes after 
TKA. This is followed by a section integrating the key discussion points of the three 
chapters (literature review, retrospective study and the prospective study) to derive 
meaningful conclusions regarding the effect of obesity (measured by WC, WHR, BIA, 
US and BMI) on patient reported outcomes following. Strength and limitations of the 
studies are then discussed followed by the implications of the findings on clinical 
practice. Finally, recommendations have been made for future research. 
 
 
8.2. Key findings 
 
The key findings of the thesis are as summarized and presented in Table 32. 
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Table 32 Key findings of the thesis 
Literature review  Inconsistencies in the evidence, making it difficult to identify if an 
effect of obesity (BMI) on outcomes after TKA exists conclusively. 
These inconsistencies seem to arise primarily as a result of the 
differences between the studies with respect to classification of 
obesity based on BMI, differences in measurement of outcomes, 
differences in the baseline characteristics of the patients and length of 
follow up. 
 Inconsistent evidence of lower complication rates and poorer 
functional outcomes across BMI classification of ≥30 kg/m2. 
 More consistent evidence of higher complication rates across BMI 
classification of ≥35 kg/m2. 
 More consistent evidence of higher complication rates and poorer 
functional outcomes across BMI classification of≥40 kg/m2 (when 
compared with BMI <30 kg/m
2
). 
 Studies with longer follow up indicated poor physical function in 
patients with BMI > 30 kg/m
2
. 
 In studies finding an effect, stair climbing, stair descending and 
walking was found to be more difficult in obese (BMI>30 kg/m
2
) 
Retrospective 
study (Chapter5) 
 Overall physical health at one year after TKA worsens with 
increasing pre operative BMI (correlation analysis) 
 Knee function (OKS) and overall physical and mental health and 
complication rates are unaffected by pre operative BMI grouping 
(using BMI ≥ 30kg/m2 as cut-off) 
Reliability study  Excellent repeatability (intra-rater) of assessment of body fat 
percentage by bioelectrical impedance analysis. 
 Excellent reliability observed for both inter-rater and intra-rater 
measurements of fat thickness above knee using ultrasonography. 
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Prospective 
study (Chapter 
7) 
 Overall physical health (PCS) at one year after TKA worsens with 
increasing pre operative BMI (correlation analysis). 
 Overall physical health (PCS) at six months after TKA worsens with 
increasing pre operative waist circumference (correlation analysis). 
 Overall mental health (MCS) at six months after TKA worsens with 
increasing pre operative waist to hip ratio (correlation analysis). 
 Knee function (OKS) worsens at six months and one year after TKA 
as pre operative BMI, waist circumference increase (correlation 
analysis) 
 Knee function, overall physical and mental health were unaffected by 
grouping using WHO definitions and median split technique  
according to pre operative classification of BMI waist circumference, 
waist to hip ratio, body fat percentage and fat thickness. 
 Patients with a higher waist to hip ratio experienced greater pain than 
those with pre operative waist to hip ratio ≤ 0.95 during walking six 
weeks after TKA. 
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8.3. Comparison of retrospective study and prospective study results 
 
8.3.1. Patient baseline characteristics 
The distribution of baseline characteristics and comorbidity across BMI groups were 
similar in both studies except for a higher proportion of females and hypertensive patients 
in the obese group in the retrospective study sample. Both studies had a significantly 
higher number of type II diabetes patients in their obese group (BMI > 30kg/m
2
). The 
average age of the sample in the prospective study was higher than that of the 
retrospective study (70.6 years vs. 66.7 years).  
Mean, standard deviation, Cohen’s effect sizes and p values for outcome measures for 
both studies are shown in Table 33. 
For both studies the baseline knee function (baseline OKS) was poorer in obese. The 
difference between means of obese and non-obese for the retrospective study was 3.5 and 
that for prospective sample was 2.8, however, only the difference in the retrospective 
sample reached a statistical significance (p = 0.003) even though the effect size was 
higher for the prospective study (0.4 and 0.48), probably due to lower sample size in the 
8.1.8. Effect of body composition: Between group comparison 
prospective study which did not have sufficient power to detect a significant difference. 
Noting the differences in baseline and follow-up between the two studies, the 
retrospective study which is probably more representative of the TKA population has 
lower baseline and follow-up values while patients who consented for the prospective 
study had better function and health 
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Table 33 Mean and standard deviation (SD), Cohen’s effect size (d) and p-value for between group differences for the 
retrospective and prospective study 
 
 
 
 
 
 
 
 
 
OKS1: OKS at baseline, OKS2: OKS at six months follow up, OKS3: OKS at one year follow up 
PCS1: SF-12 physical component summary at baseline, PCS2: SF-12 physical component summary at six months follow up, PCS3: SF-12 physical component summary at one 
year follow up 
MCS1: SF-12 mental component summary at baseline, MCS2: SF-12 mental component summary at six months follow up, MCS3: SF-12 mental component summary at one year 
follow up
 
 
 
Retrospective study Prospective study 
 Obese Non-obese    Obese Non-obese   
N Mean (SD) Mean (SD) ES p-value N Mean (SD) Mean (SD) ES p-value 
OKS1 45vs. 31 16.7 (7) 19.6 (8) -0.4 0.003 38 vs.23 20 (5.9) 22.9 (6.5) -0.48 0.082 
OKS2 45vs. 31 32.6 (8.7) 31.7 (10.2) 0.09 0.711 28 vs.17 35.3 (10.9) 38.11 (7.7) -0.30 0.89 
OKS3 45vs. 31 33.6 (9.2) 33.7 (10.9) -0.01 0.664 18 vs.14 39.2 (7.9) 40.9 (5.9) -0.25 0.77 
PCS1 45vs.36 30.3 (7.4) 30.4 (7.2) -0.01 0.902 38 vs.23 30.9 (6.6) 32 (8.5) -0.15 0.573 
PCS2 45vs.36 37.1 (10) 38.3 (10) -0.12 0.581 29vs.19 44.4 (15.4) 46.8 (16) -0.16 0.95 
PCS3 45vs.36 36.8 (9.7) 41.3 (11.1) -0.44 0.091 18 vs.14 44.8 (10.6) 46.1 (7.7) -0.14 0.82 
MCS1 45vs.36 49.2 (10.8) 50.9 (12.1) -0.15 0.364 38 vs.23 50.7 (12.7) 52.7 (10.8) -0.17 0.498 
MCS2 45vs.36 52 (10.5) 51.5 (10.6) 0.05 0.805 29 vs.19 53.7 (12.9) 57.8 (12.7) -0.33 0.171 
MCS3 45vs.36 51.9 (9.4) 51.7 (9.9) 0.02 0.827 18 vs.14 55.8 (6.7) 52.5 (11.3) -0.38 0.676 
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8.3.2. Group differences across BMI ≥ 30 kg/m2 
Despite the differences in the baseline data, no group differences were found at six month 
or one year follow up (retrospective study) and at six weeks, six months and one year 
follow up (prospective study) Although no difference were found between obesity 
groups, the thesis findings do reveal a weak negative association of body mass index and 
waist circumference with patients perception of knee specific function (prospective 
study) and overall physical health (both prospective and retrospective studies). using 
absolute scores. Thus even with poorer knee function pre-operatively (retrospective 
study), the post-operative scores were not significantly different between groups. Even 
after controlling for baseline scores using change scores or ANCOVA in the studies, no 
differences were found between the BMI groups.  
 
8.3.3. Correlation Analysis 
Negative correlations between BMI and OKS i.e., worse knee function with increasing 
BMI, at six months (r = -0.337, p = 0.024) and one year (r = -0.416, p = 0.018) were 
stronger and statistically significant in the prospective study sample and not in the 
retrospective study sample (six months r = -0.039, p = 0.737 and one year r = -0.103, p 
=0.376). However, both studies revealed significant association of BMI and physical 
component of SF-12 health survey i.e., worse overall physical health as BMI increased. 
The findings of the two studies reveal that in the thesis patient samples, a BMI cut off 
value of > 30 kg/m
2 
does not indicate a poorer outcome. However, both studies detected 
some effect of BMI on the overall physical health when using BMI as a continuous 
variable. The lack of between group differences for overall physical health across a BMI 
of 30 kg/m
2
 in both studies was reflected in the lack of an obvious relationship between 
BMI of 25 and 35 kg/m
2
 in the scatter plots. But the scatter plots for these studies show 
several cases with the lowest (poorest) scores at the higher end of the BMI. Comorbidity 
which were which were significantly higher in the obese such as type II diabetes (both 
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studies) and hypertension (retrospective study) could have impacted the overall physical 
health of the higher BMI patients.  
The two studies however differed in detecting an effect of BMI on knee function by 
OKS. The scatter plots of the significant correlations for the prospective study studies 
show values scattered largely between BMI of 25 and 35 kg/m
2
with no obvious negative 
relation (Figure 10-16, Chapter 7) but a few cases with very low (poor) OKS scores and 
higher BMI. On comparing these scatter plots with that the BMI vs. OKS scatter plots 
with the retrospective data, it was observed that while low scores were also present in the 
retrospective sample, they were scattered between lower and higher BMI and were 
further away from the regression line. Moreover, the larger sample size in the 
retrospective study would make the correlation analysis less sensitive to extreme values.   
 
 
8.4. The influence of obesity measures on outcomes following TKA 
 
8.4.1. Classification using BMI ≥ 30 kg/m2 
From the current evidence and that from previous studies it can be concluded that 
defining obesity with a BMI cut off level of greater than or less than 30 kg/m
2 
is not 
definitive in detecting an effect on patient reported outcomes or complication rates within 
one year after TKA. This is also reflected in the scatter plots of BMI vs. outcomes in the 
current thesis, with outcomes widely spread across this cut off value indicating no clear 
relationship between the variables ranging from a BMI value of 25 -35 kg/m
2
. 
Inconsistencies in evidence also exists for longer follow up periods ranging from five to 
ten years suggesting that this cut off value of BMI is also not definitive in predicting an 
effect of obesity beyond one year following TKA. Beyond ten years after TKA, this 
classification does seem to predict a poor function in obese. 
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8.4.2. Classification using BMI ≥ 35 kg/m2 
Higher and more severe complication rates have been observed for patients with BMI ≥ 
35 kg/m
2
, however, patients perceived function was not different across groups based on 
this classification (Chapter 4). Correlation analysis of significant relations in the thesis  
(Chapter 5 and Chapter 7) indicated that while the relation between BMI and outcomes 
was not clear between the BMI range of 25 -35 kg/m
2
, beyond this range the negative 
relationship appeared more clearly such that the scatter plots of BMI and outcomes in the 
current thesis showed some decreasing (worsening) of outcome score after BMI of 35 
kg/m
2
, but due to the limited number of patients in the study (and therefore also a lack of 
group analysis across this BMI value) it is not possible to draw conclusions. 
 
8.4.3. Classification using BMI ≥ 40 kg/m2 
Consistency in the previous evidence of poorer outcomes in patients with a BMI greater 
than 40 kg/m
2
and a clearer negative relation for these higher but few BMI values and 
functional outcomes in the current evidence can suggest more conclusively that patients 
at such high BMI level are at a higher risk of poorer outcomes. However due to few cases 
which could be classified as morbidly obese in the studies of the current thesis, if group 
differences between BMI > 40 kg/m
2
and BMI <30kg/m
2 
as seen by previous study exist 
could not be assessed in the current thesis. Also, if a risk of poorer outcomes extends to 
patients in the BMI range of 35 – 40 kg/m2 is unclear from the current evidence.  
Therefore while a BMI greater than 30 kg/m
2
does not indicate a poor outcome, an effect 
of BMI cannot be completely negated as high values of BMI do seem to be associated 
with poorer outcomes. A specific value of these higher BMI after which a poorer 
outcomes can be expected is cannot be given from the current evidence because of the 
limited number of patients in the studies.  
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8.4.4. Body composition and outcomes 
Measuring obesity as body fat percentage or regional fat did not detect an effect of 
obesity (Chapter 7). Therefore the effect of obesity on outcomes by the association of 
body fat percentage with morbidity risk and association of a possible effect of regional fat 
thickness on morbidity, leg muscle/fat proportion and complication during recovery due 
to intra-operative difficulties was not detected. This suggests that there is no negative 
effect of obesity (BIA and US) on outcomes after TKA through these associations of 
body composition. However, anthropometric measure of waist circumference and waist 
to hip ratio were able to detect some effect of obesity on knee function. 
The negative association of BMI and waist circumference with knee function at follow up 
suggests role of body mass and upper body mass in the higher ranges on knee function 
(Chapter 7). There is also some previous evidence of a negative association of BMI with 
weight bearing activities including walking, stair climbing and descending at one year 
following TKA and also after (Chapter 4). Oxford knee scores and PCS of SF-12 have 
question related to the patient perceived difficulty with weight bearing activities such as 
stair climbing and walking and it is known that during these weight bearing activities, 
peak stresses on the joint are high. Therefore, an effect of increased mass by additional 
stress on the joint during these activities could be possible such that a greater total body 
mass and/or trunk mass by increasing the mechanical load on the joint could result in 
producing stresses over the joint which reach a threshold to cause pain.  Moreover, 
differences between WHR groups for pain during weight bearing activities of walking, 
stairs climbing and descending six weeks after surgery (effect sizes of 0.59, 0.64 and 
0.36) suggest that android distribution of obesity can lead to greater pain during weight 
bearing activities after TKA. These findings suggest an impact of obesity in terms body 
mass and/or upper body mass during on weight bearing activities.  
Negative relationships between waist circumference and six months PCS and waist to hip 
ratio and MCS of SF-12 at six months was seen in the prospective study though 
significant, were very weak and due to two cases with very high PCS/MCS values of 99 
on the lower waist circumference/waist to hip ratio group pulling the relationship towards 
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a significant level and therefore no meaningful conclusion. This again reflects the 
limitation of the study with respect to a small sample size.  
As discussed earlier in the thesis (Chapter 3 and Chapter 7), the association of obesity 
with the joint is complex and mechanism by which it can have a negative effect on the 
joint is unclear. Obesity, in addition being a function of body mass relative to height is 
also associated metabolic and behavioral patterns which could result in poor function. 
However, obesity parameters other than body mass in this thesis (which were body fat 
percentage and regional fat thickness) could not identify any negative outcomes for 
obese. The lack of differences between groups on analyses of obesity using BMI 
classification of obesity indicates that the cut off value of 30 kg/m
2
 though universally 
accepted as indicative for health risks associated with obesity, this cut off value is not 
indicative of good or poorer outcomes following TKA. Groups based on waist 
circumference, waist to hip ratio, percentage body fat and regional fat thickness in 
addition to BMI were also not indicative of good or poorer outcomes following TKA.  
Fig. 16 shows a flow diagram representing the evidence from the current thesis and 
previous studies on the effects of BMI on outcomes after TKA.  
Flow diagram summarizing the possible effects of obesity gathered from literature is 
shown in Figure 17.
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Knee function Overall physical function
1
year
Comparable
Poorer in 
obese
Stickles et al (WOMAC)Δ [30]
Current thesis (OKS)A+Δ [30]
Nunez et al (WOMAC)Δ  [35]
Dowsey et al (KSS)A+Δ [30]
Rajgopal et al (WOMAC)A [40]
Deshmukh et al (KSS)
Stickles et al (WOMAC)
Thesis, prospective study 
(OKS)
Amin et al (KSS)A [30]
Dewan et al (KSS)A [40]
Hawker et al (WOMAC 
function)
Spicer et al (KSS)A+Δ [30]
Griffin et al (HSS, KSSknee)A 
[30]
Mont et al (KSS)A [40]
Jackson et al (HSS)A+Δ [30]
Griffin et al (KSS function)A 
[30]
Foran et al (KSS)A [30]
Krushell et al (KSS)A+Δ [40]
2-5
years
7-15
years
Comparable
Poorer in 
obese
Stickles (PCS,SF36)Δ[30]
Current thesis (PCS, SF12)A+Δ 
[30]
Deshmukh et al (NHP)
Steven-Lasley et al (SF36)
Dowsey et al (PCS, SF12)A 
[30]
Stickles et al (PCS, SF36)
Current thesis (PCS, SF12) 
Foran et al (KSS)A+Δ [30]
Winiarsky et al (KSS)A [40]
Amin et al (KSS)A [40]
 
BMI cut off values for classification are indicated in the square brackets. A: Absolute score, Δ: change score. Areas shaded in grey represent analyses with BMI 
as a continuous variable. 
Figure 16 Flowchart representing the evidence on the effect of BMI on knee specific and overall physical function outcome 
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Figure 17 Possible effects of obesity on physical function after TKA 
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8.5. Strengths and limitations of the study 
 
8.5.1. Strengths 
 
The effect of obesity (assessed by BMI) on TKA outcomes has been researched in 
prospective studies, retrospective studies, case control studies. Considering the 
inconsistent findings of the effect of BMI on outcomes following TKA from the literature 
review and the retrospective study of the thesis and the previously discussed limitations 
of BMI as a method of measuring obesity, the prospective study of the thesis is the first to 
assess the influence of different markers of obesity (waist circumference, waist to hip 
ratio, BIA and ultrasonography) in addition to BMI on the outcomes following TKA. The 
findings of the thesis thus provide an in depth evaluation of the effects of obesity on 
outcomes following TKA. 
The chosen body composition methods in this thesis (waist circumference, waist to hip 
ratio, BIA, ultrasonography and BMI) are clinically viable methods which assess 
different aspects of obesity allowing an exploration of the effects of true obesity on the 
outcomes after TKA.  
Attempts were made to maintain sample homogeneity with recruitment of patients 
undergoing surgery at a single institution (for both studies), under a single surgeon 
(retrospective study) with identical post-operative care. 
Previous research in the area have mostly used one method of evaluation, either as group 
differences between BMI groups or BMI as continuous data. The research question of 
whether obesity affects outcomes following TKA has been addressed in this thesis 
employing both an exploratory (correlations) and group comparison method. This has 
been done by using body composition measurements (waist circumference, waist to hip 
ratio, BIA, ultrasonography and BMI) as continuous variables as well as using the 
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standardized cut off values of BMI and median values for other methods to divide 
participants into obese and non obese groups.  
 
8.5.2. Limitations 
Study design 
When compared to randomized controlled trials, prospective and retrospective cohorts 
include a broader range of patients and thus deemed more representative of clinical 
practice (Ligthelm et al. 2007). However, because of non randomized nature, 
observational studies have an increased likelihood of bias (Grimes and Schulz 2002, 
Thadhani and Tonelli 2006). For example, from the differences in the values of the mean 
score between the prospective and the retrospective studies it is clear that patients who 
participate in the prospective study have better health and knee function compared as 
opposed to the retrospective study where patients were not active participants and data 
was derived from hospital records. This could be suggestive of a more representative 
sample in retrospective compared to the prospective study. 
Participant recruitment was done from a single institution for both studies and from the 
patients list of a single surgeon for the retrospective study to allow for some homogeneity 
in the sample however, this also worked to limit the number of participants available for 
assessment within the given time frame and also limits the generalizability of the results. 
Like previous studies, the research question for the current thesis addresses the effect of 
pre operative obesity status on the outcomes after surgery and therefore involved the 
assessment of obesity pre operatively which was not followed up post operatively. 
Previous studies have reported weight gain after TKA (discussed in section 4.6.2, chapter 
4) and lack of post operative body composition data does not allow evaluation of any 
change in any of the body composition markers and if an interaction exists between post 
operative or change in body composition and outcomes in this thesis.  
The section of the thesis addressing the practical considerations for measurement of body 
composition (section 7.2.3, chapter 7) highlights the difficulty in maintaining the 
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standardized hydration conditions for BIA and while assessment times were adjusted to 
accommodate participant convenience and participants were reminded of the conditions 
to follow prior to the assessment, if adequate hydration condition was maintained for all 
participants cannot be ascertained. More accurate methods of measurement of body 
composition (described in section 3.5) which could measure body composition more 
accurately and in more detail were not used due to safety (radiation exposure) and 
feasibility issues.  
The thesis aimed to assess self report outcomes to evaluate the patient’s perception of 
their outcome which is an important determinant of the success or failure of an elective 
procedure. Therefore measurement of patient physical performance, objective 
assessments such as measurement of muscle strength and range of motion or a 
combination of outcomes have not been employed in the two studies and limit the studies 
in the evaluation of an objective or a ‘technical’ outcome of TKA. 
The prospective study was not powered to detect a statistically significant difference 
between the WHR groups for pain while stair climbing. This difference had an effect size 
of 0.64. Moreover, the difference of 1.6 points on the VAS scale may be also regarded a 
clinically significant. To detect an effect size of 0.64 in this outcome, appropriately 
powered studies should have at least 39 patients in each group to achieve a power of 80% 
at 5% level of significance. The limited number of participants; especially at follow up 
the studies in this thesis render it underpowered. Meaningful statistical analysis of the 
morbidly obese group separately was also not possible with very few numbers of 
morbidly obese patients in the retrospective study (n = 19) and prospective study (n = 4). 
Confounding 
Confounding is an issue of alternative explanation to the effect on outcome. While 
standard midline incision is used for all standard TKA procedures, the type of prosthesis 
varied. The samples in the two studies were also not restricted to patients with a primary 
diagnosis of OA with a few rheumatoid arthritis patients in both studies (11 in 
retrospective study and 4 in the prospective study). 
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Possible influence of the pre-operative score on the post-operative score was controlled in 
both studies using ANCOVA in the prospective study and analysis of change score in 
addition to absolute score in the retrospective study. 
Measurement of the impact of other possible confounding factors such as physical 
activity levels, weight change after surgery, effect of contralateral and other joint disease 
and personal factors affecting recovery that have been discussed in the previous section 
(section 4.6, chapter 4) were not recorded in  this PhD.  
Age group (mean 70.6 ± 8) in the study reflects the national average age of those 
undergoing primary TKA reported in Scottish Arthroplasty Register report for the year 
2009. According to the national trend, a larger proportion (approximately 60%) of 
primary TKA patients is female. The prospective study had a slightly lower percentage of 
females (54%) in the sample and thus a more equitable distribution of gender. While the 
literature is not consistent with effect of age and gender on outcomes, there is some 
evidence that older age is associated with worse self-report function particularly in 
women (Santaguida et al. 2008, Cushnaghan et al. 2008). Lack of an adequate sample 
size did not allow for age or gender to be used as a covariate in the studies to control for 
the influence of these factors. 
The number of obese was larger than non-obese in the studies reflecting the finding that 
population of obese in TKA population is high (Fehring et al. 2007). The disparity in 
numbers between BMI groups was not too high to not allow meaningful analysis. When 
grouping was done according to previously used classification of waist circumference, 
waist to hip ratio and body fat percentage, a very high proportion of patients were in the 
‘obese’ group and the difference between the group numbers was too high for any 
meaningful statistical analysis and thus we used a median split techniques for these 
measures. Previously used classifications of these measures would be possible with a 
larger sample size. 
If  more severe comorbidity observed in a few cases of high BMI range (BMI >40 kg/m
2
) 
had an effect on the outcomes was difficult to judge from the studies which further 
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highlights the limitation of our study in lacking a separate analysis of the morbidly obese 
groups.  
Bias: Response to follow up 
For the prospective study, while the six week outcomes had a high response rate, the 
drop- out rates were high for six month and one year follow up (29.7 % dropout & 50 % 
dropout respectively). This loss to follow up can be a limiting factor resulting in a 
response bias as patients who do not response to health questionnaire are often those who 
have a poorer function outcome (Kim et al. 2004). Moreover, the pain sores were not 
available for any patient at six month or one year as these are not collected for the 
hospital database. Since pain may improve even after one year following surgery, follow 
up pain measurement at six weeks at best can offer an estimate of the rate of recovery 
from pain and not really the comparison of improvement in pain.  
Pain relief is heavily dependent on the patient’s use of pain medication and while the 
prescription of pain medication is standard at the time of discharge, the consumption is 
controlled by the patient. This study like others did not record pain medication. 
 
 
8.6. Implications for practice 
 
The current thesis questions the method of defining obesity for total knee replacement 
patients in clinical practice and research. The findings of the thesis show that categorizing 
patients as obese using a BMI cut off of 30 kg/m2 does not reveal a poorer outcomes with 
respect to post-operative complications, level of knee function and overall physical and 
mental health and pain in the early post-operative period. no difference between groups 
were found either on using other body composition methods which are closely related to 
morbidity in addition to BMI in the latter study of the thesis. The obesity categories for 
these body composition measures in the thesis were based on a median split and whether 
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known classifications for some of these measures (waist circumference, waist to hip ratio, 
body fat percentage) based on morbidity risk would find a difference in outcomes is not 
known from this thesis. Although no difference were found between obesity groups, the 
thesis findings do reveal a weak negative association of body mass index and waist 
circumference with patients perception of knee specific function (prospective study) and 
overall physical health (both prospective and retrospective studies). Another finding of 
the thesis was that patients with higher (greater than 0.95) waist to hip ratio indicated 
greater pain on weight bearing activities (walking and stair climbing) in the early post-
operative period.  
The obese patients (according to BMI) in the thesis samples had higher proportions of 
hypertension and diabetes which could have impacted the relation between obesity and 
overall physical function and thus indicative of an effect of obesity on function through a 
metabolic pattern. The lack of group difference but a negative association with physical 
function outcome using continuous variables in this thesis suggests that while outcomes 
are similar across a cut-off point of 30 kg/m
2
, higher BMI through a variety of 
mechanisms affect outcomes at short term. Although at what value of BMI or other body 
composition measures outcomes begin to be affected cannot be known through the results 
of the thesis. Moreover, since obese patients perspective of function improved as 
substantially from the per operative to post-operative stage as that in non-obese, TKA is 
an effective procedure for irrespective of obesity, rationing of TKA on the basis of BMI 
alone is not justified. However, keeping in mind the level of obesity and the associated 
comorbidity in the individual patients; carefully considered medical counseling, 
encouragement to lose weight, preferably as early as possible during the course of the 
disease and medical or surgical interventions for highly obese patients would be 
recommended in clinical practice.  
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8.7. Future research recommendations 
 
The current thesis (prospective study) is the first to explore the effect different definitions 
of obesity on outcomes following TKA. Both studies in the thesis did not see striking 
effect of obesity on the self-report outcomes; however, the studies were restricted in their 
sample sizes therefore not adequately powered to demonstrate the influence of body 
composition on TKA outcomes. This study can be considered as a pilot based on which 
future studies on body composition and TKA outcomes can be developed. Particularly, 
analysis which includes a larger number of morbidly obese patients is important as the 
correlation analysis in this study and previous gives suggests poor outcomes in highly 
obese patients. A larger sample size would also allow for inclusion of confounding 
factors discussed in the earlier sections as covariates in analyses.  
The current study has defined obesity in different ways other than just a state of increased 
body mass. The measures used in the study have been chosen such that their applicability 
in a in a clinical setting is practical and feasible. There are several options for defining 
obesity which can be used by future studies and though there is not a ‘gold standard’ 
method more accurate methods for determining fat mass that that used in this study such 
as DEXA scans can be added for more accurately defining adipose levels in future 
research. Also, in future studies with larger samples it would be feasible to group patients 
using these body composition measures according to classifications based on morbidity 
risk instead of median split technique to identify if there is a difference in outcomes.  
Patient perception of the benefits of the surgery is important in assessing the success of 
an elective procedure and the current study has focused on the effect on patient reported 
outcome measure. Woolhead et al. (2005) in a qualitative study identified that patients 
expression of outcomes through formal questioning similar to that when using 
questionnaires indicates a keenness of the patients to state that the outcomes of their TKA 
was good. But when given time to describe their outcomes patients acknowledged 
continued problems with pain and mobility and tried to rationalize these continued 
difficulties and tend to take responsibility for them.  It is also recognized that patient 
235 
 
perceived outcomes after arthroplasty is not always congruent with that of a health care 
professional (Leiberman et al.1996). Like most studies, the use of the chosen outcomes 
measures in this study does not address these complex issues surrounding the 
improvement after surgery. A large scope of outcomes definitions and measurements 
which could be used in combination is available for future research assessing effect of 
body composition.   
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CHAPTER 9: THESIS CONCLUSION 
 
 
The literature review of the effect of BMI on TKA outcomes revealed inconsistencies in 
the evidence due the differences classification of obesity based on BMI, differences in 
measurement of outcomes, differences in the baseline characteristics of the patients and 
length of follow up in previous studies. Conflicting results appear primarily among 
studies assessing an effect of BMI on outcomes using a BMI classification of BMI > 30 
kg/m2 with many studies not finding a difference across this BMI value. Both the 
retrospective study and the prospective study reveal no group differences and no 
definitive negative association between the BMI ranges of 25-35 kg/m2. These studies 
thus give evidence that group division of obesity based on the WHO classification of 
greater than or less than 30 kg/m
2
 cannot identify an effect of obesity on outcomes. More 
consistent results in pervious evidence is seen for the morbidly obese group with a BMI 
cut off of > 40 kg/m2. Also the negative association seen with BMI as a continuous 
variable on physical function is clearer only at higher BMI ranges, could indicate an 
effect in the higher ranges of BMI. 
Body composition measures of body fat percentage and regional fat thickness did not find 
any effect of obesity on outcomes in this thesis. Waist circumference and waist to hip 
ratio (only pain during walking after TKA) did find some effect of obesity similar that 
that found by BMI. From this thesis, it can be concluded that anthropometric measures of 
BMI and waist circumference and to some extent waist to hip ratio are best to determine 
any effect of obesity.  
Due to the limited number of participants, at which high value of BMI a definite negative 
outcome can be seen, cannot be derived from the results of this thesis. The limited 
number of participants in both studies of the thesis renders it underpowered and 
adequately powered future studies could give more definitive answers to the effect of 
body composition on outcomes following TKA. 
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APPENDIX 
 
 
Appendix A: Retrospective Study Normality Tests 
 
Table A1: Normality Test for OKS Absolute scores 
BMI group of the patient Shapiro-Wilk 
Statistic df Sig. 
OKS pre using 
new scoring 
non obese BMI 
< 30 
.976 31 .691 
obese BMI ≥ 30 .965 45 .184 
OKS 6mo new 
scoring 
non obese BMI 
< 30 
.951 31 .168 
obese BMI ≥ 30 .920 45 .004 
OKS 1year new 
scoring 
non obese BMI 
< 30 
.913 31 .015 
obese BMI ≥ 30 .907 45 .002 
 
Table A2: Normality Test for OKS Change scores 
BMI group of the patient Shapiro-Wilk 
Statistic df Sig. 
oks 6 mo - oks 
pre 
non obese BMI 
< 30 
.978 31 .767 
obese BMI ≥ 30 .982 45 .712 
oks 1 yr - oks 
pre 
non obese BMI 
< 30 
.971 31 .536 
obese BMI ≥ 30 .977 45 .490 
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Table A3: Normality Test for PCS (SF12) Absolute and Change scores 
BMI group of the patient Shapiro-Wilk 
Statistic Df Sig. 
pre operative 
physical 
component sf12 
non obese BMI 
< 30 
.896 36 .003 
obese BMI ≥ 30 .984 45 .793 
post operative 
physical 
component sf12 
non obese BMI 
< 30 
.944 36 .066 
obese BMI ≥ 30 .963 45 .153 
follow up 
physical 
component sf12 
non obese BMI 
< 30 
.918 36 .011 
obese BMI ≥ 30 .968 45 .236 
pcs 6mo - pre non obese BMI 
< 30 
.957 36 .169 
obese BMI ≥ 30 .971 45 .312 
pcs 1 yr - pre non obese BMI 
< 30 
.953 36 .133 
obese BMI ≥ 30 .974 45 .400 
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Table A4: Normality Test for MCS (SF12) Absolute and Change scores 
BMI group of the patient Shapiro-Wilk 
Statistic Df Sig. 
pre operative 
mental 
component score 
of SF12  
non obese BMI 
< 30 
.915 36 .009 
obese BMI ≥ 30 .907 45 .002 
post operative 
mental 
component score 
of SF12  
non obese BMI 
< 30 
.874 36 .001 
obese BMI ≥ 30 .876 45 .000 
follow up mental 
component score 
of SF12 
non obese BMI 
< 30 
.868 36 .001 
obese BMI ≥ 30 .953 45 .066 
mcs 6 mo - pre non obese BMI 
< 30 
.961 36 .225 
obese BMI ≥ 30 .964 45 .172 
mcs 1 year - pre non obese BMI 
< 30 
.959 36 .198 
obese BMI ≥ 30 .960 45 .123 
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Appendix B: Prospective Study Normality Tests 
Table A1: Normality test for all follow up data (prospective) 
Outcome measure Shapiro-Wilk Normality test 
Test statistic df Significance 
OKS pre op 0.98 61 .305 
OKS 6 weeks 0.97 61 .217 
OKS 6 months 0.89 45 .000 
OKS 1 year 0.9 32 .010 
PCS pre op 0.96 61 .070 
PCS 6 weeks 0.97 60 .119 
PCS 6 months 0.85 48 .000 
PCS 1 year 0.92 32 .021 
MCS pre op 0.93 61 .001 
MCS 6 weeks 0.87 60 .000 
MCS 6 months 0.83 48 .000 
MCS 1 year 0.80 32 .000 
Pain at rest pre op 0.96 59 .041 
Pain at rest 6 weeks 0.81 59 .000 
Pain walking pre op 0.92 59 .001 
Pain walking 6 weeks 0.90 59 .000 
Pain stair climb pre op 0.91 59 .000 
Pain stair climb 6 weeks 0.87 59 .000 
Pain stair descend pre op 0.88 59 .000 
Pain stair descend 6 
weeks 
0.90 59 .000 
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Table A2: Normality tests for BMI groups  
 
BMI - OKS 
 
BMI group 
Shapiro-Wilk 
 Statistic Df Sig. 
OKS pre op non obese = BMI< 30 .970 23 .678 
obese = BMI ≥ 30 .972 38 .452 
OKS 6 weeks post op non obese = BMI< 30 .963 23 .528 
obese = BMI ≥ 30 .968 38 .353 
OKS 6 months post op non obese = BMI<30 .903 17 .075 
obese = BMI ≥ 30 .873 28 .003 
OKS 1 year post op non obese = BMI<30 .884 14 .067 
obese = BMI ≥ 30 .914 18 .102 
 
 
BMI- SF12 
 
BMI group 
Shapiro-Wilk 
 Statistic df Sig. 
PCS pre op non obese = BMI<30 .928 23 .100 
obese = BMI ≥ 30 .970 38 .397 
PCS 6 weeks post op non obese = BMI<30 .943 23 .204 
obese = BMI ≥ 30 .966 37 .305 
PCS 6 months post op non obese = BMI<30 .819 19 .002 
obese = BMI ≥ 30 .862 29 .001 
PCS 1 year post op non obese = BMI<30 .896 14 .098 
obese = BMI ≥ 30 .903 18 .066 
MCS pre op non obese = BMI<30 .929 23 .102 
obese = BMI ≥ 30 .914 38 .006 
MCS 6 weeks post op non obese = BMI<30 .874 23 .008 
obese = BMI ≥ 30 .853 37 .000 
MCS 6 months post op non obese = BMI<30 .790 19 .001 
obese = BMI ≥ 30 .844 29 .001 
MCS 1 year post op non obese = BMI<30 .805 14 .006 
obese = BMI ≥ 30 .796 18 .001 
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BMI – Pain scores 
 
BMI group 
Shapiro-Wilk 
 Statistic df Sig. 
pain rest pre op non obese = BMI<30 .956 23 .382 
obese = BMI ≥ 30 .926 36 .019 
pain rest 6 week post op non obese = BMI<30 .881 22 .013 
obese = BMI ≥ 30 .771 37 .000 
pain walking pre op non obese = BMI<30 .956 23 .393 
obese = BMI ≥ 30 .893 36 .002 
pain walking 6 week post op non obese = BMI<30 .897 22 .026 
obese = BMI ≥ 30 .891 37 .002 
pain stair climb pre op non obese = BMI<30 .923 23 .078 
obese = BMI ≥ 30 .905 36 .005 
pain stair climb 6 week post 
op 
non obese = BMI<30 .821 22 .001 
obese = BMI ≥ 30 .889 37 .001 
pain stair descend pre op non obese = BMI<30 .825 22 .001 
obese = BMI ≥ 30 .910 33 .010 
pain stair descend 6 week 
post op 
non obese = BMI<30 .891 22 .019 
obese = BMI ≥ 30 .899 36 .003 
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Table A3: Normality test for WC groups 
 
WC – OKS 
 
WC median split groups 
Shapiro-Wilk 
 Statistic df Sig. 
OKS pre op WC ≤ 41.5 .977 31 .731 
WC > 41.5 .968 30 .493 
OKS 6 weeks post op WC ≤ 41.5 .967 31 .446 
WC > 41.5 .961 30 .327 
OKS 6 months post op WC ≤ 41.5 .919 23 .063 
WC > 41.5 .892 22 .021 
OKS 1 year post op WC ≤ 41.5 .876 19 .018 
WC > 41.5 .947 13 .555 
 
 
WC – SF12 
 
WC median split groups 
Shapiro-Wilk 
 Statistic df Sig. 
PCS pre op WC ≤ 41.5 .962 31 .320 
WC > 41.5 .957 30 .253 
PCS 6 weeks post op WC ≤ 41.5 .949 31 .143 
WC > 41.5 .960 29 .329 
PCS 6 months post op WC ≤ 41.5 .785 26 .000 
WC > 41.5 .919 22 .072 
PCS 1 year post op WC ≤ 41.5 .886 19 .028 
WC > 41.5 .925 13 .289 
MCS pre op WC ≤ 41.5 .879 31 .002 
WC > 41.5 .934 30 .064 
MCS 6 weeks post op WC ≤ 41.5 .874 31 .002 
WC > 41.5 .838 29 .000 
MCS 6 months post op WC ≤ 41.5 .786 26 .000 
WC > 41.5 .839 22 .002 
MCS 1 year post op WC ≤ 41.5 .796 19 .001 
WC > 41.5 .888 13 .093 
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WC- Pain Scores  
 
WC median split groups 
Shapiro-Wilk 
 Statistic df Sig. 
pain rest pre op WC ≤ 41.5 .949 31 .149 
WC > 41.5 .895 28 .009 
pain rest 6 week post op WC ≤ 41.5 .873 29 .002 
WC > 41.5 .780 30 .000 
pain walking pre op WC ≤ 41.5 .926 31 .033 
WC > 41.5 .900 28 .011 
pain walking 6 week post op WC ≤ 41.5 .886 29 .005 
WC > 41.5 .902 30 .009 
pain stair climb pre op WC ≤ 41.5 .919 31 .022 
WC > 41.5 .900 28 .011 
pain stair climb 6 week post 
op 
WC ≤ 41.5 .793 29 .000 
WC > 41.5 .914 30 .018 
pain stair descend pre op WC ≤ 41.5 .862 30 .001 
WC > 41.5 .902 25 .021 
pain stair descend 6 week 
post op 
WC ≤ 41.5 .863 29 .001 
WC > 41.5 .920 29 .030 
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Table A4: Normality test for WHR groups 
WHR – OKS 
 
 
WH median split groups 
Shapiro-Wilk 
 Statistic Df Sig. 
OKS pre op WH ≤ 0.95 .975 32 .647 
WH > 0.95 .976 29 .733 
OKS 6 weeks post op WH ≤ 0.95 .972 32 .554 
WH > 0.95 .965 29 .438 
OKS 6 months post op WH ≤ 0.95 .912 21 .059 
WH > 0.95 .868 24 .005 
OKS 1 year post op WH ≤ 0.95 .912 16 .127 
WH > 0.95 .871 16 .028 
 
 
WHR – SF12 
 
 
WH median split groups 
Shapiro-Wilk 
 Statistic df Sig. 
PCS pre op WH ≤ 0.95 .972 32 .564 
WH > 0.95 .922 29 .034 
PCS 6 weeks post op WH ≤ 0.95 .933 31 .053 
WH > 0.95 .970 29 .554 
PCS 6 months post op WH ≤ 0.95 .747 24 .000 
WH > 0.95 .882 24 .009 
PCS 1 year post op WH ≤ 0.95 .901 16 .083 
WH > 0.95 .923 16 .189 
MCS pre op WH ≤ 0.95 .907 32 .009 
WH > 0.95 .909 29 .016 
MCS 6 weeks post op WH ≤ 0.95 .854 31 .001 
WH > 0.95 .825 29 .000 
MCS 6 months post op WH ≤ 0.95 .791 24 .000 
WH > 0.95 .821 24 .001 
MCS 1 year post op WH ≤ 0.95 .828 16 .006 
WH > 0.95 .739 16 .000 
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WHR – Pain Scores 
 
WH median split groups 
Shapiro-Wilk 
 Statistic df Sig. 
pain rest pre op WH ≤ 0.95 .965 31 .393 
WH > 0.95 .927 28 .053 
pain rest 6 week post op WH ≤ 0.95 .822 30 .000 
WH > 0.95 .831 29 .000 
pain walking pre op WH ≤ 0.95 .927 31 .036 
WH > 0.95 .894 28 .008 
pain walking 6 week post op WH ≤ 0.95 .824 30 .000 
WH > 0.95 .946 29 .148 
pain stair climb pre op WH ≤ 0.95 .898 31 .006 
WH > 0.95 .913 28 .023 
pain stair climb 6 week post 
op 
WH ≤ 0.95 .856 30 .001 
WH > 0.95 .904 29 .012 
pain stair descend pre op WH ≤ 0.95 .884 30 .003 
WH > 0.95 .905 25 .023 
pain stair descend 6 week 
post op 
WH ≤ 0.95 .872 30 .002 
WH > 0.95 .885 28 .005 
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Table A5: Normality test for BF% groups 
 
BF% - OKS 
 Body fat median split 
groups 
Shapiro-Wilk 
 Statistic Df Sig. 
OKS pre op BF ≤ 39.9 .970 30 .539 
BF > 39.9 .949 30 .164 
OKS 6 weeks post op BF ≤ 39.9 .960 30 .303 
BF > 39.9 .982 30 .885 
OKS 6 months post op BF ≤ 39.9 .863 21 .007 
BF > 39.9 .896 23 .021 
OKS 1 year post op BF ≤ 39.9 .832 13 .017 
BF > 39.9 .930 19 .171 
 
 
BF% - SF12 
 Body fat median split 
groups 
Shapiro-Wilk 
 Statistic df Sig. 
PCS pre op BF ≤ 39.9 .938 30 .078 
BF > 39.9 .955 30 .227 
PCS 6 weeks post op BF ≤ 39.9 .953 30 .199 
BF > 39.9 .968 29 .499 
PCS 6 months post op BF ≤ 39.9 .886 22 .015 
BF > 39.9 .819 25 .000 
PCS 1 year post op BF ≤ 39.9 .855 13 .033 
BF > 39.9 .938 19 .246 
MCS pre op BF ≤ 39.9 .909 30 .014 
BF > 39.9 .922 30 .030 
MCS 6 weeks post op BF ≤ 39.9 .929 30 .045 
BF > 39.9 .820 29 .000 
MCS 6 months post op BF ≤ 39.9 .828 22 .001 
BF > 39.9 .796 25 .000 
MCS 1 year post op BF ≤ 39.9 .743 13 .002 
BF > 39.9 .809 19 .002 
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BF% - Pain Scores  
 Body fat median split 
groups 
Shapiro-Wilk 
 Statistic df Sig. 
pain rest pre op BF ≤ 39.9 .939 29 .093 
BF > 39.9 .944 29 .124 
pain rest 6 week post op BF ≤ 39.9 .855 29 .001 
BF > 39.9 .730 29 .000 
pain walking pre op BF ≤ 39.9 .900 29 .010 
BF > 39.9 .938 29 .091 
pain walking 6 week post op BF ≤ 39.9 .897 29 .008 
BF > 39.9 .860 29 .001 
pain stair climb pre op BF ≤ 39.9 .925 29 .040 
BF > 39.9 .893 29 .007 
pain stair climb 6 week post 
op 
BF ≤ 39.9 .880 29 .003 
BF > 39.9 .867 29 .002 
pain stair descend pre op BF ≤ 39.9 .817 27 .000 
BF > 39.9 .912 27 .025 
pain stair descend 6 week 
post op 
BF ≤ 39.9 .898 28 .011 
BF > 39.9 .889 29 .005 
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Table A6: Normality test for US groups 
 
US - OKS 
 
US1mediansplit 
Shapiro-Wilk 
 Statistic Df Sig. 
OKS pre op 1.00 .968 30 .483 
2.00 .974 31 .640 
OKS 6 weeks post op 1.00 .963 30 .360 
2.00 .973 31 .619 
OKS 6 months post op 1.00 .819 21 .001 
2.00 .911 24 .037 
OKS 1 year post op 1.00 .802 15 .004 
2.00 .934 17 .250 
 
 
US - SF12 
 
US1mediansplit 
Shapiro-Wilk 
 Statistic df Sig. 
PCS pre op 1.00 .957 30 .254 
2.00 .957 31 .248 
PCS 6 weeks post op 1.00 .951 30 .185 
2.00 .950 30 .171 
PCS 6 months post op 1.00 .866 23 .005 
2.00 .750 25 .000 
PCS 1 year post op 1.00 .838 15 .012 
2.00 .956 17 .559 
MCS pre op 1.00 .890 30 .005 
2.00 .934 31 .057 
MCS 6 weeks post op 1.00 .883 30 .003 
2.00 .864 30 .001 
MCS 6 months post op 1.00 .815 23 .001 
2.00 .825 25 .001 
MCS 1 year post op 1.00 .695 15 .000 
2.00 .845 17 .009 
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US – Pain scores 
 
US1mediansplit 
Shapiro-Wilk 
 Statistic df Sig. 
pain rest pre op 1.00 .928 29 .050 
2.00 .959 30 .297 
pain rest 6 week post op 1.00 .825 29 .000 
2.00 .786 30 .000 
pain walking pre op 1.00 .927 29 .047 
2.00 .907 30 .013 
pain walking 6 week post op 1.00 .910 29 .017 
2.00 .852 30 .001 
pain stair climb pre op 1.00 .932 29 .060 
2.00 .886 30 .004 
pain stair climb 6 week post 
op 
1.00 .867 29 .002 
2.00 .862 30 .001 
pain stair descend pre op 1.00 .836 26 .001 
2.00 .915 29 .023 
pain stair descend 6 week 
post op 
1.00 .874 28 .003 
2.00 .903 30 .010 
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Appendix C: Participant Information Sheets and Consent Form 
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Appendix E: Copy of Retrospective review paper accepted for publication 
 
 
